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Abstract: The Chinese medicinal plant Artemisia annua L. (Qinghao) is the only known 
source of the sesquiterpene artemisinin (Qinghaosu), which is used in the treatment of 
malaria. Artemisinin is a highly oxygenated sesquiterpene, containing a unique 1,2,4-
trioxane ring structure, which is responsible for the antimalarial activity of this natural 
product. The phytochemistry of A. annua is dominated by both sesquiterpenoids and 
flavonoids, as is the case for many other plants in the Asteraceae family. However, A. 
annua is distinguished from the other members of the family both by the very large number 
of natural products which have been characterised to date (almost six hundred in total, 
including around fifty amorphane and cadinane sesquiterpenes), and by the highly 
oxygenated nature of many of the terpenoidal secondary metabolites. In addition, this 
species also contains an unusually large number of terpene allylic hydroperoxides and 
endoperoxides. This observation forms the basis of a proposal that the biogenesis of many 
of the highly oxygenated terpene metabolites from A. annua – including artemisinin itself – 
may proceed by spontaneous oxidation reactions of terpene precursors, which involve these 
highly reactive allyllic hydroperoxides as intermediates. Although several studies of the 
biosynthesis of artemisinin have been reported in the literature from the 1980s and early 
1990s, the collective results from these studies were rather confusing because they implied 
that an unfeasibly large number of different sesquiterpenes could all function as direct 
precursors to artemisinin (and some of the experiments also appeared to contradict one 
another). As a result, the complete biosynthetic pathway to artemisinin could not be stated 
conclusively at the time. Fortunately, studies which have been published in the last decade 
are now providing a clearer picture of the biosynthetic pathways in A. annua. By 
synthesising some of the sesquiterpene natural products which have been proposed as 
biogenetic precursors to artemisinin in such a way that they incorporate a stable isotopic 
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label, and then feeding these precursors to intact A. annua plants, it has now been possible 
to demonstrate that dihydroartemisinic acid is a late-stage precursor to artemisinin and that 
the closely related secondary metabolite, artemisinic acid, is not (this approach differs from 
all the previous studies, which used radio-isotopically labelled precursors that were fed to a 
plant homogenate or a cell-free preparation). Quite remarkably, feeding experiments with 
labeled dihydroartemisinic acid and artemisinic acid have resulted in incorporation of label 
into roughly half of all the amorphane and cadinane sesquiterpenes which were already 
known from phytochemical studies of A. annua. These findings strongly support the 
hypothesis that many of the highly oxygenated sesquiterpenoids from this species arise by 
oxidation reactions involving allylic hydroperoxides, which seem to be such a defining 
feature of the chemistry of A. annua. In the particular case of artemisinin, these in vivo 
results are also supported by in vitro studies, demonstrating explicitly that the biosynthesis 
of artemisinin proceeds via the tertiary allylic hydroperoxide, which is derived from 
oxidation of dihydroartemisinic acid. There is some evidence that the autoxidation of 
dihydroartemisinic acid to this tertiary allylic hydroperoxide is a non-enzymatic process 
within the plant, requiring only the presence of light; and, furthermore, that the series of 
spontaneous rearrangement reactions which then convert this allylic hydroperoxide to the 
1,2,4-trioxane ring of artemisinin are  also non-enzymatic in nature. 
Keywords: artemisinin; dihydroartemisinic acid; sesquiterpene; biosynthesis; Artemisia 
annua; phytochemistry; oxidation; allylic hydroperoxide  
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1. Introduction 
1.1. Malaria 
Malaria is an infectious disease which has affected human beings since the dawn of recorded 
history. By the middle of the last century, however, many felt that malaria was on the retreat and that 
one day it might even be vanquished. Two factors were primarily responsible for this perceived 
reduction in the severity of the malarial threat. Firstly, the Anopheles mosquito, which transmits the 
disease to humans, could at last be controlled by widespread application of the insecticide DDT. 
Secondly, the Plasmodium parasite, which causes malaria (four members of the genus infect humans: 
P. falciparum, P. vivax, P. malariae and P. ovale), could also be effectively be controlled by the use of 
synthetic analogues of quinine (itself also a natural product, obtained from the bark of the cinchona 
tree), such as chloroquine, which had been developed before World War II. 
By the 1960’s, however, malaria was back with a vengeance. The mosquitoes were developing 
resistance to DDT, which was soon to be banned in any case because of environmental concerns. The 
Plasmodium falciparum parasite, which is responsible for cerebral malaria, an often fatal complication, 
was also developing resistance to chloroquine. Thailand and South America were the first regions to be 
affected, but resistance to chloroquine soon spread to many other parts of the World. Nowadays, it is 
particularly serious in South East Asia. It was against this background of increasing resistance, and of 
the on-going wars in neighboring Cambodia and Vietnam, that the Chinese government began a major 
initiative to discover new antimalarials from plants used in Traditional Chinese Medicine (TCM).   
 
1.2. Artemisia annua (Qinghao) 
 
The herb “Qinghao” first appeared in a book entitled “Wu Shi Er Bing Fang” (Prescriptions for 
Fifty-Two Ailments) more than two thousand years ago. The earliest reported use for Qinghao was for 
the treatment of haemorroids; but “Zhou Hou Bei Ji Fang” (Handbook of Prescriptions for Emergency 
Treatment), written in 340 AD, describes the use of Qinghao as a treatment for fevers [1]. The first text 
in which Qinghao might specifically be identified as a remedy for malaria  is “Ben Cao Gang Mu” 
(1596) in which the herb is described as “a treatment for hot and cold due to intermittent fever illness”. 
These old pharmacopeias describe preparations in which the leaves (collected in summer or spring) are 
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pounded with a pestle and mortar in order to express the “juice”. This procedure was, perhaps, 
intended to improve the recovery of essential oils from trichomes on the leaf surface, in which the 
active principal, artemisinin, is now thought be contained. 
It is not entirely clear whether “Qinghao” which is referred to in these ancient texts is solely  
Artemisia annua L. [2]; and it has sometimes been suggested that the term may also have been used 
synonomously for Artemisia apiacea Hance [1]. In the modern pharmacopeia of the People’s Republic 
of China, however, Qinghao is now officially listed as the aerial parts of A. annua L. [3] (5g dried 
herb/1L water is suggested for the preparation of a decoction). In the TCM system, A. annua is cool in 
nature (yin) and is therefore suitable for treating “heat” syndromes (yang), such as malaria; other 
applications described for this cooling herb, such as the relief of symptoms of febrile diseases, tidal 
fever, low grade fever and summer heat stroke, are also consistent with this classification. 
 
1.3. Artemisinin (Qinghaosu) 
 
As has been noted, after a brief respite lasting only a few decades, malaria was once again on the 
increase in the 1960s. In 1967, the Chinese government launched a program to discover new 
antimalarial drugs based on a systematic investigation of indigenous plants used in TCM.  
When the Chinese scientists made infusions of A. annua with hot or boiling water, as described in 
the ancient texts, they observed no activity against mice infected with Plasmodium berghei (a rodent 
malarial parasite). However, thanks to the insight of Prof. Tu, cold ethereal extracts of A. annua were 
also tested and these did show encouraging activity, leading to the isolation of the active principle, 
artemisinin, in 1972 (the original reports of this new drug referred to “Qinghaosu”, meaning “principle 
from Qinghao” [4]). Nowadays, artemisinin is extracted from A. annua using diethyl ether, hexane, 
petroleum ether or even petrol as solvent [5]. 
At first sight, the lack of effectiveness for hot water extracts from A. annua appears to be at 
variance with the reports in the traditional pharmacopeias (in addition, we now know that artemisinin 
is  virtually insoluble in water). One possible explanation is that the original recipes normally required 
that A. annua preparations be made in conjunction with other herbs (so-called “minister” or “guide” 
herbs). For example, in the herbal “Wen Bing Tiao Bian” (1798), an infusion of A. annua together with 
Amyda sinensis, Rehmannia glutinosa, Anemarrhena asphodeloides and Paeonia suffructicosa is 
described. It is quite possible that saponins, or other components from the latter three herbs which are 
capable of acting as detergents, might be able to assist the dissolution of artemisinin in water (cf. the 
suggestion in Section 2.4 that flavonoids, which are present both in A. annua and other herbs, may be 
able to potentiate the antimalarial effect of artemisinin in crude plant preparations).  
Clinical studies in the late 1970s with patients infected with P. vivax or P. falciparum demonstrated 
that artemisinin could kill the malarial parasite very quickly at the schizont stage of the parasite’s life 
cycle (i.e. while it infected the human red blood cell) and with no obvious side effects [6]. Most 
importantly, artemisinin was completely effective in the treatment of chloroquine-resistant Falciparum 
malaria [7]. The discovery of this new and potent antimalarial attracted the attention of the World 
Health Organization (WHO), which had the resources to develop artemisinin globally; and both A. 
annua and artemisinin soon became well known outside of China. However, the therapeutic value of 
artemisinin was limited by its low solubility in both oil and water, and this has lead to the development 
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of semi-synthetic drugs with pharmacological properties superior to those of the parent [8]. The most 
important such derivatives are artemether, arteether and artesunate (Figure 1), which exhibit greater 
potency than artemisininin itself, as well as improved solubility, and favourable metabolic and 
hydrolytic stabilities. Formulations based on these drugs are now at the heart of the WHO’s global 
fight against malaria The entire world production of such semi-synthetic artemisinin derivatives is 
currently reliant on harvesting and extraction of artemisinin from A. annua plants, which is practiced 
on a multi-tonne scale in countries such as China and Vietnam. 
Figure 1. Artemisinin and its semi-synthetic derivatives, which are currently used in the 
treatment of malaria. 
 
 Artemisinin    Artemether Arteether Artesunate 
 
Malaria is now the most serious infectious disease in the World, with at least 300 million cases 
reported every year. It is estimated to be responsible for up to 2 million deaths annually - mainly 
amongst children - with more than half of the deaths occurring amongst the poorest 20% of the World's 
population. The importance of artemisinin has been founded on a continuing lack of resistance almost 
three decades after its introduction – although, very recently, reports of the emergence of resistance 
have indeed begun to appear [7,8] This slow onset of resistance may be a consequence of the unique 
mechanism of action for this drug, which is associated with the unusual endoperoxide group. It is 
thought that artemisinin becomes activated when its endoperoxide group comes into contact with 
Fe(II) in free haem groups, which have been liberated by the parasite’s digestion of the haemoglobin 
contained in the red blood cell.   
The appearance of resistance to artemisinin could be a devastating blow for many parts of South 
East Asia and Africa, where artemisinin-based drugs are currently the only effective treatment for 
malaria (resistance to the older generation of quinine-derived antimalarials having already become 
endemic to these regions). In an attempt to forestall the emergence of resistance, the WHO have been 
recommending that artemisnin should be taken in combination with another antimalarial drug – so-
called Artemisinin Combination Therapy (ACT). This strategy is designed to slow the development of 
resistance, because during treatment with two drugs, the chance of a mutant emerging which is 
resistant to both is the product of the probabilities of resistance arising to either drug separately. It 
seems that, in the continuing absence of an effective malaria vaccine, the development of new 
antimalarial drugs – most likely derived from, or inspired by, artemisinin – will continue to be our 
primary weapon in the fight against malaria.  
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2. The Phytochemistry of Artemisia annua L. (Qinghao) 
 
Artemisia annua Linn. (sweet wormwood; Chinese wormwood) is a member of the Asteraceae 
family of plants (formerly Compositae). It is a native of China, originally found in the steppes of 
Chahar and Suiyuan Provinces, but is now widespread in many parts of the World,  and is cultivated in 
countries such as Vietnam, Thailand, Burma, Madagascar, Malaysia, USA, Brazil, Australia 
(Tasmania), Holland, Switzerland, France and Finland. Most phytochemical investigations of A. annua 
have employed the aerial parts (leaves and/or stems - sometimes also including the flowers) although 
one report has concentrated on the seeds [9]. The phytochemistry of A. annua is dominated by 
terpenoids (in particular sesquiterpene lactones), flavonoids, coumarins and other shikimate 
metabolites, as is the case for many other members of the genus Artemisia. The sesquiterpene, 
artemisinin, is however unique to A. annua – it has been searched for on several occasions in other 
species in the genus Artemisia, always without success [10,11]. The artemisinin content from A. annua 
is highly variable, ranging anywhere between 0.01% and 1%, depending on variety, and can even be as 
high as 1.4% in some cultivated strains. 
There have been several reviews of the phytochemistry of A. annua [12-15]. In this section, an 
attempt has been made to provide a comprehensive review of the original phytochemical literature 
concerning A. annua up to 2009. Almost six hundred secondary metabolites are described, which have 
been divided into eight sections (Sections 2.1-2.8) and further sub-divided into more than forty Tables. 
The grouping of these natural products from A. annua is based on the (largely biogenetic) 
classification adopted by a standard reference work, the Dictionary of Natural Products [16]. Thus, the 
structurally most simple group of metabolites – derivatives of aliphatic hydrocarbons (branched, 
unbranched, saturated or unsaturated) with varying levels of oxidation at C-1 (alcohol, aldehyde, 
ketone, acid or ester) - are described first in Section 2.1. The next major group to be covered in Section 
2.2 comprises derivatives of simple aromatic hydrocarbons. The phenylpropanoids, in which a C3 
substituent is attached to the aromatic unit (C6), form a biosynthetically distinct group of aromatic 
metabolites, which is described in Section 2.3. The flavonoids, which are biosynthetically derived from 
this same  C6C3 precursor, constitute the second largest group of metabolites from A. annua, and are 
described separately in Section 2.4. By far the largest group of metabolites from A. annua is the 
terpenoids, which are biosynthetically derived from a branched isoprenoid unit (C5). They have been 
further subdivided into monoterpenoids (C10;  i.e. 2 × C5); sesquiterpenoids (C15 ; i.e. 3 × C5); and 
higher terpenoids (which include both diterpenes (C20), triterpenes (C30) and sterols (C29). These large 
groupings are covered in Sections 2.5, 2.6 and 2.7, respectively. Finally, a very small number of 
miscellaneous nitrogen-containing natural products appear in Section 2.8. 
The essential oil of A. annua was first studied as long ago as 1917 [17,18]. Researchers have 
continued to analyse the volatile constituents of this essential oil over the past century, primarily 
utilising gas chromatography (GC) and the hyphenated analytical technique of gas chromatography-
mass spectrometry (GC-MS) [19-35]. GC/GC-MS studies of the essential oil of A. annua have been 
reported from countries as diverse as France [36], Finland [37], Hungary [38], Romania [39], 
Kazakhstan [40], Iran [41,42], India [43-45], China [46-50] and Vietnam [51]. A detailed study of the 
essential oils from Chinese and Vietnamese varieties of A. annua demonstrated that the Chinese 
variety contained predominantly artemisia ketone, while the Vietnamese oil was dominated by 
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camphor and germacrene D [21] (others have confirmed the absence of artemisia ketone from 
Vietnamese oil) [52]. Interestingly, this difference was also reflected in the artemisinin content of 
Chinese and Vietnamese plants at 0.17% and 1.0% dry weight, respectively. Others have reported a 
similar variation in essential oil content between varieties of A. annua [53,54] and have concurred that 
differences in the essential oil composition should be ascribed to the existence of chemotypes (or 
chemical races) in this species [43] (see also Section 4.1). 
GC-MS studies are particularly suited to the analysis of the more volatile components of the plant 
metabolome, such as the monoterpenes (Section 2.5) and some of the unfunctionalized sesquiterpene 
hydrocarbons which are reported in Section 2.6. The identification of a metabolite by GC-MS 
generally requires that its retention time and mass spectrum be matched with that of a known standard, 
which is recorded  in a database. Using this thechnique, it is therefore possible to make a very rapid 
analysis of a large number of compounds employing a relatively small amount of plant material. Many 
of the simple aliphatic and aromatic metabolites which are reported in Sections 2.1 and 2.2 are actually 
comparatively minor components of the essential oil of A. annua, that have been identified solely on 
this basis. Although it is also possible to analyse more highly oxygenated sesquiterpenes, such as 
artemisinin and its biosynthetic precursors by GC-MS  [55] (Section 2.6), these less volatile 
components are generally more easily isolated by liquid chromatography (LC) [15]. LC is definitely 
the technique of choice for the more non-volatile compounds of the extract of A. annua, which include 
flavonoids (Section 2.4), and many triterpenoids and sterols (Section 2.7). In the preparative mode, the 
LC techniques [56] of column chromatography and high performance liquid chromatography (HPLC) 
can provide sufficient material to allow for the subsequent structural elucidation  of completely novel 
metabolites, when used in conjunction with techniques such as nuclear magnetic resonance (NMR) 
spectroscopy and X-ray crystallography. Most of the structures of the more highly oxygenated 
cadinane and amorphane sesquiterpenoids from A. annua which are reported in Section 2.6.3, were 
determined by this more powerful, but also more laborious approach. The majority of these 
components are unique to this species and several have turned out to be relevant to the biosynthesis  
of artemisinin.  
The highly oxygenated nature of many of the terpenoid metabolites from A. annua  has been 
stressed throughout this review, because of its perceived relevance to the biosynthesis of artemisinin. 
In particular, the reader’s attention has been drawn to the unusually wide diversity of terpenoid allylic 
hydroperoxides and endoperoxides which have been recorded from this species. It is suggested that 
several of these peroxides result from the reaction of molecular oxygen with the tri-substituted double 
bond of an appropriate (and frequently abundant) mono- sesqui- or diterpene precursor. Thus, allylic 
hydroperoxides are found for monoterpenes (264 and 265; Section 2.5.1), sesquiterpenes (414 and 481; 
Section 2.6.3) and diterpenes (553; Section 2.7.1), all of which might be derived from abundant 
hydrocarbon precursors; in addition to one monoterpene endoperoxide (329; Section 2.5.3) and three 
sesquiterpene endoperoxides (465, 495 and 497; Section 2.6.3). These reactive hydroperoxides might 
then be responsible for the formation of a large number of the highly-oxygenated terpenes reported 
from A. annua. 
Finally, it has recently been proposed that the the yin-yang nature of Chinese herbal medicine might 
equate to antioxidation-oxidation in modern parlance [57]. If this is true, then the wide-ranging 
antioxidant properties associated with the various terpenoidal components from A. annua (i.e. their 
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propensity to undergo spontaneous autoxidation) would be entirely consistent with its classification as 
a cooling herb in the TCM system. 
2.1. Aliphatic Hydrocarbons, Alcohols, Aldehydes and Acids 
 
All possible saturated unbranched hydrocarbons between C16 [hexadecane; (5)] and C26 
[hexacosane; (14)] have now been reported from GC-MS studies of A. annua (Table 1). 
Table 1. Saturated Unbranched Hydrocarbons. 
Structure Name CAS Number References 
CH3(CH2)3CH3 Pentane (1) [109-66-0]  [58] 
CH3(CH2)4CH3 Hexane (2) [110-54-3]  [22] 
CH3(CH2)10CH3 Dodecane (3) [112-40-3]  [24] 
CH3(CH2)11CH3 Tridecane  (4) [629-50-5]  [24] 
CH3(CH2)14CH3 Hexadecane  (5) [544-76-3]  [24] 
CH3(CH2)15CH3 Heptadecane  (6) [629-78-7]  [27] 
CH3(CH2)16CH3 Octadecane (7) [593-45-3]  [32,43] 
CH3(CH2)17CH3 Nonadecane (8) [629-92-5]  [27,32,43] 
CH3(CH2)18CH3  Eicosane (9) [112-95-8]  [32,43] 
CH3(CH2)19CH3 Heneicosane (10) [629-94-7]  [32,34] 
CH3(CH2)21CH3 Tricosane  (11) [638-67-5]  [32] 
CH3(CH2)22CH3 Tetracosane  (12) [646-31-1]  [32] 
CH3(CH2)23CH3 Pentacosane (13) [629-99-2]  [32] 
CH3(CH2)24CH3 Hexacosane  (14) [630-01-3]  [32] 
CH3(CH2)27CH3 Nonocosane (15)  [630-03-5]  [58] 
CH3(CH2)32CH3   Tetratriacontane (16) [14167-59-0]  [59] 
Table 2. Saturated Unbranched Alcohols, Aldehydes and Ketones. 
Structure Name Alternative Name(s) CAS Number References
Alcohols 
CH3(CH2)3CH2OH 1-Pentanol (17) Pentyl alcohol [71-41-0]  [24] 
CH3(CH2)4CH2OH n-Hexanol (18)  [111-27-3]  [22, 32, 43] 
CH3(CH2)4CH2O-
(C=O)CH2CH(CH3)2 
n-Hexyl isovalerate (19) 3-Methylbutyric acid hexyl ester [10032-13-0]  [32, 43] 
CH3(CH2)4CH2O-
(C=O)C(CH3)=CHCH3 
n-Hexyl tiglate (20) (2E)- 2-Butenoic acid, 2-methyl-, hexyl 
ester 
[16930-96-4]  [32, 43] 
CH3(CH2)6CH2OH 1-Octanol (21) Caprylic alcohol [111-87-5]  [24] 
CH3(CH2)7CH2OH n-Nonyl alcohol  (22) 1-Nonanol [143-08-8]  [24] 
CH3(CH2)26CH2OH Octacosanol (23)  [557-61-9]  [59, 60, 61] 
CH3(CH2)27CH2OH Nonacosanol (24)  [6624-76-6]  [59, 62] 
Aldehydes and Ketones     
CH3COCH3 Acetone (25) 2-Propanone [67-64-1]  [24] 
CH3(CH2)2CHO Butanal  (26) Butyraldehyde   [50] 
CH3(CH2)4CHO Hexanal  (27) Caproic aldehyde [66-25-1]  [23] 
CH3CO(CH2)4CH3 2-Heptanone (28) Methyl pentyl ketone [110-43-0]  [45] 
CH3(CH2)6CHO Octanal (29) Capric aldehyde [124-13-0]  [32] 
CH3(CH2)11CHO Tridecanal (30) Tridecyl aldehyde [10486-19-8]  [24] 
 
The saturated fatty acids listed in Table 3 are likely to be the biogenetic parents of the saturated 
hydrocarbons, alcohols, aldehydes and ketones which appear in Tables 1 and 2. Saturated fatty acids 
have been obtained from A. annua as a continuous series between C12 [dodecanoic acid; (36)] and C20 
[eicosanoic acid; (48)]. Hexadecanoic acid (41; C16) and octadecanoic acid (45; C18) are the most 
dominant saturated lipids from A. annua (Table 3), while oleic acid (80) (C18) is the most abundant 
unsaturated fatty acid (Table 5). 
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Table 3. Saturated Unbranched Carboxylic Acids and Esters. 
Structure Name Alternative Name(s) CAS Number References
CH3CH2OCHO Ethyl formate  (31)  [109-94-4]  [50] 
CH3CH2CO2CH2CH3 Propanoic acid, ethyl ester (32) Ethyl propionate   [105-37-3]  [50] 
CH3(CH2)3CO2H Pentanoic acid  (33) Valeric acid [109-52-4]  [24] 
CH3(CH2)3CO2C(CH3)3 Pentanoic acid, tert-butyl ester (34) Pentanoic acid, 1,1-
dimethylethyl ester 
[23361-78-6]  [50] 
CH3(CH2)8CO2H Decanoic acid (35)  Capric acid [334-48-5]  [63, 64] 
CH3(CH2)10CO2H Dodecanoic acid (36) Lauric acid [143-07-7]  [63, 64] 
CH3(CH2)10CO2CH2CH3 Dodecanoic acid, ethyl ester (37) Ethyl laurate   [106-33-2]  [24] 
CH3(CH2)11CO2H Tridecanoic acid  (38)  [638-53-9]  [63] 
CH3(CH2)12CO2H Tetradecanoic acid (39) Myristic acid [544-63-8]  [23, 63, 64] 
CH3(CH2)13CO2H Pentadecanoic acid  (40)  [1002-84-2]  [63] 
CH3(CH2)14CO2H Hexadecanoic acid (41) Palmitic acid [57-10-3] [20, 23, 24, 27, 32, 
43, 63, 64,  65] 
CH3(CH2)14CO2CH3 Hexadecanoic acid, methyl ester 
(42) 
Methyl hexadecanoate 
Methyl  palmitate 
[112-39-0]  [27] 
CH3(CH2)14CO2CH2CH3 Hexadecanoic acid, ethyl ester (43) Ethyl palmitate   [628-97-7]  [24] 
CH3(CH2)15CO2H Heptadecanoic acid  (44) Margaric acid [506-12-7]  [63] 
CH3(CH2)16CO2H Octadecanoic acid (45) Stearic acid [57-11-4]  [27, 43, 63,  64] 
CH3(CH2)16CO2CH3 Octadecanoic acid, methyl ester (46) Methyl octadecanoate 
Methyl stearate 
[112-61-8]  [27] 
CH3(CH2)17CO2H Nonadecanoic acid   (47)  [646-30-0]  [20] 
CH3(CH2)18CO2H Eicosanoic acid  (48) Arachidic acid [506-30-9]  [64] 
CH3(CH2)20CO2H Docosanoic acid  (49) Behenic acid [112-85-6]  [64] 
CH3(CH2)22CO2H Tetracosanoic acid  (50)  Lignoceric acid [557-59-5]  [64] 
CH3(CH2)28CO2(CH2)30CH3 Hentriacontanyl  triacontanoate (51) Triacontanoic acid 
 hentriacontyl ester
[135729-36-1]  [59, 62] 
 
Table 4. Unbranched Alkenic Hydrocarbons and Alcohols. 
Structure Name Alternative 
Name(s) 
CAS Number References 
Hydrocarbons 
CH2=CHCH=CHCH3 1,3-Pentadiene (52) 1-Methyl-1,3-
butadiene 
[504-60-9]  [50] 
CH3CH=CHCH=CHCH3 trans,trans-2,4-Hexadiene (53)  [5194-51-4]  [50] 
H2C=CHCH=CHCH=CHCH3 trans,trans-1,3,5-Heptatriene (54)  [17679-93-5]  [50] 
H2C=CH(CH2)4CH=CH2 1,7-Octadiene  (55)  [3710-30-3]  [50] 
H2C=CH(CH2)2CH=CH(CH2)2CH=CH2 trans-1,5,9-Decatriene (56)  [39139-91-8]  [50] 
Alcohols 
CH2=CHCH2CH(OH)CH3 4-Pentene-2-ol (57) 1-Penten-4-ol [625-31-0]  [25] 
CH2=CH(CH2)3O-(C=O)CH2CH3 4-Penten-1-ol, propionate  (58) 4-Pentenyl 
propionate 
[30563-30-5]  [43] 
CH3(CH2)2CH=CHCH2OH (E)-2-Hexenol (59) 2-Hexen-1-ol [928-95-0]  [45] 
CH3CH2CH=CHCH2CH2OH (E)-3-Hexen-1-ol (60)   [928-97-2]  [19] 
CH3CH2CH=CHCH2CH2OH (Z)-3-Hexen-1-ol (61) Phyllol [928-96-1]    [22, 32, 43] 
CH3CH2CH=CHCH2CH2O-(C=O)CH3 (E)-3-Hexen-1-ol, acetate (62)  [3681-82-1]  [19] 
CH3CH2CH=CHCH2CH2O-(C=O)CH2CH3 (Z)-3-Hexenyl propanoate (63)  [33467-74-2]  [20] 
CH3CH2CH=CHCH2CH2O-
(C=O)CH2CH2CH3 
3-Hexenyl butanoate (64)  [2142-93-0]  [23] 
CH3CH2CH=CHCH2CH2O-
(C=O)(CH2)4CH3 
3-Hexenyl hexanoate (65)  [84434-19-5]  [24] 
CH3CH2CH=CHCH2CH2O-
(C=O)CH2CH(CH3)2 
(Z)-3-Hexenyl isovalerate (66)  [35154-45-1]  [32] 
CH3CH2CH=CHCH2CH2O-
(C=O)C(CH3)=CHCH3 
(Z)-3-Hexenyl tiglate (67)  [67883-79-8]  [43] 
H2C=CHCH(OH)(CH2)3CH3 1-Hepten-3-ol (68)  [4938-52-7]  [24] 
H2C=CHCH(OH)(CH2)4CH3 1-Octen-3-ol  (69)  [3391-86-4] [31,32,43] 
H2C=CH(CH2)7CH2OH 9-Decen-1-ol (70)  [13019-22-2]  [32, 43] 
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Table 5. Unbranched Alkenic Ketones, Aldehydes, Carboxylic acids and Esters. 
Structure Name Alternative 
ame(s) 
CAS 
Number 
References 
Ketones and aldehydes 
H2C=CHCH2CH2CHO 4-Pentenal (71)  [2100-17-6]  [50] 
CH3(CH2)2CH=CHCHO 2-Hexenal (72) Leaf aldehyde [505-57-7] 
[6728-26-3]   
 [24, 31, 
43] 
CH3(CH2)3CH=CHCHO 2-Heptenal (73)  [2463-63-0]  [24] 
CH3(CH2)5CH=CHCHO (Z)-2-Nonenal (74)  [60784-31-8]  [50] 
CH3(CH2)3CH=CHCH=CHCHO (2E,4E)- Nonadienal (75)  [5910-87-2]  [19] 
CH3(CH2)4CH=CHCOCH3 3-Nonen-2-one (76)   [14309-57-0]  [24] 
CH3(CH2)6CH=CHCHO 2-Decenal  (77)  [3913-71-1]  [24] 
CH3(CH2)4CH=CHCH=CHCHO 2,4-Decadienal (78)    [2363-88-4]  [24] 
H2C=CH(CH2)8CHO 10-Undecenal (79)  [112-45-8]  [24] 
Carboxylic acids and esters 
CH3(CH2)7CH=CH(CH2)7CO2H Oleic acid (80) (Z)-9-
Octadecanoic acid   
[112-80-1] 
[27104-13-8] 
[28, 63, 64] 
CH3(CH2)7CH=CH(CH2)7CO2CH3 Methyl 9-octadecenoate 
(81) 
Methyl elaidate [2462-84-2]  [24] 
CH3(CH2)7CH=CH(CH2)7CO2CH2CH(OH)CH2OH 9-Octadecenoic acid, 2,3-
dihydroxypropyl  ester 
(82) 
 [251983-54-
7] 
 [24] 
 
CH3(CH2)4CH=CHCH2CH=CH(CH2)7CO2H Linoleic acid (83) (Z,Z)-9,12-
Octadecadienoic 
acid 
[60-33-3] 
[27213-43-0] 
[28984-77-2] 
 [20, 63] 
CH3CH2CH=CHCH2CH=CHCH2CH=CH(CH2)7CO2H α-Linolenic acid  (84) (Z,Z,Z)-9,12,15-
Octadecatrien-oic 
acid 
[463-40-1]  [20, 63] 
Table 6. Branched Aliphatic Hydrocarbons and Alcohols. 
Structure Name Alternative Name(s) CAS Number References
Hydrocarbons     
CH3(CH2)8CH(CH3)CH2CH2CH(CH3)2 Tetradecane, 2,5-dimethyl- (85)  [56292-69-4]  [24] 
 
(CH3)2CH(CH2)26CH(CH3)2 Triacontane, 2,29-dimethyl- (86) 2,29-Dimethyltriacontane [135729-37-2]  [62] 
(CH3)2CHC(CH3)3 2,2,3-Trimethylbutane (87)  [464-06-2]  [50] 
CH3(CH2)3CH(CH3)(CH2)7CH3 Tridecane, 5-methyl- (88) 5-Methyltridecane [25117-31-1]  [24] 
Alcohols     
(CH3)2CHCH2CH2O-(C=O)CH3 3-Methyl-1-butanol, acetate (89) Isoamyl acetate [123-92-2]  [43] 
(CH3)2CHCH2O-(C=O)CH2CH3 2-methylpropylpropionate (90) Isobutyl propionate [540-42-1]  [50] 
(CH3)2C(OH)(CH2)2CH3 2-Methyl-2-pentanol (91)  [590-36-3]  [25] 
(CH3)2C(OH)(CH2)3CH3 2-Methyl-2-hexanol (92)  [625-23-0]  [24] 
(CH3)2CH(CH2)3CH2OH 5-Methyl-1-hexanol (93) 1-Hexanol, 5-methyl- [627-98-5]  [24] 
Aldehydes and Ketones 
(CH3)2CHCH2CHO 3-Methylbutanal (94) Isovaleraldehyde   [590-86-3]  [24] 
CH3CH2CH(CH3)CH2CHO 3-Methylpentanal (95)  [15877-57-3]  [20] 
(CH3)2CHCH2COCH3 4-Methyl-2-pentanone (96) Isobutyl methyl ketone [108-10-1]  [24] 
(C6H5)CH2CH(CHO)(CH2)5CH3 2-Benzyloctanal (97) Benzenepropanal, α-
hexyl- 
[161403-65-2]  [24] 
(CH3)2CH(CH2)5C=O(CH2)14CH2OH 8-Tricosanone, 23-hydroxy-2-
methyl- (98) 
 [135729-35-0]  [59, 62] 
 
Table 7. Branched Aliphatic Carboxylic Acids, Esters and Anhydrides. 
Structure Name Alternative Name(s) CAS Number References
CH3CH2CH(CH3)CO2H 2-Methylbutanoic acid (99)  [868-57-5]    [22] 
CH3CH2CH(CH3)CO2CH2CH3 2-Methyl butanoic acid, ethyl 
ester (100) 
Ethyl 2-methylbutyrate [7452-79-1]  [22, 32] 
 
(CH3CH2CH(CH3)CO2)O 2-Methylbutanoic acid anhydride 
(101) 
2-Methylbutyryl 
anhydride 
[1519-23-9]  [50] 
CH3CH2CH(CH3)CO2(CH2)4CH3 Amyl 2-methylbutyrate (102) Pentyl 2-
methylbutanoate 
[68039-26-9]  [43] 
CH3CH2CH(CH3)CO2CH2CH(CH3)CH2CH3 2-Methyl-butanoic acid, 2-
methylbutyl ester  (103) 
2-Methylbutyl 2-
methylbutyrate 
[2445-78-5]  [31] 
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Table 7. Cont. 
(CH3)2CHCH2CO2CH2CH3 3-Methylbutanoic acid, ethyl 
ester (104) 
Ethyl 3-
methylbutanoate  
Ethyl isovalerate   
[108-64-5]  [23] 
(CH3)2CHCH2CO2(CH2)3CH3 3-Methylbutanoic acid, butyl 
ester (105) 
Butyl-3-
methylbutanoate 
[109-19-3]  [25] 
(CH3)2CHCH2CO2CH2CH2C(=CH2)CH3 3-Methylbutanoic acid, 3-
methyl-3-butenyl ester (106) 
3-Methyl-3-butenyl 3-
methylbutyrate   
[54410-94-5]  [20] 
CH3CH2CH(CH2CH3)CO2CH3 2-Ethylbutanoic acid, methyl 
ester (107) 
2-Methyl-
ethylbutanoate 
[816-11-5]  [25] 
Table 8. Branched Alkenic Hydrocarbons and Aldehydes. 
Structure Name Alternative Name(s) CAS 
Number 
References 
Hydrocarbons 
H2C=CHC(CH3)3 3,3-Dimethyl-1-butene (108)  tert-Butylethylene [558-37-2]  [20] 
H2C=CHCH(CH3)2 2,4-Dimethyl-2-pentene (109)  [625-65-0]  [24] 
CH3CH=CHCH(CH3)CH2CH3 trans-4-Methyl-2-hexene (110)  [3683-22-5]  [20] 
Aldehydes 
CH3(CH2)4CH=CH(CHO)(CH2)3CH3 2-Butyl-2-octenal (111)   [13019-16-4]   [24] 
(CH3)2C=CHCH=CH(C=O)CH3 6-Methyl-3,5-heptadien-2-one (112)  [16647-04-4]   [66] 
Artemisia annua contains relatively few polyacetylenes by comparison with other members of the 
genus Artemisia (and also as compared to other members of the Asteraceae family). The only two such 
compounds to be reported to date are ponticaepoxide (121) and annuadiepoxide (122), which have 
been isolated from both leaves [67] and seeds [9] of A. annua. 
Table 9. Acetylenic Hydrocarbons. 
Structure Name Alternative Name(s) CAS Number References 
CH3C≡CCH2OMe 1-Methoxy-2-butyne 
(113) 
 [2768-41-4]  [50] 
H2C=CH(CH2)3C≡CH 1-Hepten-6-yne (114)  [65939-59-5]  [50] 
CH3O(C=O)C≡C(CH2)5CH3 2-Nonynoic cid, methyl 
ester (115) 
Methyl 2-nonynoate [111-80-8]  [50] 
CH3(CH2)9C≡CH 1-Dodecyne (116) Decylacetylene [765-03-7]  [23] 
CH3C≡C(CH2)8CH2OH 10-Dodecyn-1-ol (117)  [69221-99-4]  [23] 
(CH3)2CHC≡CCH=CHCH(CH3)2 3-Octen-5-yne, 2,7-
dimethyl- (118) 
 [91400-77-0]  [50] 
 
CH3(CH2)6CH=CHC≡CH3 3-Undecen-1-yne (119)  [74744-32-4] 
[91250-91-8] 
 [23]  
(C6H5)CH2C≡C-C≡C-CH3 Capillene (120) 2,4-Hexadiynylbenzene [520-74-1]    [30] 
 Ponticaepoxide (121) 2-Ethenyl-3-(1-nonen-3,5,7-
triynyl)oxirane 
2-(1-Nonen-3,5,7-triynyl)-3-
vinyloxirane 
3,4-Epoxy-1,5-tridecadiene-
7,9,11-triyne 
[3562-36-5]  [9, 67] 
 Annuadiepoxide (122)   1,3,5-Tridecatriene-7,9,11-triyne 
(E,E), 3,4:5,6-diepoxide 
3,4:5,6-Diepoxy-1-tridecene-
7,9,11-triyne 
[139122-80-8]  [9, 67] 
 
  (121) 
(122) 
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Table 10. Cyclic Hydrocarbons.  
Name Alternative Name(s) CAS Number References 
1,1'-Bicyclopropyl, 2,2'-dimethyl (123)  [1975-84-6]  [23] 
Bicyclo[2.2.2]octa-2,5-diene, 1,2,3,6-tetramethyl- (124)  [62338-43-6]  [20] 
3,5-Cycloheptadienone (125)  [1121-65-9]  [28] 
Cyclooctane, 1,4-dipropyl- (126)  [251983-53-6]  [24] 
Cyclopropane, (1-methyl-1,2-propadien-1-yl)-  (127) 3-Cyclopropyl-1,2-butadiene [51549-86-1]  [50] 
Cyclopropene, 3-ethenyl-3-methyl-(128) 3-Methyl-3-vinylcyclopropene [71153-30-5]  
1,1-Dicyclopropylethylene (129) Cyclopropane, 1,1'-ethenylidenebis-   [822-93-5]  [50] 
Hexylcyclohexane (130)  [4292-75-5]  [20] 
Jasmone (131) 3-Methyl-2-(2-pentenyl)-2-cyclopenten-1-one [488-10-8]  [22, 32, 43] 
Methyl cyclopentane  (132)  [96-37-7]  [22] 
            
(123) (124) (125) (126) (1
       
   
(128) (129) (130) (131) (1
Table 11. Furans. 
Name Alternative Name(s) CAS Number References 
2,5-Dihydro-3-methylfuran (133)  [1708-31-2]  [50] 
2-Ethylfuran  (134)  [3208-16-0]  [50] 
4-Methyl-2,3-dihydrofuranfuran (135)  [34314-83-5]  [34] 
3-Methylfuran (136)  [930-27-8]  [34] 
5-Methyl-2-furancarboxyaldehyde (137) 5-Methylfurfural [620-02-0]     [24] 
       
(133) (134) (135) (136) (137) 
2.2. Aromatic Alcohols, Ketones and Acids 
The simple aromatic compounds described in Tables 12, 13 and 14 form a relatively small group of 
natural products from A. annua. Metabolites in this section are probably biosynthesised by both the 
polyketide and shikimate pathways (some simple aromatics which are derived from the terpenoid 
pathway are discussed separately in Section 2.5.3). 
Table 12. Simple Phenols and Benzylic Alcohols. 
Name Alternative Name(s) CAS Number References 
Anisole (138) Phenyl methyl ether [100-66-3]  [48] 
Benzyl isovalerate (139) 3-Methylbutanoic acid, benzyl ester [103-38-8]  [22, 23, 25, 32, 43] 
Benzyl 2-methyl butyrate  (140) 2-Methylbutanoic acid, benzyl ester [56423-40-6]  [41] 
Benzyl phenylacetate (141) Benzeneacetic acid, phenylmethyl ester   [102-16-9]  [50] 
Benzyl valerate  (142) Benzyl pentanoate [10361-39-4]  [19, 23] 
5-Nonadecylresorcinol-3-O-methyl ether (143) Phenol 3-methoxy-5-nonadecyl   [68] 
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Tabel 12. Cont. 
   
(138) (139-142) (143) 
                                
Table 13. Simple Aryl Ketones. 
Name Alternative Name(s) CAS number References 
2’,4’,6’-Trihydroxyacetophenone 2’,4’-dimethyl ether 
(144) 
2-Hydroxy-4,6-dimethoxyacetophenone    [68] 
2’,4’,6’-Trihydroxyacetophenone 2’-methyl ether (145) 2’,4’-dihydroxy-6’-
methoxyacetophenone 
[3602-54-8]  [68, 69] 
2’,4’,6’-Trihydroxyacetophenone 2’-methyl ether 4’-O-β-
D-glucopyranosde (146) 
Annphenone [61775-18-6]  [70] 
2’,4’,6’-Trihydroxyacetophenone 4’-methyl ether 2-O-β-
D-glucopyranoside (147) 
Domesticoside    [24587-97-1]  [15] 
   
(144) R1=Me; R2=Me 
(145) R1=Me; R2=H 
(146) R1=Me; R2=Glc 
 (147) R1=Glc; R2=Me 
 
  
   Table 14. Simple Benzoic Acids and their Homologues. 
Name Alternative Name(s) CAS Number References 
Benzoic acid (148)  [65-85-0]  [9, 24] 
Salicylic acid (149) 2-Hydroxybenzoic acid [69-72-7]  [15] 
Methyl salicylate  (150) Methyl-2-hydroxybenzoate [119-36-8]  [27, 32] 
2-Hydroxybenzoic acid, 3-methylbutyl ester (151) Isoamyl salicylate [87-20-7]  [24] 
3,4-Dihydroxybenzoic acid (152) Benzoic acid, 3,4-dihydroxy- 
Protocatechuic acid 
[99-50-3]  [71] 
Protocatechuic acid 4-glucoside  (153) Benzoic acid, 4-(β-D-glucosyloxy)-3-hydroxy-   [7361-59-3]  [71] 
Phenylacetic acid (154)  [103-82-2]  [24] 
Phenylpropanoic acid (155)    [9] 
Benzenepropanoic acid, 3-cyanophenyl ester (156)  [40123-39-5]   [50] 
  
 
(148) (149) R=H 
(150) R=Me   
(151) 
R=CH2CH2CH(CH3)2         
(152) R=H  
(153) R=Glc            
(154) n=1; R=H 
(155) n=2; R=H 
(156) n=2  
                              
OH
MeO C19H39
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2.3. Phenylpropanoids 
 
The phenylpropanoids, all of which contain a C3 substituent fused to a benzene ring (C6), are 
produced by the shikimate pathway, which is unique to plants. Most of the simple phenylpropanoids 
reported in Table 15 were described from GC-MS studies. Compounds 166-182 (Table 16), which are 
esters formed by various combinations of ferulic and cinnamic acid with the four hydroxyl groups of 
quinic acid, were isolated from a single HPLC-MS study [71]. Some of the coumarins reported in 
Table 17 have also been obtained from undifferentiated tissue cultures (callus and suspension) of A. 
annua (see Section 4.2). The structures of both of the 2,2-dihydroxychromene natural products 190 and 
191, which appear in Table 17, are questionable on thermodynamic grounds - one might expect both to 
lose a molecule of water thereby forming a more highly conjugated coumarin.  
Table 15. Simple Phenylpropanoids. 
Name Alternative Name(s) CAS Number References 
p-Allylanisole (157) 1-Methoxy-4-(2-propenyl)benzene [140-67-0]  [29, 72, 73] 
Anethole (158) 1-Methoxy-4-(1-propenyl)benzene [4180-23-8]  [32, 43, 50] 
3-Allyl-6-methoxyphenol (159) 4-Allyl-2-hydroxyl-1-methoxybenzene [501-19-9]  [48] 
Eugenol (160) 2-Methoxy-4-(2-propenyl)phenol [97-53-0]    [19, 32, 41, 43, 74] 
Methyl eugenol  (161) 1,2-Dimethoxy-4-(2-propenyl)benzene [93-15-2]  [43, 48] 
Eugenyl isovalerate (162) 2-Methoxy-4-(2-propenyl)phenol 3-methylbutanoyl [61114-24-7]  [34] 
2-Methoxy-3-(2-propenyl)phenol (163)  [1941-12-4]  [23] 
 
(157) (158) (159) R1=Me; R2=H 
(160) R1=OH; R2=Me 
(161) R1=Me;R2=Me 
(162) R1=(C=O)CH2CH(CH3)2; 
R2=Me 
(163) 
Table 16. Cinnamyl, Caffeoyl and Ferruloyl esters. 
Name Alternative Name(s) CAS Number Refs 
Methyl cinnamate  (164) 3-phenyl-2-propenoic acid methyl ester [103-26-4]  [24] 
Benzyl cinnamate   (165) 3-Phenyl-2-propenoic acid benzyl ester [103-41-3]  [24] 
Chlorogenic acid (166) 3-(3,4-Dihydroxycinnamoyl)quinic acid [327-97-9]  [71] 
Cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-[[3-(4-hydroxy-
3-methoxyphenyl)-1-oxo-2-propenyl]oxy]-, (167) 
 [53905-80-9]  [71] 
Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-
2-propenyl]oxy]-1,4,5-trihydroxy-, (168) 
 [342811-68-1]  [71] 
Isochlorogenic acid B (169) 3,4-Di-O-caffeoylquinic acid [4534-61-3]  [71] 
3-Caffeoyl-4-feruloylquinic acid (170) 4-O-Feruloyl-5-O-caffeoylquinic acid [125132-81-2]  [71] 
3,4-Diferuoylquinic acid (171)  [342811-70-5]  [71] 
Isochlorogenic acid A (172) 3,5-bis-(3,4-Dihydroxycinnamoyl)quinic acid) [2450-53-5]  [71] 
3-Caffeoyl-5-feruloylquinic acid (173)  [478156-24-0]  [71] 
3-Feruloyl-5-caffeoylquinic acid (174)  [1039007-73-2]  [71] 
3,5-Diferuoylquinic acid (175)  [333753-65-4]  [71] 
Isochlorogenic acid C (176) 4,5-Di-O-caffeoylquinic acid [57378-72-0]  [71] 
4-Caffeoyl-5-feruloylquinic acid (177)  [478156-25-1]  [71] 
4-Feruloyl-5-caffeoylquinic acid  (178)  [882535-14-0]  [71] 
4,5-Diferuoylquinic acid (179)  [342811-69-2]  [71] 
Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-
2-propenyl]oxy]-4,5-dihydroxy-1-[[3-(4-hydroxy-3-
methoxyphenyl)-1-oxo-2-propenyl]oxy]-, (180)  
 [865095-58-5]  [71] 
1-Caffeoyl-5-feruoylquinic acid  (181)  [865095-57-4]  [71] 
Cyclohexanecarboxylic acid, 3,4,5-tris[[3-(3,4-dihydroxy 
phenyl)-1-oxo-2-propenyl]oxy]-1-hydroxy-(182) 
 [437611-66-0]  [71] 
 
OR1
R2O
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Table 16. Cont. 
Table 17. Coumarins (2H-1-Benzopyran-2-one, 9CI). 
Name Alternative Name(s) CAS Number References
Coumarin (183) 2H-1-Benzopyran-2-one [91-64-5]  [56, 65, 68, 75- 
77, 79-80] 
Scopoletin (184) 7-Hydroxy-6-methoxycoumarin  
7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one  
[92-61-5]  [77, 79, 80- 87] 
Scoparone (185) 6,7-Dimethoxycoumarin   
6,7-Dimethoxy-2H-1-benzopyran-2-one 
[120-08-1]  [69, 88, 89] 
Scopolin (186) Scopoletin-O--D-glucopyranoside  
7-Hydroxy-6-methoxycoumarin-O--D-
glucopyranoside 
[531-44-2]  [15, 71, 79, 89, 
90] 
Isofraxidin (187) 6,8-Dimethoxy-7-hydroxy coumarin   [486-21-5]  [79, 86, 87, 89] 
Tomentin (188) 5,6,7-Trihydroxy-2H-1-benzopyran-2-one 6,7-
dimethyl ether 
[28449-62-9]  [89] 
6,7-Dimethoxydihydrocoumarin 
(189) 
2H-1-Benzopyran-2-one,3,4  3,4-Dihydro-6,7-
dimethoxy-coumarin 
[56680-28-5]  [88] 
2,2,6-Trihydroxychromene (190) 2H-1-Benzopyran-2,2,6-triol [161585-88-2]  [89] 
2,2-Dihydroxy-6-methoxy-2H-1-
benzopyran  (191) 
6-Methoxy-2H-1-benzopyran-2,2-diol  
2H-1-Benzopyran-2,2,6-triol 6-methyl ether 
[161585-87-1]  [89] 
   
 
(164) R=Me 
(165) R=(C6H5)CH2 
(166) R1=Caffeoyl; R2=H; R3=H; R4=H 
(167) R1= Feruloyl; R2=H; R3= H;  R4=H  
(168) R1= H; R2=H; R3= Caffeoyl;  R4=H  
(169) R1=Caffeoyl; R2=Caffeoyl; R3=H; R4=H 
(170) R1=Caffeoyl; R2=Feruloyl; R3=H; R4=H 
(171) R1=Feruloyl; R2=Feruloyl; R3=H; R4=H 
(172) R1=Caffeoyl; R2=H; R3=Caffeoyl; R4=H 
(173) R1=Caffeoyl; R2=H; R3=Feruloyl; R4=H 
(174) R1= Feruloyl; R2=H; R3= Caffeoyl;  R4=H 
(175) R1=Feruloyl; R2=H; R3=Feruloyl; R4=H 
(176) R1=H; R2=Caffeoyl; R3=Caffeoyl; R4=H 
(177) R1=H; R2=Caffeoyl; R3=Feruloyl; R4=H 
(178) R1=H; R2= Feruloyl; R3= Caffeoyl;  R4=H 
(179) R1=H; R2=Feruloyl; R3=Feruloyl; R4=H 
(180) R1=H; R2=H; R3= Caffeoyl l; R4=Feruloyl 
(181) R1=H; R2=H; R3=Feruloyl; R4=Caffeoyl  
(182) R1=Caffeoyl; R2=Caffeoyl; R3=Caffeoyl; R4=H  
   
(183) R1=H; R2=H; R3=H; R4=H         
(184) R1=H; R2=OMe; R3=OH; R4=H    
(185) R1=H; R2=OMe; R3=OMe; R4=H   
(186) R1=H; R2=OMe; R3=OGlc; R4=H   
(187) R1=H; R2=OMe; R3=OH; R4=OMe 
(188) R1=OH; R2=OMe; R3=OMe; R4=H   
(189)    (190) R1=H 
(191) R1=Me 
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2.4. Flavonoids 
A. annua L. is a rich source of flavonoids, as are many other members of the Asteraceae family. It 
has been suggested that some of the more abundant methoxylated flavonoids from A. annua may 
potentiate the antimalarial activity of artemisinin in crude extracts of this plant.  These flavones 
include: casticin (227), artemetin (228) [91], chrysosplenol D (225) and chrysoplenetin (226)  [92] 
(interstingly, the latter two flavonoids are also reported to potentiate the activity of berberine and 
norfloxacin against a resistant strain of Staphylococcus aureus). Perhaps for this reason, phytochemical 
studies have sometimes sought to determine the distribution of bioactive flavonoids (such as 
chrysoplenetin (226), casticin (227), eupatin (232) and artemetin (228)) in conjunction with that of 
artemisinin [93]. 
The flavonoids are produced from the cyclization of a C15 chalcone precursor, which is in turn 
derived from malonyl coenzyme A and p-coumaryl coenzyme A (see Section 2.3). A biogenetic 
classification has been adopted in this section. Thus, this large group of flavonoids has been further 
sub-divided into flavonones (Table 18), which are produced directly by cyclization of this precursor; 
and flavonols (3-hydroxy-2-phenyl-4H-1-benzopyran-4-ones), which have undergone subsequent 
oxygenation at the 3-position (Tables 19-22). The flavonols have been further grouped into 
tetrahydroxyflavonols in Table 19 [many are related to kaempferol (203)]; pentahydroxyflavonols in 
Table 20 [many are based on quercetin (207)]; hexahydroxyflavonols, based on quercetagetin (221) in 
Table 21; and miscellaneous hexahydroxyflavonols (Table 22).  
Table 18. Flavones (2-Phenyl-4H-1-benzopyran-4-one). 
Name Alternative Name(s) CAS Number References 
Apigenin (192) 4’,5,7-Trihydroxyflavone 
5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one 
[520-36-5]  [71, 89] 
Luteolin tetrahydroxyflavones 
Luteolin  (193)  
 
3’,4’,5,7-Tetrahydroxyflavone 
2-(3,4-Dihydroxyphenyl)-5,7,-dihydroxy-4H-1-benzopyran-4-one 
[491-70-3]  [84, 89] 
Luteolin-7-methyl ether  (194) 3’,4’,5-Trihydroxy-7-methoxyflavone 
2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-methoxy-4H-1-
benzopyran-4-one 
[20243-59-8]  [89] 
Glucoluteolin (195) 3,4’,5,7-Tetrahydroxyflavone-7-O--D-glucopyranoside 
Luteolin 7-glucoside 
[5373-11-5]  [84, 89] 
Chrysoeriol (196) 4’,5,7-Trihydroxy-3’-methoxyflavone 
5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-1-
benzopyran-4-one 
[491-71-4]  [76, 94] 
Other tetrahydroxyflavones 
Cirsimaritin  (197) 4’,5-Dihydroxy-6,7-dimethoxyflavone 
5-Hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-4H-1-
benzopyran-4-one 
[6601-62-3]  [76, 94] 
Pentahydroxyflavones 
Cirsiliol  (198) 3’,4’,5,6,7-Pentahydroxyflavone 6,7-dimethyl ether
3’,4’,5-Trihydroxy-6,7-dimethoxyflavone 
[34334-69-5]  [76, 94] 
Eupatorin (199) 6-Methoxy luteolin 7,4’-dimethyl ether   
3’,5-Dihydroxy-4’,6,7-trimethoxyflavone 
5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4H-
1-benzopyran-4-one 
[855-96-9]  [76, 94, 95] 
5-Hydroxy-3',4',6,7-
tetramethoxyflavone  (200) 
3’,4’,5,6,7-Pentahydroxyflavone 3’,4’,6,7-tetra methyl ether [21763-80-4]  [96] 
4H-1-Benzopyran-4-one, 2-(2,4-
dihydroxyphenyl)-5-hydroxy-6,7-
dimethoxy- (201) 
 [101909-51-7]  [76] 
 
Hexahydroxyflavones 
2,4’,5’-Trihydroxy-5’6,7-
trimethoxyflavone (202) 
   [94] 
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Table 18. Cont. 
   
(192) (193) R1=H; R2=H                   
(194) R1=Me; R2=H                 
(195) R1=Glc; R2=H                 
(196) R1=H; R2=Me 
(197) 
 
(198) R1=H; R2=H         
(199) R1=H; R2=Me  
(200) R1=Me; R2=Me              
(201) (202) 
 
Table 19. Tetrahydroxy Flavonols. 
Name Alternative Name(s) CAS 
Number 
References 
 Kaempferols 
Kaempferol  (203)  
 
3,4’,5,7-Tetrahydroxyflavone 
3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-
benzopyran-4-one 
 4’,5,7-Trihydroxyflavonol 
[520-18-3]  [84, 89] 
Kaempferol-3-O-glucoside (204) 
 
Astragalin   
3-O--D-Glucopyranosyloxy-4’,5,7-
trihydroxyflavone 
[480-10-4]  [84, 89] 
 
Rhamnocitrin (205) 3,4’,5-Trihydroxy-7-methoxyflavone 
3,5-Dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-
4H-1-benzopyran-4-one 
4’,5-Dihydroxy-7-methoxyflavonol 
[569-92-6]  [76, 94] 
Other Tetrahydroxyflavonols 
4H-1-Benzopyran-4-one, 3-hydroxy-
6,7-dimethoxy-2-(4-methoxyphenyl)- 
(206) 
 [77184-81-7]  [71] 
 
 
 
(203) R1=H; R2=H   
(204) R1=Glc; R2=H 
(205) R1=H; R2=Me 
(206) 
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Table 20. Pentahydroxy Flavonols. 
Name Alternative Name(s) CAS Number Refs 
Quercetin 
Quercetin  (207) 3,3’,4’,5,7-Pentahydroxyflavone 
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one  
3’,4’,5,7-Tetrahydroxyflavonol 
[117-39-5]  [84] 
Quercetin 3-methyl ether  (208) 3’,4’,5,7-Tetrahydroxy-3-methoxyflavone 
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-methoxy-4H-1-
benzopyran-4-one 
[1486-70-0]  [76, 
94] 
Isoquercitrin  (209) Quercetin-3-glucofuranoside 
2-(3,4-Dihydroxyphenyl)-3-(-D-glucopyranosyloxy)-5,7-dihydroxy-
4H-1-benzopyran-4-one   
3-Glucopyranosyloxy-3’,4’,5,7-tetrahydroxyflavone 
Quercetin-3-glucopyranoside 
[21637-25-2] 
[482-35-9] 
 [71, 
89] 
Quercetin 3-rutinoside   (210)  [153-18-4]  [84] 
Isorhamnetin 3-glucoside (211) 3-Glucopyranosyloxy-4’,5,7-trihydroxy-3’-methoxyflavone [5041-82-7]  [71] 
Rhamnetin (212) 
 
 
 
3,3’,4’,5-Tetrahydroxy-7-methoxyflavone 
2-(3,4-Dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4H-1-
benzopyran-4-one 
3’,4’5-Trihydroxy-7-methoxyflavonol 
[90-19-7]  [76, 
94] 
Quercimeritrin (213) 7-O--D-glucopyranosyloxy-3,3’,4’,5-tetrahydroxyflavone 
Quercetin 7-glucoside 
[491-50-9]  [89] 
Isorhamnetin (214) 3,4’,5,7-Tetrahydroxy-3’-methoxyflavone 
3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-1-benzopyran-
4-one   
4’,5,7-Trihydroxy-3’-methoxyflavonol 
Quercetin 3’-methyl ether 
[480-19-3]  [89] 
Quercetin 3'-glucoside  (215) 3,3,’4’,5,7-Pentahydroxyflavone 3’-O--D-glucopyranoside [19254-30-9]   [84, 
89] 
Tamarixetin  (216) 3,3’,5,7-Tetrahydroxy-4’-methoxyflavone 
3,5,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-
4-one  
3’,5,7-Trihydroxy-4’-methoxyflavonol 
[603-61-2]  [76, 
94] 
Other pentahydroxyflavonols 
Eupalitin  (217) 3,4’,5-Trihydroxy-6,7-dimethoxyflavone 
3,5-Dihydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-
4-one 
4’,5-Dihydroxy-6,7-dimethoxyflavonol   
[29536-41-2]  [96] 
Penduletin (218) 3,4’,5,6,7-Pentahydroxyflavone 3,6,7-trimethyl ether 
4’,5-Dihydroxy-3,6,7-trimethoxyflavone 
[569-80-2] [76, 94, 
97] 
3,4’,5,6,7-Pentahydroxyflavone 
3,4’,6,7-tetramethyl ether  
(219) 
5-Hydroxy-3,4’,6,7-tetramethoxyflavone [14787-34-9] [61, 75, 
78,  97] 
Mikanin (220) 3,4’,5,6,7-Pentahydroxyflavone 4’,6,7-trimethyl ether  
3,5-Dihydroxy-4’,6,7-trimethoxyflavone 
[4324-53-2]  [71] 
 
(207) R1=H; R2=H; R3=H; R4=H      (212) R1=H; R2=Me; R3=H; R4=H 
(208) R1=Me; R2=H; R3=H; R4=H    (213) R1=H; R2=Glc; R3=H; R4=H  
(209) R1=Glc; R2=H; R3=H; R4=H   (214) R1=H; R2=H; R3=Me; R4=H 
(210) R1=Sugar; R2=H; R3=H; R4=H  (215) R1=H; R2=H; R3=Glc; R4=H  
(211) R1=Glc; R2=H; R3=Me; R4=H   (216) R1=H; R2=H; R3=H; R4=Me         
(217) R1=H; R2=H; R3=H 
(218) R1=Me; R2=H; R3=H 
(219) R1=Me; R2=H; R3=Me 
 (220) R1=H; R2=H; R3=Me 
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Table 21. Quecetagetin (Hexahydroxy) Flavonols. 
Name Alternative Name(s) CAS 
Number 
References 
Quercetagetin 3-methyl 
ether  (221) 
3’,4’,5,6,7-Pentahydroxy-3-methoxyflavone 
2-(3,4-Dihydroxyphenyl)-5,6,7-trihydroxy-3-methoxy-4H-1-
benzopyran-4-one 
[64190-88-1]  [89] 
Axillarin  (222) Quercetagetin 3,6-dimethyl ether 
 3’,4’,5,7-Tetrahydroxy-3,6-dimethoxyflavone 
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-1-
benzopyran-4-one 
[5188-73-8]  [76, 84]  
 
Quercetagetin-3,4’-
dimethyl ether (223) 
3’,5,6,7-Tetrahydroxy-3,4’-dimethoxyflavone 
3,3’,4’,5,6,7-Hexahydroflavone 3,4’-di-methyl ether 
[59171-34-5]  [76]   
Bonanzin (224) 5,7-Dihydroxy-3,3’,4’,6-tetramethoxyflavone 
2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-1-
benzopran-4-one 
[35688-42-7]  [96] 
Chrysosplenol D  (225) 2-(3,4-Dihydroxyphenyl)-5-hydroxy-3,6,7-trimethoxy-4H-1-
benzopyran-4-one 
[14965-20-9]  [15, 76, 84, 
92, 94, 95, 98] 
Chrysosplenetin (226) Chrysosplenol B   
5,4’-Dihydroxy-3,6,7,3’-tetramethoxyflavone  
5-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-
4H-1-benzopyran-4-one 
[603-56-5]  [15, 76, 80, 
84, 91, 92, 95, 
96, 99-101] 
Casticin  (227) Quercetagetin 6,3,7,4’-tetramethyl ether 
 3’,5-Dihydroxy-3,4’,6,7-tetramethoxyflavone   
 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-
4H-benzopyran-4-one 
[479-91-4]  [76, 84, 91, 
94, 95, 98, 99, 
100, 103] 
Artemetin (228) 5-Hydroxy-3,6,7,3’,4’-Pentamethoxyflavone 
2-(3,4,-Dimethoxyphenyl)-5-hydroxy-3,6,7-trimethoxy-4H-1-
benzopyran-4-one 
[479-90-3]  [15, 75, 77, 
78, 80, 94, 95, 
96, 98, 100, 
105, 106] 
Patuletin-3-O-glucoside 
(229)   
 
Quercetagetin 6-methyl ether 3-O-glucoside  
6-Methoxykaempferol -3-O-glucoside 
[19833-27-3]  [84] 
Patuletin  (230) 3,3’,4’,5,7-Pentahydroxy-6-methoxyflavone 
 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxy-4H-1-
benzopyran-4-one 
 3’,4’,5,7-Tetrahydroxy-6-methoxyflavonol 
[519-96-0]  [84] 
Cirsilineol  (231) 3’,4’,5,6,7-Pentahydroxyflavone  3’,6,7-tri methyl ether 
4’,5-Dihydroxy-3’,6,7-trimethoxyflavone 
[41365-32-6]  [76, 94, 95, 
98] 
Eupatin  (232) 3,3’,5-Trihydroxy-4’,6,7-trimethoxyflavone 
3,5-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-
4H-1-benzopyran-4-one 
3’,5-Dihyhdroxy-4’,6,7-trimethoxyflavonol 
Quercetagetin 4’,6,7-trimethyl ether 
[19587-65-6]  [61, 77, 98] 
Quercetagetin-6,7,3’,4’-
tetramethylether 
 (233) 
3,5-Dihydroxy-3’,4’,6,7-tetramethoxyflavone 
3,3’,4’,5,6,7-Hexahydroflavone 3’,4’,6,7-tetra methyl ether 
  [57296-14-
7] 
 [61, 71, 77, 
105, 107] 
 
Quercetagetin 4’-methyl 
ether (234) 
3,3’,4’,5,6,7-Hexahydroxyflavone 4’-methyl ether 
3,3’,5,6,7-Pentahydroxy-4’-methoxyflavone 
3’,5,6,7-Tetrahydroxy-4’-methoxyflavonol 
[161585-86-
0] 
 [89] 
(221) R1=Me; R2=H; R3=H; R4=H; R5=H 
(222) R1=Me; R2=Me; R3=H; R4=H; R5=H 
(223) R1=Me; R2=H; R3=H; R4=H; R5=Me 
(224) R1=Me; R2=Me; R3=H; R4=Me; R5=Me 
(225) R1=Me; R2=Me; R3=Me; R4=H; R5=H 
(226) R1=Me; R2=Me; R3=Me; R4=Me; R5=H 
(227) R1=Me; R2=Me; R3=Me; R4=H; R5=Me 
(228) R1=Me; R2=Me; R3=Me; R4=Me; R5=Me 
(229) R1=Glc; R2=Me; R3=H; R4=H; R5=H 
(230) R1=H; R2=Me; R3=H; R4=H; R5=H 
(231) R1=H; R2=Me; R3=Me; R4=Me; R5=H 
(232) R1=H; R2=Me; R3=Me; R4=H; R5=Me 
(233) R1=H; R2=Me; R3=Me; R4=Me; R5=Me 
(234) R1=H; R2=H; R3=H; R4=H; R5=Me 
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Table 22. Other Hexahydroxy Flavonols. 
Name Alternative Name(s) CAS Number References 
4H-1-Benzopyran-4-one 5-hydroxy-2-(2-hydroxy-3,4-
di-methoxyphenyl)-3,7-dimethoxy (235) 
 [1186306-45-5]    [15]  
 
4H-1-Benzopyran-4-one, 2-(3,5-dihydroxy-4-methoxy-
phenyl)-3-(β-D-glucopyranosyloxy)-5,7-dihydroxy- 
(236) 
 [230283-37-1]  [71] 
 
Mearnsetin (237) 3,3’,5,5’,7-Pentahydroxy-4’-methoxy-
flavone  
 2-(3,5-Dihydroxyphenyl-4-methoxy-
phenol)-3,5,7-trihydroxy-4H-1-
benzopyran-4-one  
3’,5’,5’,7-Tetrahydroxy-4’-methoxy-
flavonol 
[16805-10-0]  [71] 
Chrysosplenol E (238) 2’,3,4’,5,5’,7-Hexahydroxyflavone 
3,4’,5’,7-tetramethyl ether   
2’,5-Dihydroxy-3,4’,5’,7-tetramethoxy-
flavone 
[23289-81-8]  [80] 
5,3’-Dihydroxy, 3,6,7,5’-tetramethoxyflavone (239)    [99] 
3’,5,7,8-Tetrahydroxy-3,4’-dimethoxyflavone (240) 3,3’,4’,5,7,8-Hexahydroxyflavone 3,4’-di-
ethyl ether 
[123563-74-6]  [76, 94] 
 
   
(235) (236) R1=Glc; R2=H            
(237) R1=H; R2=H              
(238) 
 
 
(239) (240) 
 
The miscellaneous polycyclic aromatic natural product acenaphthylene, 1,2,4,5-tetrahydro- 
([54271-92-0]) (241) is also reported from A. annua [34]. 
 
 
(241) 
 
2.5. Monoterpenoids 
 
Monoterpenoids generally contain ten carbons (C10) and are the principal components of the 
essential oil of A. annua  obtained by steam distillation (or other techniques that are selective for more 
volatile natural products). It is widely believed that monoterpenes are located in the glandular 
trichomes – small structures, which are loosely attached to the surfaces of the leaves and flowers [108]. 
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The regular acyclic monoterpenes which are described in Section 2.5.1 consist of an eight-carbon 
chain, which is often functionalized at the 1-position, with methyl substituents at the 3- and 7-positions 
(Table 23). They are formed by ionization of the pyrophosphate group in one of the C10 precursors: 
geranyl pyrophosphate (GPP), neryl pyrophosphate (NPP) or linalyl pyrophosphate (LPP) (Figure 2) 
[these monoterpene precursors are, in turn, formed from the “head-to-tail” condensation of a “starter” 
molecule of dimetylallypyrophosphate (DMAPP) with a “chain extender” of isopentenyl 
pyrophosphate (IPP) (both C5)]. A. annua is also a rich source of irregular acyclic monoterpenoids  
(Section 2.5.2), which are derived from the “head-to-middle” condensation of two C5 precursors. 
 
Figure 2. Structures of isopentenyl pyrophosphate (IPP), dimethylallyl pyrophosphate 
(DMAPP), geranyl pyrophosphate (GPP), neryl pyrophosphate (NPP) and linaloyl 
pyrophosphate (LPP) which are all possible precursors to monoterpenes from A.annua. 
 
 
 
The “regular” acyclic monoterpenoid precursors can then undergo further intramolecular reactions 
to yield monocyclic monoterpenes (Section 2.5.3). The largest group of such monocyclic 
monoterpenes in A. annua is the p-menthane series (Table 25), which incorporate a single six-
membered ring. Further cyclization produces bicyclic monoterpenes (Section 2.5.4), which may 
contain an additional five-membered ring (e.g., camphanes in Table 26); or a four-membered ring 
(pinanes, Table 27); or a three-membered ring (thujanes, Table 28). Studies with 14C-labeled LPP have 
shown that in A. annua this precursor is converted to cyclised monoterpenes such as 1,8-cineole (326) 
and α-pinene (347) with greater efficiency than the alternative precusors, NPP and GPP [109]. 
2.5.1. Regular Acyclic Monoterpenes 
A cDNA  for (3R)-linalool synthase, which converts GPP to (3R)-linalool (250) by ionization of the 
pyrophosphate group, has been described recently from A. annua [110]. Most of the regular acyclic 
monoterpenes reported in Table 23 can be derived by further functional group modifications 
(dehydration, reduction or oxidation) of  linalool (250) or its isomers, geraniol (244) and nerol (248). 
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Table 23. Regular Acyclic Monoterpenoids (2,6-Dimethyloctane, 9CI, 8CI). 
Name Alternative Name(s) CAS number References 
Citronellol  (242) 3,7-Dimethyl-6-octen-1-ol [106-22-9]  [24] 
Citronellal   (243) 3,7-Dimethyl-6-octenal [106-23-0]  [28] 
Geraniol (244) (E)-3,7-Dimethyl-2,6-octadien-1-ol [106-24-1]  [22] 
Geranyl acetate   (245) (E)-3,7-Dimethyl-2,6-octadien-1-ol acetate [105-87-3]  [23, 51] 
3,7-Dimethyl-2,6-octadienyl, isobutyric 
acid, ester  (246) 
(E)-Isobutyric acid, 3,7-dimethyl-2,6-octadienyl 
ester   
[1188-06-3]  [50] 
2,6-Octadien-1-ol, 2,6-dimethyl-8-
[(tetrahydro-2H-pyran-2-yl)oxy]- (247) 
 [80444-67-3]  [23] 
 
Nerol (248) (Z)-3,7-Dimethyl-2,6-octadien-1-ol [106-25-2]  [23, 58] 
Neryl acetate (249) (Z)-3,7-Dimethyl-2,6-octadien-1-ol acetate [141-12-8]  [45] 
Linalool  (250) 3,7-Dimethyl-1,6-octadien-3-ol  [78-70-6]  [19, 28, 31, 32, 
45, 51, 74, 111] 
Linalyl acetate  (251) 3,7-Dimethyl-1,6-octadien-3-ol acetate [115-95-7]  [32, 43] 
3,7-Octadien-2-ol, 2,6-dimethyl- (252)  [62911-76-6]  [23] 
Myrcenol (253) 2-Methyl-6-methylene-7-octen-2-ol [543-39-5]  [30] 
Myrcene (254) 7-Methyl-3-methylene-1,6-octadiene [123-35-3]  [19, 23, 29, 32, 
33, 34, 43, 45, 
50, 51, 73, 112, 
113] 
Ipsdienol (255) 2-Methyl-6-methylene-2,7-octadien-4-ol [35628-00-3]  [28] 
allo-Ocimene  (256) 2,6-Dimethyl-2,4,6-octatriene [673-84-7]  [22] 
trans--Ocimene (257) 3,7-Dimethyl-1,3,7-Octatriene [27400-72-2] 
[3779-61-1] 
 [22, 32, 111] 
(E)- 3,7-Dimethyl-1,3,6-octatriene (258)  [3779-61-1]   [43] 
(Z)-3,7-Dimethyl-1,3,6-octatriene (259)  [3338-55-4]    [32, 43] 
2,6-Dimethyl-3,5,7-octatrien-2-ol (260)  [103272-78-2]  [23] 
3,7-Dimethyl-1,5,7-octatrien-3-ol (261)  [29957-43-5]    [48] 
2,6-Dimethyl-1,5,7-octatrien-3-ol (262)  [29414-56-0]  [23] 
3,7-Octadien-2-ol, 2-methyl-6-methylene 
(263) 
 [22459-09-2]  [31] 
-myrcene hydroperoxide  (264) 2-Methyl-6-methylene-3,7-octadiene-2-ol (E), 2-
hydroperoxide 
  [9, 114] 
- myrcene hydroperoxide (265) 2-Methyl-6-methylene-1,7-octadiene, 3-hydro-
peroxide 
  [9, 114] 
1,6-Octadien-4-one, 7-methyl-3-
methylene- (266) 
 [1079223-79-
2] 
 [43] 
 
1,7-Octadien-3-one, 2-methyl-6-
methylene- (267) 
2-Methyl-6-methylene-1,7-octadien-3-one [41702-60-7]  [20] 
cis-Epoxyocimene (268) 3,7-Dimethyl-1,3,6-Octatriene 6R,7-epoxide [255832-06-5]  
2,6-Dimethyl-1,3,5,7-octatetraene (269)  [90973-78-7]  [50] 
Perillene (270) 3-(4-Methyl-3-pentenyl)furan [539-52-6]  [23, 43] 
1,10-Oxy--myrcene hydroxide (271)    [9] 
1,10-Oxy--myrcene hydroxide  (272)    [9] 
 
  
(242) (243) 
 
 
(244) R1=H; R2=H 
(245) R1=(C=O)CH3; R2=H 
(246) R1=(C=O)CH(CH3)2; R2=H 
(247)       R2=OH 
 
 
 
1
2
3
4
5
6
78
9 10
OH
Molecules 2010, 15                            
 
 
7625
Table 23. Cont. 
(248) R=H 
(249) R=(C=O)CH3 
(250) R=H 
(251) R=(C=O)CH3 
  
(252) (253) 
  
(254) R=H 
(255) R=OH (256) 
  
(257) (258) 
  
(259) (260) 
 
 
(261) (262) 
  
(263) R=H(264) R=OH (265) 
  
(266) (267) 
  
(268) (269) 
 
 
(270) (271) 
(272) 
Myrcene (254) is the most abundant regular acyclic monoterpene from A. annua, and can account 
for up to 5% of the essential oil [22,33,43]. The secondary and tertiary allylic hydroperoxides, - and 
-myrcene hydroperoxide (265 and 264), have been isolated from A. annua on more than one 
occasion [9,114], and are possibly formed by an “ene”-type reaction of  molecular oxygen with the tri-
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substituted double bond in myrcene (254), occurring in the presence of light and a photosensitizer (i.e. 
singlet oxygen, 1O2), as is shown in Scheme 1. Further known reactions of these allylic hydroperoxides 
might account for the formation of other highly oxygenated myrcene monoterpenoids from A. annua, 
such as compounds 267 and 263 (Scheme 1). This propensity towards spontaneous autoxidation has 
also been suggested for several other terpenoidal hydroperoxides from A. annua, and it is repeatedly 
stressed in this review because of its perceived relvance to the biosynthesis of artemisinin (Section 
3.3). Compounds 271 and 272 are also derivatives of myrcene, in which oxidation at C-1 and C-10 has 
produced a 1,4-dihydrofuran functionality, rarely found in natural products. It has been proposed that 
the biogenesis of the secondary and teriary allylic hydroxide functionality in this pair of compounds  
might also be explained by similar autoxidation reactions of a putatative  monoterpene precursor 
(closely related to perillene (270)), which also proceeds via a pair of secondary and tertiary allylic 
hydroperoxide intermediates [9], as is shown in Scheme 1. 
Scheme 1. Postulated biosynthesis of allylic hydroperoxides: α-myrcene hydroperoxide 
(265) and β-myrcene hydroperoxide (264) via spontaneous autoxidation reactions at the tri-
substituted bond of the  precursor myrcene (254). Further reactions of such allylic 
hydroperoxides would account for the biogenesis of oxygenated monoterpenes such as 
(267), (263), (271) and (272). 
 
 
 
2.5.2. Irregular Acyclic Monoterpenes 
Phytochemists were interested in A. annua before the discovery of artemisinin because it is a rich 
source of unusual irregular acyclic monoterpenoids, such as artemisia ketone (276) [115-120], which is  
the major constituent of the essential oil in some varieties of A. annua [29,37,42,73], and can account 
for up to 50% of the total [22,25,33,43,45,53]. It is often found in conjunction with smaller amounts of 
artemisia alcohol (273) [22,33,38,121]. Artemisia ketone (276) is formed by a non-standard “head-to-
middle” condensation of DMAPP [104,122-126], which is thought to proceed as shown in Scheme 2 
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via chrysanthemyl pyrophosphate, an intermediate containing a three-membered ring. The mechanism 
for the formation of this unusual intermediate [127], is believed to mimic the formation of presqualene, 
another naturally-occuring cyclopropane, which is involved in the biosynthesis of the triterpene 
precursor, squalene (see Section 2.7.2) [128]. Two other classes of irregular cyclic monoterpenoids, 
the lavandulanes 279)–281 and the santolinanes 282 and 283, are also known from A. annua. The 
formation of all three skeletons has been explained in terms of different cleavage reactions occurring at 
each of the three carbon-carbon bonds in the cyclopropyl ring of the common precursor, chysanthemyl 
pyrophosphate (Scheme 2) [126]. 
Scheme 2. Formation of the irregular artemisyl, lavandulyl and santolinyl skeletons in A. 
annua by “head-to-middle” condensation of a DMAPP (C5) precursor and subsequent 
carbon-carbon cleavage reactions of the resulting intermediate, chryanthemyl pyrophosphate. 
 
Table 24. Irregular Acyclic Monoterpenoids. 
Name Alternative Name(s) CAS Number References 
Artemisanes 
Artemisia alcohol  (273) 3,3,6-Trimethyl-1,5-heptadien-4-ol [29887-38-5] 
[27644-04-8] 
[77363-66-7] 
 [19, 23, 29, 33, 38, 40, 43, 45, 
48, 51, 66, 73, 121] 
Artemisyl acetate (274) Artemisia alcohol acetate  
3,3,6-Trimethyl-1,5-heptadien-4-ol  acetate 
[3465-88-1] 
[29887-38-5] 
 [25, 40, 43, 45, 72, 112, 113]  
(E)-2-Butenoic acid, 2-methyl-, 2,2-
dimethyl-1-(2-methyl-1-propenyl)-
3-butenyl ester (275) 
 [62594-30-3]  [30] 
Artemisia ketone (276) 3,3,6-Trimethyl-1,5-heptadien-4-one [546-49-6]  [19, 21-24, 26, 29, 31, 33, 36, 
38, 40-45, 49, 53, 66, 72, 73, 
112, 113, 121] 
Yomogi alcohol (277) 2,5,5-Trimethyl-3,6-heptadien-2-ol [26127-98-0]  [19, 32, 38, 45] 
Artemisiatriene (278) 2,5,5-Trimethyl-1,3,6-heptatriene [29548-02-5]  [23]  
Lavandulanes 
trans-5-Hydroxy-2-isopropenyl-5-
methylhex-3-en-1-ol (279) 
3-Hexene-1,5-diol, 5-methyl-2-(1-methyl-
ethenyl)- 
[403797-33-1]  [129] 
4-Hydroxy-2-isopropenyl-5-
methylene-hexan-1-ol (280) 
   [9] 
Lavandulyl acetate (281) 5-Methyl-2-(1-methylethenyl)-4-hex-en-1-ol [20777-39-3]  [19] 
Santolinanes 
Santolina alcohol (282) 3-Ethenyl-2,5-dimethyl-4-hexen-2-ol [35671-15-9]  [19, 32, 43] 
Santolinatriene (283) 3-Ethenyl-2,5-dimethyl-1,4-hexadiene [70005-95-7] 
[2153-66-4] 
 [23, 25, 43, 45, 50] 
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Table 24. Cont. 
(273) R=H 
(274) R=(C=O)CH3 
(276) (277) 
 
 (278) (279) 
 
(280) (281) (282) 
  
 (283)  
 
Both the lavandulane tertiary allylic alcohol 279 and its secondary allylic alcohol analogue 280 
have been proposed to be derived from the precursor, lavandulol, by spontaneous autoxidation 
reactions which yield allylic hydroperoxide intermediates as shown in Scheme 3 [129]. This 
suggestion was supported by a biomimetic synthesis, in which photooxygenation of racemic lavandulol 
yielded both of the hydroperoxide intermediates expected from the reaction of singlet oxygen with the 
tri-substituted double bond in this precursor. Reduction of the tertiary allylic hydroperoxide product 
then resulted in a tertiary allylic alcohol identical with the natural product 279. 
Scheme 3. Proposed formation of lavandulanes 279 and 280 by spontaneous autoxidation reactions. 
 
2.5.3. Monocyclic Monoterpenes 
Two unusual cyclopentane monoterpeneoids, α-campholenal ([4501-58-0]) (284) [19] and 
cyclopentene, 4-ethenyl-1,5,5-trimethyl- ([1727-69-1]) (285) [23] are reported from A. annua. Both are 
probably derived from cleavage reactions of the corresponding bicyclic monoterpenoids (see Section 
2.5.4). 2-Ochtoden-1-al [26532-25-2] (286) [25] is another unusual six-membered monoterpene, 
belonging to the ochtodane class of monoterpenoids (3-ethyl-1,1-dimethylcyclohexane, 9CI). The vast 
(275
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majority of monocyclic monoterpenes from A. annua, however, are p-menthanes (Table 25), 
incorporating a six-membered ring, which is formed directly by cyclization of an LPP/NPP precursor. 
   
(284) (285) (286) 
 
Table 25. p-Menthane Monoterpenoids, 8CI (1-Methyl-4-(1-methylethyl)cyclohexane, 9CI). 
Name Alternative Name(s) CAS number References 
p-Menth-3-ene  (287)  [500-00-5]  [50] 
p-Mentha-2,4-diene (288)  [586-68-5]  [25] 
α-Phellandrene (289) p-Mentha-1,5-diene [99-83-2]  [32] 
β-Phellandrene  (290) p-Mentha-1(7),2-diene [555-10-2]  [22, 25, 45] 
α-Terpinene  (291) p-Menthan-1,3-diene [99-86-5]  [19, 32, 40, 41, 45, 
66, 74] 
-Terpinene (292) p-Menthan-1,4,diene [99-85-4]  [19, 28, 32, 40, 41, 
43, 66] 
Terpinolene  (293) p-Mentha-1,4(8)-diene   [586-62-9]  [32, 43] 
Limonene (294) p-Mentha-1,8-diene [138-86-3] 
[5989-27-5] 
 [24, 31, 34, 43, 45, 
50, 66, 111] 
p-Cymene  (295) 1-Methyl-4-isopropyl benzene [99-87-6]  [19, 24, 25, 28, 29, 
32, 34, 38, 40, 43, 45, 
48, 73, 74] 
Cuminic alcohol   (296) p-Mentha-1,3,5-trien-7-ol  
4-Isopropenylbenzyl alcohol   
[536-60-7]  [51] 
Cuminal (297) Cuminaldehyde 
p-Menthan-1,3,5-trien-1-al 
4-Isopropylbenzaldehyde 
[122-03-2]  [23, 25, 32, 43, 45] 
Carvacrol (298) p-Mentha-1,3,5-trien-2-ol [499-75-2]  [31, 32, 43] 
Thymol (299) p-Cymen-3-ol  
p-Mentha-1,3,5-trien-3-ol 
[89-83-8]  [19, 32, 43] 
p-Cymen-8-ol  (300) 2-(4-Methylphenyl)-2-propanol [1197-01-9]  [19, 25, 32] 
Menthol  (301) p-Menthan-3-ol [89-78-1]   [23, 25, 30, 60, 111] 
β-Terpineol (302) p-Menth-8-en-1-ol [7299-41-4]  [43] 
cis-p-Menth-2-en-1-ol  (303)  [29803-81-4]  [19, 45] 
trans-p-Menth-2-en-1-ol (304)  [29803-82-5]   [19, 45] 
p-Menth-2,8-dien-1-ol (305) 1-Methyl-4-(1-methylethyl)-2-cyclohexen-1-
ol 
[3886-78-0]  [32] 
trans-Carveol (306) p-Mentha-1,8-dien-6-ol, trans- [1197-07-5]  [19, 25, 41, 43, 45] 
cis-Carveol  (307) p-Mentha-1,8-dien-6-ol, cis- [1197-06-4]  [19, 41, 43]  
trans-Carvyl acetate (308) p-Mentha-6,8-dien-2-ol, acetate, trans- [1134-95-8]  [19, 31] 
cis-Carvyl acetate   (309) p-Mentha-6,8-dien-2-ol, acetate, cis- [1205-42-1]  [19] 
Carvone (310) p-Mentha-1,8-dien-6-one [99-49-0]    [19, 24, 25, 28, 32, 
43] 
p-Mentha-1(7),5-dien-2-ol (311)  [30681-15-3]  [43] 
p-Mentha-1(7),8-dien-2-ol  (312)  [35907-10-9]  [51] 
p-Menth-1-en-5-ol (313)  [55708-42-4]  [22] 
p-Mentha-1,4(8)-dien-3-ol  (314)  [6753-08-8]  [32] 
3-Cyclohexene-1-methanol 2-hydroxy-
α,α,4-trimethyl-, 1-acetate (315)  
 [138913-54-9]  [25] 
 
Iso-menthone (316) p-Menthan-3-one [491-07-6]  [45] 
Piperitone  (317) p-Menth-1-en-3-one [89-81-6]  [24] 
Terpinen-4-ol  (318) p-Menth-1-en-4-ol [562-74-3]  [19, 30, 31, 32, 34, 
41, 43, 45, 51, 66] 
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Table 25. Cont. 
4-Terpinyl acetate (319) p-Menth-1-en-4-ol acetate [4821-04-9]  [34] 
Phellandral  (320) p-Menth-1-en-7-al [21391-98-0]  [23] 
Perillaldehyde  (321) p-Mentha-1,8-dien-7-al [2111-75-3]  [45] 
α-Terpineol  (322)    
 
l-α-Terpineol  
 p-Menth-1-en-8-ol 
[98-55-5]  
[10482-56-1] 
 [19, 22, 23, 28, 32, 
40, 43, 45, 74] 
-Terpineol  (323) p-Menthen-1(7)-en-8-ol [7299-42-5]  [19] 
Limonene-1,2-epoxide (324) 
 
Limonene oxide  
1,2-Epoxy-p-menth-8-ene   
[1195-92-2]  [23, 51] 
1,4-Cineole (325) 1,4-Epoxy-p-menthane [470-67-7]    [112] 
1,8-Cineole  (326)   
 
Eucalyptol 
1,8-Epoxy-p-menthane 
[470-82-6]  [19, 22-25, 28, 29, 32, 
33, 34, 36-38, 40, 41, 
43, 45, 48-51, 53, 66, 
72-74, 112, 113] 
2,3-Dihydro-1,8-cineole  (327) 1,8-Epoxy-p-menth-2-ene [92760-25-3]  [19, 32, 41, 43] 
2-α-Hydroxy-1,8-cineole (328)  [60761-00-4]  [113] 
Ascaridole (329) 1,4-Epidioxy-p-menth-2-ene [512-85-6]  [28] 
2-Cyclohexen-1-one,  2-methyl-5-(1-
methylcyclopropyl)- (330) 
 [26541-44-6]  [43] 
 
           
(287) (288) (289) (290) (291) (292) (293) 
 
(295) R1=Me; R2=H; R3=H; R4=H 
(296) R1=CH2OH; R2=H; R3=H; R4=H 
(297) R1=CHO; R2=H; R3=H; R4= H 
(298)  R1=Me; R2=OH; R3=H; R4= H 
(299)  R1=Me; R2=H; R3=OH; R4=H                      
(300)  R1=Me; R2=H; R3=H; R4=OH 
   
   
(294)  (301) (302) 
   
(306) R=2β-OH 
(307) R=2α-OH 
(308) R=2β-O(C=O)CH3 
(309) R=2α- O(C=O)CH3     
(303) 1β-OH 
(304) 1α-OH 
(305)    (310)  (311) 
         
(312)  (313)  (314)  (315)  (316)  (317)  (318) R=H 
(319) 
R=(C=O)CH3 
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(320)  (321)  (322) (323) (324) (325)  (326)
 
   
(327) (328) (329)   (330) 
1,8-Cineole (326) is the most abundant p-menthane monoterpene from A. 
annua [22,29,40,42,43,45,73], accounting for as much as 10-30% of the essential 
oil [25,28,33,34,41,53]. 1,8-Cineole is sometimes accompanied by significant quantities of p-cymene 
(295)  [28,34] and α-terpineol (322) [28], which could be derived from opening of the ether linkage in 
1,8-cineole (326). 
Only two o-menthanes: o-cymene (1-isopropyl-2-methylbenzene [527-84-4] [25155-15-1]) 
(331) [41] and o-mentha-1(7),8-dien-3-ol ([15358-81-3]) (332) [23]; and one m-menthane: m-cymene 
(β-cymene; 1-methyl-3-(1-methylethyl)benzene [535-77-3]) (333) [31] are reported from A. annua. 
These unusual skeletons presumably arise by migration of a methyl group in the corresponding p-
menthane precursor (i.e. 331 and 333 are perhaps derived from 295). 
 
 
(331) (332) (333) 
2.5.4. Bicyclic Monoterpenes 
Further cyclization of the carbocation which produces the p-menthane skeleton results in bicyclic 
monoterpenes. In the camphane monoterpenes listed in Table 26, the second cyclization has produced 
an additional five-membered ring. The most abundant member of this class of monoterpenoids is 
camphor (341) [25,29,37,45], which can account for up to 10-30% of the essential oil [19,22,41,42]. 
Borneol (334) [46,73] and bornyl acetate (335) [29] are sometimes reported together with camphor 
(351) as significant constituents of the essential oil. 
 
OH
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Table 26. Camphane Monoterpenoids (1,7,7-Trimethylbicyclo-[2.2.1]heptane, 9CI). 
Name Alternative Name(s) CAS Number References 
Borneol  (334)  [464-43-7] 
[507-70-0] 
[124-76-5] 
 [19, 25, 29, 30, 31, 34, 40, 41, 
43, 45, 72, 73, 111, 112] 
Bornyl acetate (335)  [76-49-3] 
[92618-89-8] 
 [25, 31, 40, 45] 
Borneol  isobutyrate (336)  [24717-86-0]  [45] 
Bornyl valerate (337) Bornyl pentanoate [7549-41-9]  [31] 
2-Butenoic acid, 3-methyl-
(1S,2R,4S)-1,7,7-
trimethylbicyclo[2.2.1]hept-2-yl ester 
(338) 
 [91404-82-9]  [31] 
 
Cyclopentanecarboxylic acid, 3-
methylene-, 1,7,7-trimethylbicyclo-
[2.2.1]hept-2-yl ester (339) 
 [74793-59-2]  [31] 
 
Isobornyl acetate  (340) 2-Bornanol acetate [125-12-2]  [19] 
Camphor (341) 1,7,7-Trimethylbicyclo[2.2.1] 
heptan-2-one 
[76-22-2] 
[464-48-2] 
 [19, 23, 25, 26, 29, 32, 34, 
36-38, 40-45, 48, 49, 51, 53, 
66, 72- 74, 112, 113] 
endo-Dehydronorborneol (342) Bicyclo[2.2.1]hept-5-en-2-ol [694-97-3]  [23] 
 
 
   
(334) R=H 
(335) R=(C=O)CH3 
(336) R=(C=O)CH(CH3)2 
(337) R=(C=O)(CH2)3CH3 
(338) R=(C=O)CH=C(CH3)2 
(340) (341) 
(339)  
 
 
  (342)  
Other miscellaneous bicyclic monoterpenoids which contain both 5- and 6-membered rings are: 
camphene (2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane [79-92-5]) (343) [19,23,25,26,28,29,31,32, 
34,36,37,40,41,43,45,51,73,74,130]; camphene hydrate ([465-31-6]) (344) [19]; fenchol (fenchyl 
alcohol; 1,3,3-trimetylbicyclo[2.2.1]heptan-2-ol [1632-73-1]) (345) [66]; and trans-pinene hydrate (2-
norbornanol, 2,7,7-trimethyl-, endo-; bicyclo[2.2.1]heptan-2-ol, 2,7,7-trimethyl-, endo-; [3247-40-3]) 
(346) [25]. Camphene (343) has been obtained as both its ()- and (-)-enantiomeric forms [37]. 
     
(343) (344) (345) (346) 
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In the pinane monoterpenes (Table 27), the second cyclization of the C10 p-menthane precursor has 
produced an additional four-membered ring. α-Pinene (347) [40,42,43] is the most abundant pinane 
monoterpene from A. annua (up to 10%) [33], and sometimes co-occurrs with significant amounts of 
either β-pinene (356) [101] or pinocarvone (360) [42]. A β-pinene synthase, which converts GPP to 
both (-)-α-pinene (347) and (-)-β-pinene (356), has recently been described from A. annua [131]. α-
Pinene (347) is known in both its ()- and (-)-enantiomeric forms from this species [37]. 
Table 27. Pinane Monoterpenoids (2,6,6-Trimethylbicyclo[3.1.1]heptane, 9CI). 
Name Alternative Name(s) CAS Number References 
-Pinene  (347) 2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene [80-56-8] 
[7785-26-4] 
[7785-70-8] 
 [19, 22, 25, 28, 29, 32-34, 
36-38, 40-45, 50, 51, 66, 73, 
74, 112, 113, 120, 132] 
Verbenyl acetate (348) Verbenol acetate  
2-Pinen-4-ol, acetate 
[33522-69-9]  [23] 
trans-Chrysanthenol (349)  [38043-83-3]  [43] 
cis-Chrysanthenyl acetate (350)  [67999-48-8]  [19] 
Myrtenol (351) 2-Pinen-10-ol [515-00-4] 
[564-94-3] 
 [19, 23, 32, 41, 43, 66] 
(-)-Myrtenyl acetate (352) (-)-O-Acetylmyrtenol [36203-31-3]  [23] 
Verbenone (353) 2-Pinen-4-one  [80-57-9]  [19, 25, 34, 43, 45] 
Chrysanthenone  (354) 2-Pinen-6-one [473-06-3]  [32, 43, 66] 
Myrtenal (355) 2-Pinen-10-al [23727-16-4]  [66] 
-Pinene (356) 6,6-Dimethyl-2-methylenebicyclo[3.1.1]-
heptane 
[127-91-3] 
[1330-16-1] 
 [19, 22, 23, 25, 26, 27, 28, 
32, 33, 34, 36, 38, 40, 43, 
45, 51, 66, 73, 74, 112, 113, 
120, 132] 
(-)-trans-Pinocarveol (357) 2(10)-Pinen-3-ol [547-61-5] 
[3917-59-7] 
 [19, 23, 25, 32, 33, 40, 43] 
cis-Pinocarveol (358) Isopinocarveol 
 2(10)-Pinen-3-ol, cis- 
[6712-79-4] 
[5947-36-4] 
 [30, 43] 
Pinocarvyl acetate (359) 2(10)-Pinen-3-ol, acetate [1078-95-1]  [30] 
Pinocarvone  (360) 2(10)-Pinen-3-one [30460-92-5] 
[19890-00-7] 
 [19, 23, 25, 28, 30, 32, 33, 
42, 43, 45, 66] 
3-Pinanol (361) 2,6,6-Trimethylbicyclo[3.1.1]heptan-3-ol [25465-95-6]  [30]   
β-Pinene oxide (362) 2,10-Epoxypinane [6931-54-0]  [19] 
Bicyclo[3.1.1]heptan-3-one, 2,6,6-
trimethyl-4-methylene- (363) 
 [62594-31-4]  [30] 
 
       
(347) R1=H; R2=H; R3=H 
(348) R1=O-(C=O)CH3; R2=H; R3=H  
(349) R1=H; R2=β-OH; R3=H  
(350) R1=H; R2=α-O-(C=O)CH3; R3=H 
(351) R1=H; R2=H; R3=OH  
(352) R1=H; R2=H; R3=O-(C=O)CH3 
(353) (354) (355) 
       
 
(356) R=H 
(357) R=β-OH 
(358) R=α-OH 
(359) R= α-O-(C=O)CH3 
(360) (361) (362) (363) 
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Only two caranes  (3,7,7-trimethylbicyclo[4.1.0]heptane, 9CI): α-carene ([13466-78-9]) 
(364) [32,41] and 2-acetyl-3-carene ([40824-36-0]) (365) [23] are known from A. annua: the majority 
of monoterpenes which incorporate an additional three-membered ring belong to the thujane class 
(Table 28). Two of the most abundant thujanes are sabinene hydrate (373) [34] and sabinol (371) [43], 
both of which can be present at around levels of 7% of the total essential oil. 
    
(364) R=H  
(365) R= -O-(C=O)CH3  
Table 28. Thujane Monoterpenoids (4-Methyl-1-(1-methylethyl)-bicyclo[3.1.0]hexane, 9CI). 
Name Alternative Name(s) CAS Number References 
α-Thujene (366) 3-Thujene   
2-Methyl-5-(1-methylethyl)bicyclo[3.1.0]hex-2-ene 
[2867-05-2]  [28, 34, 41, 
43, 45, 66] 
3-Thujen-2-ol (367) Bicyclo[3.1.0]hex-3-en-2-ol, 4-methyl-1-(1-methylethyl) [3310-03-0]  [25] 
3-Thujen-10-al (368)  [57129-54-1]     [50] 
(-)-α-Thujone (369)  [546-80-5]  [45, 66, 111] 
Sabinene (370) 4(10)-Thujene 
Bicyclo[3.1.0]hexane,4-methylene-1-(1-methylethyl)-  
[2009-00-9] 
[3387-41-5] 
[204524-73-2] 
 [19, 23, 31, 
32, 34, 40, 41, 
43, 45, 51, 66, 
74, 113] 
Sabinol (371) 4(10)-Thujen-3-ol [471-16-9]  [32, 43] 
trans-Sabinyl acetate (372) Bicyclo[3.1.0]hexan-3-ol, 4-methylene-1-(1-methylethyl)-, 3-acetate [139757-62-3] 
[3536-54-7]  
 [43] 
-Sabinene hydrate (373) 4-Thujanol   [546-79-2] 
[15537-55-0] 
[17699-16-0] 
 [19, 25, 32, 
34, 41, 43, 45] 
Sabina ketone (374) Didehydrosabina ketone 
Bicyclo[3.1.0]hexan-2-one, 5-(1-methylethyl)-,  5-Isopropyl- 
bicyclo[3.1.0]hexan-2-one 
[513-20-2] 
[110716-99-9] 
[147043-52-5] 
 [19, 43] 
         
(366) R1=H; R2=Me 
(367) R1=OH; R2=Me 
(368) R1=H; R2=CHO 
(369) (370) R=H 
(371)  R=β-OH 
(372)  R=β-O-(C=O)CH3 
(373) (374) 
Tricyclene ([508-32-7] [160339-05-9]) (375) [25,32,41,43,45] is the only tricyclic monoterpenoid 
known from A. annua.   
 
             (375) 
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2.6. Sesquiterpenoids 
Sesquiterpenoids (C15) constitute the most abundant and most diverse group of natural products 
from A. annua. All are produced from farnesyl pyrophosphate (FPP; 378), which is the product of a 
“head-to-tail” condensation of three C5 units (IPP and DMAPP; see Figure 2). Sesquiterpene 
hydrocarbons are generally more volatile than their highly oxygenated counterparts and are more 
suited to study by GC-MS (cf. monoterpenes in Section 2.5, which are the other major components of 
the  essential oil from A. annua). More highly oxygenated sesquiterpenes, such as artemisinin (495), 
are best analysed by liquid chromatography.   
 
2.6.1. Farnesane Sesquiterpenes 
The farnesanes are the structurally simplest  group of sesquiterpenes. This acyclic group of natural 
products is produced by ionization of the pyrophosphate group in the 15-carbon precursor, FPP (378), 
followed either by quenching with water or loss of a proton, which results in the variety of structures 
shown in Table 29. Alternatively, FPP can undergo further cyclization to mono-cyclic sesquiterpenes 
(Section 2.6.2), bicyclic sesquiterpenes (Section 2.6.3) or tricyclic sesquiterpenes (Section 2.6.4), 
according to enzymatically-catalysed mechanisms which bear close analogies with the biosynthesis of 
the cyclized monoterpenoids (Sections 2.5.3 and 2.5.4). 
β-Farnesene (382) is the most abundant member of this class of sesquiterpenes [22,43], constituting 
up to 10% of the essential oil [19,27]. A cDNA clone encoding (E)-β-farnesene synthase, which 
catalyzes the formation of β-farnesene (382) from FPP (378), has recently been isolated from A. 
annua [133]. Interestingly, the enzyme amorpha-4,11-diene synthase, which catalyses the formation of 
the bicyclic sesquiterpene amorpha-4,11-diene, (Section 2.6.3) also produces small amounts of acyclic 
sesquiterpenes such as trans-nerolidol (380) and (E)-1,3(15),6,10-farnesatetraene (382), both of which 
are reported as natural products from A. annua [134] (Table 29). 
Table 29. Farnesane Sesquiterpenoids (2,6,10-Trimethyldodecane, 9CI). 
Name Alternative Name(s) CAS Number References 
Farnesol  (376) 2,6,10-Farnesatrien-1-ol  
3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol 
[4602-84-0] 
[106-28-5] 
 [23, 27, 135]   
2,6,10-Farnesatrien-1-ol acetate (377) 
 [4128-17-0]  [27]   
Farnesyl pyrophosphate  (378) Farnesyl diphosphate 
2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, 
trihydrogen pyrophosphate  
Diphosphoric acid, mono (3,7,11-trimethyl-2,6,10-
dodecatrienyl) ester   
[13058-04-3]  [135, 136] 
Farnesal (379) 2,6,10-Farnesatrien-1-al 
3,7,11-Trimethyl-2,6,10-dodecatrienal 
[19317-11-4]  [27] 
trans-Nerolidol (380) 3,6,10-Farnesatrien-3-ol   
3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol   
[7212-44-4] 
[3790-78-1]   
 [19, 23, 27, 32, 43, 45, 
134] 
(E)-Nerolidyl acetate (381) 
(E)-Nerolidol acetate 
1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, 3-acetate [85611-33-2] 
 [27] 
trans--Farnesene (382) (E)-1,3(15),6,10-Farnesatetraene  
(E)-7,11-Dimethyl-3-methylene-1,6,10-dodecatriene   
[77129-48-7] 
[18794-84-8] 
 [19, 22, 27, 30, 32, 43, 48, 
50, 51, 66, 134, 135] 
(Z)-1,3(15),6,10-Farnesatetraene (383) 
 [28973-97-9]  [23, 31, 32]  
α-Farnesene  (384) 
1,3,6,10-Farnesatetraene   
3,7,11-Trimethyl-1,3,6,10-dodecatetraene [502-61-4] 
[125037-13-0] 
 [27, 41, 48, 50, 74, 111] 
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Table 29. Cont. 
 
(376) R=H 
(377) R=(C=O)CH3 
(378) R=(P=O)(OH)-O-(P=O)(OH)2 
(379) 
(380) R=H  
(381) R=(C=O)CH3 
(382) 
 
(383) (384) 
  
2.6.2. Monocyclic Sesquiterpenes 
 
The six-membered ring in the bisabolane sesquiterpenes from A. annua (Table 30) is formed by 
cyclization of the C15 precursor, FPP (378), in much the same way that the p-menthane monoterpenes 
(Section 2.5.3) arise from the corresponding C10 precursor. Alternative cyclizations of FPP can lead to 
the ten-membered germacrane sesquiterpenes, which are described in Table 31, and the eleven-
membered humulane sesquiterpenes in Table 33. The bicyclic caryophyllanes, which are formed by a 
further cyclization of a humulane precursor,  have also been included in Table 33. 
 
2.6.2.1. Bisabolanes 
α- and β-Bisabolene are the most abundant bisabolane sesquiterpenes from A. annua, constituting 
up to 5% of the essential oil [28,46]. The bisabolane sesquiterpene, α-bisabolol (385), has been found 
as a minor product from the enzyme amorpha-4,11-diene synthase from A. annua (Section 2.6.3) 
[136]. Several other bisabolanes, which have not yet been reported as natural products from A. annua, 
were also obtained from the cyclization of FPP which is catalysed by this enzyme [134] [these 
included zingiberene; β-sesquiphellandrene; and zingiberenol (see Figure 3, Section 3.1)]. 
Table 30. Bisabolanes Sesquiterpenoids (1-(1,5-Dimethylhexyl)-4-methylcyclohexane, 9CI). 
Name Alternative Name(s) CAS Number References 
 -Bisabolol (385)  [515-69-5]  [31, 32, 43, 45, 134] 
cis-Lanceol (386) 2,7(14),10-Bisabolatrien-12-ol [147129-37-1]  [46] 
2,7,10-Bisabolatriene (387)  [58845-44-6]    [28] 
2,3-Epoxy-7,10-bisaboladiene (388)  [111536-37-9]    [23] 
7-Oxabicyclo[4.1.0]heptane, 4-(1,5-dimethyl-4-hexen-1-
ylidene)-1-methyl-, (1R,4Z,6S)- (389) 
 [94347-02-1]  [31] 
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Table 30. Cont. 
 
   
(385) (386) (387) 
 
(388) (389) 
 
2.6.2.2. Germacranes and Elemanes 
Germacrene D (392) is the most abundant member of the germacrane class of 
sesquiterpenes [22,37,46] and can constitute between 5-20% of the essential oil [19,42,43]. 
Germacrene A synthase, the enzyme which catalyzes the cyclization of FPP (378) to germacrene A 
(390), has recently been isolated from the glandular trichomes of A. annua [137]. Compound (395) 
([24703-35-3]) is the only example of a bicyclogermacrane sesquiterpene so far described from A. 
annua  [19,32,43,45,74].  
 
Table 31. Germacrane Sesquiterpenoids (1,7-Dimethyl-4-(1-methylethyl)cyclodecane, 9CI). 
Name Alternative Name(s) CAS Number References 
 (+)-Germacrene A  (390) Germacrene  
(1(10)E,4(E))-Germacra-1(10),4,11-triene 
[28028-64-0]  [74] 
Germacrene B (391) (1(10)E,4(E)-1(10),4,7(11)-Germacratriene [15423-57-1]  [23, 28, 46] 
Germacrene D (392) 1(10),4(15),5-Germacratiene [23986-74-5]  [19, 23, 31-33, 36, 
37, 42, 43, 45, 48, 
66, 135] 
1-Hydroxy-4(15),5(E),10(14)-
germacratriene  (393) 
   [9] 
 
Pregeijerene  (394) 11,12,13-tri-nor-1(10),4,6,-Germacratriene  
1,5-Dimethyl-1,5,7-cyclodecatriene 
[20082-17-1]  [41] 
 
 
     
(390) (391) (392) 
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Table 31. Cont. 
   
(393) (394) (395) 
 
The ten-membered germacrane ring frequently occurs with unsaturation at the 1(10) and 4-
positions, as is apparent from Table 31. The six-membered ring in the elemane sesquiterpenes (Table 
32) is thought to be formed by Cope rearrangement of such 1(10),4-germacradienes. Elemanes may 
thus be artifacts which are introduced during the extraction and isolation process, especially, perhaps, 
as a result of the high temperatures often associated with GC-MS analysis (e.g., 397 may be formed 
thermally from 391; and 396 may be formed from 390 by just such a pericyclic reaction). 
Table 32. Elemane Sesquiterpenoids (1-Ethyl-1-methyl-2,4-bis-(1-methylethyl)cyclohexane, 9CI). 
Name Alternative Name(s) CAS Number References 
-Elemene (396) 1,3,11-Elematriene [33880-83-0]  
[515-13-9] 
 [27, 31, 34, 40, 
43, 45] 
-Elemene (397) 1,3,7(11)-Elematriene [29873-99-2] 
[3242-08-8] 
 [23, 28, 31] 
-Elemene (398) 1,3,6-Elemantriene [20307-84-0]  [32, 48] 
Elemol (399) 1,3-Elemadien-11-ol [639-99-6]  [27] 
Elemyl acetate (400) Elemol acetate [60031-93-8]  [19] 
 
 
(396) (397) 
 
(398) (399) R=H 
(400) R= (C=O)CH3 
          
2.6.2.3. Humulanes and Caryophyllanes 
β-Caryophyllene (405) is the most abundant member of this group of 
sesquiterpenes [26,37,40,43,46] and can be found at levels of up to 5-10% of the total essential 
oil [19,22,42]. A cDNA clone for -caryophyllene synthase, the sesquiterpene cyclase which converts 
FPP (378) to β-caryophyllene (405) has now been isolated from  A. annua [139]. The -caryophyllene 
synthase gene was found to be expressed widely in most plant tissues during early development, and 
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could be induced in mature tissue in response to a fungal elicitor. This was interpreted as evidence that 
β-caryophyllene (405) might play a role in plant defense [139]. The enzyme amorpha-4,11-diene 
synthase  from A. annua has been observed to produce small amounts of γ-humulene (isomeric with α-
humulene (401) in Table 33 – see also Figure 3, Section 3.1), as well as the expected bicyclic 
product [134]. 
Table 33. Humulane Sesquiterpenoids (1,1,4,8-Tetramethylcycloundecane, 9CI) and 
Caryophyllane Sesquiterpenoids (2,6,10,10-Tetramethylbicyclo[7.2.0]undecane, 9CI). 
Name Alternative Name(s) CAS Number References 
Humulanes 
 -Humulene (401) 2,6,9-Humulatriene   [6753-98-6]  [19, 27, 28, 32, 40, 43, 
66] 
14-Hydroxy-α-humulene (402)  [108043-85-2]  [27] 
Humulene epoxide I (403) 2,3-Epoxy-6,9-humuladiene [19888-33-6]  [45] 
Humulene epoxide II  (404) 6,7-Epoxy-2,9-humuladiene [19888-34-7]  [27, 45] 
Caryophyllanes 
-Caryophyllene (405)  
 
(E)-3(15),6-Caryophylladiene [87-44-5]  [19, 22, 23, 24, 26, 27, 
29, 32, 36, 37, 40, 41-
43, 45, 48, 49, 51, 66, 
72- 74, 112, 140] 
-Caryophyllene (406) Isocaryophyllene 
 (Z)-3(15),6-Caryophylladiene   
[118-65-0]  [31] 
(1R,3Z,9S)-Bicyclo[7.2.0]undec-3-
ene, 4,11,11-trimethyl-8-methylene-  
(407) 
 [136296-35-0]  [50] 
 
Caryophylladienol I (408) Caryophyllenol 
Bicyclo[7.2.0]undecan-5-ol, 10,10-dimethyl-2,6-
bis(methylene)-, (1S,5S,9R)-Caryophylla-
4(12),8(13)-dien-5β-ol 
[19431-80-2] 
[38284-26-3] 
 [28, 32, 43] 
 
 
Caryophylladienol II (409) Caryophyllenol   
Bicyclo[7.2.0]undecan-5-ol, 10,10-dimethyl-2,6-
bis(methylene)-, (1S,5R,9R)-Caryophylla-
4(12),8(13)-dien-5α-ol 
[19431-79-9] 
[38284-26-3] 
 [28, 32, 43] 
Caryophyllene oxide (410) Isocaryophyllene oxide   
6,7-Epoxy-3(15)-caryophyllene   
[1139-30-6] 
[113877-94-6] 
[17627-43-9] 
[9, 19, 23, 25, 27, 30, 
32, 34, 43, 45, 48, 49, 
50, 66] 
cis-Caryophyllene oxide (411) 5-Oxatricyclo[8.2.0.04,6]dodecane, 4,12,12-
trimethyl-9-methylene-, (1R,4S,6R,10S)- 
[60594-23-2] [32] 
 
  
(401) R=H 
(402) R=-O-(C=O)CH3 
(403) (404) (405) 
   
(406) (407)                   (408) α-OH  
(409) β-OH              
(410) β-C-O
(411) α-C-O
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2.6.3. Bicyclic Sesquiterpenes 
 
2.6.3.1. Eudesmanes and Eremophilanes 
The bicyclic eudesmane sesquiterpenes (Table 34) are thought to be derived from further 
cyclization of the monocyclic germacranes (Table 31, Section 2.6.2). Eudesmanes are sometimes 
referred to as selinanes in the older literature and the most abundant eudesmane from A. annua is β-
selinene (412) [40,42]. The isolation of the eudesmane allylic hydroperoxide (414) from A. annua  is 
significant, as its structure is suggestive of formation by spontaneous autoxidation of the hydrocarbon 
precursor selina-4,11-diene (422) [9]. It has been suggested that reduction of the hydroperoxide in 414 
would then result in the allylic alcohol group observed in the natural product 5α-hydroxy-eudesma-
4(15),11-diene (413), as shown in Scheme 4 [9]. 
Scheme 4. Postulated biogenesis of (414) and (413) by spontaneous autoxidation reaction 
of (422), followed by reduction. 
 
 
Table 34. Eudesmane (Selinane) Sesquiterpenoids (Decahydro-1,4α-dimethyl-7-(1-
methylethyl)-naphthalene, 9CI). 
Name Alternative Name(s) CAS Number References 
-Selinene (412) 4(15),11-Eudesmadiene [17066-67-0]  [19, 23, 28, 30-32, 34, 
40, 42, 43, 48, 113] 
5α-Hydroxy-eudesma-4(15),11-diene (413) 4(15),11-Eudesmadien-5-ol   [9, 97] 
5α-Hydroperoxy-eudesma-4(15),11-diene (414)    [9] 
1,6-Dihydroxy-4(15)-eudesmane (415)    [9] 
1-Hydroxy-4(15),5-eudesmadiene (416)    [9] 
1-Hydroxy-4(15),7-eudesmadiene  (417)    [9] 
γ-Selinene  (418) 4(15),7(11)-Eudesmadiene  
4(15),7(11)-Selinadiene 
[515-17-3]  [45, 48] 
β-Eudesmol  (419)    4(15)-Eudesmen-11-ol [473-15-4]  [45] 
α-Selinene  (420) (5α,7β,10β)-α-Eudesmane 
 3,11-Eudesmadiene 
Selina-3,11-diene 
[473-13-2]   [34, 111] 
 
Kongol  (421) 11-Eudesmen-4-ol(4α,5α,7β,10β) 
Selin-11-en-4α-ol   
[16641-47-7]  [19, 27] 
Selina-4,11-diene (422) Eudesma-4,11-diene [17627-30-4]  [135] 
γ-Eudesmol  (423) 4-Eudesmen-11-ol [1209-71-8]  [27] 
10-epi-γ-Eudesmol  (424) 4-Eudemen-11-ol (7β,10α) [15051-81-7]  [27, 45] 
Occidentalol  (425) 1,3-Eudesmadien-11-ol [473-17-6]  [27] 
Occidentalol acetate (426)  [346608-97-7]  [27] 
Occidol  (427) 1,2,3,4-Tetrahydro-α,α-5,8-
tetramethyl-2-naphthalenemethanol 
[5986-36-7]  [27] 
Artemisin  (428)    [141] 
α-Hydroxysantonin (429)    [142] 
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Table 34. Cont. 
   
(412) R1=H 
(413) R1=OH 
(414) R1=OOH 
(415) (416) 
  
(417) (418) (419) 
(420) (421) (422) 
  
(423) β‐Me 
(424) α‐Me 
(425) R=H 
(426) R=(C=O)CH3 
(427) 
  
 (428) R1=OH; R2=H 
(429) R1=H; R2=OH 
 
 
The eremophilane skeleton (decahydro-1,8a-dimethyl-7-(1-methylethyl)naphthalene, 9CI) is 
thought to be derived from the eudesmane skeleton by migration of the C-10 methyl group to C-5 [16]. 
Two eremophilanes: nootkatone (1(10),11-eremophiladiene-2-one [4674-50-4]) (430) [22,43] and 
valencene  (1(10),11-eremophiladiene (4α,5α,7β) [4630-07-3]) (431) [28] are currently reported from 
A. annua. The aristolane sesquiterpenoid, β-gurjunene (1(10)-aristolene [73464-47-8]) (432) [34], is 
the only example of a 6,11-cycloeremophilane from this species. 
O
O
O
R2
R1
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(430) (431) (432) 
 
2.6.3.2. Cadinanes, Muurolanes and Amorphanes 
The amorphane/cadinane group of bicyclic sesquiterpenes is by far the largest class of 
sesquiterpenes found in A. annua. Unfortunately, the nomenclature and stereochemistry reported for 
cadinanes and amorphanes in the literature has sometimes become quite confusing. In this review, the 
relative stereochemistry at the 1-, 6- and 7-positions is used to define four skeletal types, according to 
guidelines which are set out in the Dictionary of Natural Products [16]. Thus, in the cadinane skeleton, 
the decalin ring is trans-fused (1α,6,7β), while in the muurolane skeleton (1,6,7β), it is cis-fused. 
The cadinane and muurolane sesquiterpenes found in A. annua have been grouped together in Table 
35. Amorphane sesquiterpenes also incorporate a cis-decalin ring junction, but differ from the 
muurolane sesquiterpenes in their relative stereochemistry at the 7-position. The very large group of 
amorphane sesquiterpenes from A. annua  is listed in Table 36. (No representative of the bulgarane 
sesquiterpenes (1α,6,7α), the fourth possible skeleton allowed by this classification scheme, is known 
from A. annua). 
Table 35. Cadinane and Muurolane Sesquiterpenoids (Decahydro-1,6-dimethyl-4-(1-
methylethyl)-naphthalene, 9CI). 
Name Alternative Name(s) CAS number References 
Cadinanes    
Artemisinol (433) 12-Cadinanol [82890-78-6]  [143] 
-Cadinene  (434) 1(10),4-Cadinadiene  [483-76-1]  [19, 23, 30, 31, 
32, 40, 43, 48, 
51] 
14-Hydroxy--cadinene  (435)  [153408-92-5]  [27] 
4(15),5,11-Cadinatriene (436) 1-epi-Bicyclosesquiphellandrene [54274-73-6]  [48] 
-Cadinene (437) 4,9-Cadinadiene [24406-05-1]  [111, 130] 
β-Cadinene (438) 3,9-Cadinadiene [523-47-7]  [22, 66] 
γ-Cadinene (439) 4(10),15-Cadinadiene [39029-41-9]    [32, 34, 40, 43] 
-Cadinol (440) 4-Cadinen-10-ol [481-34-5]  [19, 43, 45] 
γ-Cadinol (441) 2-Naphthalenol, 1,2,3,4,4a,7,8,8a-octahydro-2,5-
dimethyl-8-(1-methylethyl)- 
[50895-55-1]  [45] 
cis-Calamenene  (442)  [72937-55-4]  [32, 43] 
Cubenol (443) 4-Cadinen-1-ol [21284-22-0]  [19, 43] 
epi-Cubenol (444) 4-Muurolen-1-ol [19912-67-5]    [41] 
Muurolanes    
γ-Muurolene (445) 4,10(14)-Muuroladiene [30021-74-0]  [43] 
-Muurolene  (446) 4(15),10(14)-Muuroladiene [1136-29-4]  [23] 
4-Muurolen-10-ol (447) Cedrelanol [5937-11-1]    [25] 
t-Muurolol (448) 4-Muurolen-10-ol (1β, 6β, 7β,10β) [19912-62-0]    [19] 
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Table 35. Cont. 
  
(433) (434) R=H 
(435) R=OH 
(436) 
 
(437) (438) (439) 
 
(440) (441) (442) 
 
(443) (444) (445) 
 
(446) (447) (448) 
 
Both the synthesis [144] and NMR properties [145,146] of amorphane and cadinane sesquiterpenes 
from A. annua have been reviewed. Artemisinic acid (473) [105,147,148], arteannuin B 
(462) [105,147,149] and artemisinin (495) [105,147,150] are the most abundant representatives of this 
class of natural products and were amongst the first sesquiterpenes to be reported from A. annua. 
Several of the amorphane sesquiterpenes in Table 36 have since been implicated as biosynthetic 
precursors to artemisinin (495), which has been classified as a seco-cadinane in Table 37 (the prefix 
“seco-“ indicates that carbon-carbon bond cleavage has occurred – in this case between C-4 and C-5). 
HO
1
2
3
4
5
6
7 8
9
10
11
12 13
14
15
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The amorphane sesquiterpene, artemisinic acid (473) (Table 36) was first isolated in 1981 by Prof 
Tu's group [151]. Its structure was confirmed both by X-ray crystallography [148,152] and by NMR 
spectroscopy [153]; and subsequently by synthesis [154,155]. Depending on the chemotype of A. 
annua being studied, artemisinic acid (473) can be present at ten times the concentrations of 
artemisinin (495). For this reason, much research has been undertaken into the chemical conversion of 
artemisinic acid (473)  to artemisinin (495), which can be achieved with  an efficiency of greater than 
40% [156,157] (see also Section 4.4 for an application of this conversion to the production of 
artemisinin). By varying the conditions for the oxidation step, artemisinic acid (473) can be converted 
to various other sesquiterpenes from A. annua, including: arteannuin B (462) [158, 159], 
deoxyarteannuin B (477) [160] and epi-deoxyarteannuin B (478) [161,162] (note that deoxyarteannuin 
B (477) [129,161], epi-deoxyarteannuin  (478) [68,158,160,163,164] and 6, 7-dehydroartemisinic acid 
(476) [165] have all also been obtained independently by chemical synthesis). 
Dihydroartemisinic acid (480), which is the 11,13-dihyro analogue of artemisinic acid (473) in 
Table 36, was first isolated as a natural product several years after artemisinic acid [166,167] and it has 
also been chemically synthesised [168,169]. It is particularly significant that dihydroartemisinic acid 
hydroperoxide (481), the tertiary allylic hydroperoxide from dihydroartemisinic acid, has also been 
isolated as a natural product from A. annua [170]. This has led to the suggestion that  
dihydroartemisinic acid (480)  might be converted to its tertiary hydroperoxide (481) in the living plant 
by a non-enzymatic process as shown in Scheme 5. This hypothesis has apparently been confirmed by 
recent in vivo and in vitro experiments [155,185] (see Section 3.3) which also suggested that (481) can 
undergo further non-enzymatic conversion to (495). 
Although both artemisinic acid (473) and dihydroartemisinic acid (480) are the most signifcant 
amorphane sesquiterpenes from A. annua in regard of the biosynthesis of artemisinin (495), several 
other amorphanes from this species have also been implicated in this process (see Section 3.3). These 
amorphane sesquiterpenes appear amongst the alphabetical listings in Table 36. Arteannuin A (461) 
was one of the first sesquiterpenes to be reported from A. annua and it has since been synthesized on 
two occasions [171,172]. The structure of arteannuin B (462) was  determined  in 1972 by X-ray 
crystallography [173] in combination with 1D- [174] and 2D- [175] NMR spectroscopy,  and  it has 
also been confirmed by chemical reactions [176]. Several syntheses of arteanuin B are 
reported [158,171,177-179] and  arteannuin C [180] is now thought to be identical with arteannuin 
B [175]. Syntheses have also been reported of arteannuin E (463) [181] and arteannuin F (464) [182] 
(which is also referred to as artemisilactone) [171].  
The structures of arteannuin H (465) [166,183], arteannuin I (466) [166], arteannuin  J (467)  [166], 
arteannuin K (468)  [166,184], arteannuin L (469) [166,184] and arteannuin M (470) [166,184] were 
all deduced by 2D-NMR spectroscopy, when they were first described as natural products from A. 
annua. All of these compounds have been reported as metabolites of dihydroartemisinic acid (480) in 
vivo (Scheme 5) [185], and there is evidence from in vitro studies to support the biogenetic proposal 
that arteannuin H (465) might be produced by spontaneous autoxidation reactions involving a 
secondary allylic hydroperoxide, which is derived from dihydroartemisinic acid (480) as shown in 
Scheme 5 [183]. The stereochemistry of the 5-hydroxyl group was wrongly assigned when arteannuins 
K (468), L (469) and M (470) were first reported as natural products [166]. The correct 
stereochemistry at the 5-OH group has now been established as α (as drawn) by 2D-NMR studies 
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involving derivitization of synthetic arteannuins K, L and M as their Mosher esters [184]; and by 
chemical synthesis of  both natural (-)-arteannuin M [184] and its ()-enantiomer  [186-188]. The 
structure of the natural product arteannuin O (471), which is epimeric with  arteannuin M (470) at the 
4-position, was confirmed by X-ray crystallography; arteannuin O (471) has also been obtained by a 
reconstructive synthesis from artemisinin (495) via dihydro-epi-dexoyarteannuin B (485) [184]. 
Scheme 5. Proposed biogenesis of arteannuin H (465) and other amorphane sesquiterpenes 
from A. annua via tertiary and allylic secondary hydroperoxides which are derived from 
spontaneous autoxidation of dihydroartemisinic acid (480)/artemisinic acid (473). 
 
All of the five-membered lactones, dihydro-deoxyarteannuin B (484) [129], dihydroarteannuin B 
(479) [166,189] and dihydro-epi-deoxyarteannuin B (485) [166,189] were also fully characterized by 
2D-NMR when first reported as natural products. Dihydro-epi-deoxyarteannuin B (485) has since been 
obtained by synthesis on several occasions [68,169,190-192] and is probably derived from the allylic 
hydroperoxide (481) in vivo as shown in Scheme 5. 4,5-Epoxy-6-hydroxy amorphan-12-oic acid 
(489) can be regarded as the lactone-ring opened analogue of dihydroarteannuin B (479) [193]; and α-
epoxyartemisinic acid (487) has also been obtained by synthesis [194]. 
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Table 36. Amorphane Sesquiterpenoids (Decahydro-1,6-dimethyl-4-(1-methylethyl)-naphthalene, 9CI). 
Name Alternative Name(s) CAS Number References 
4,7(11)-Amorphadien-12-al (449) Cadin-4,7(11)-dien-12-al (name ascribed by original authors) [67604-12-0]  [66] 
4(15),11-Amorphadien-9-one (450) Cadin-4(15),11-dien-9-one (name ascribed by original 
authors) 
[159662-31-4]  [66] 
(-)-Amorpha-4,11-diene (451) Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-4,7-dimethyl-1-(1-
methylethenyl)-, (1R,4R,4aS,8aR)- 
[92692-39-2]  [135, 136, 196] 
 
4-Amorphene-3,7-diol (3,7) (452)    [97] 
4-Amorphene-3,7-diol (3,7), acetate-   
(453) 
7-Dihydroxyamorph-4-ene 3-acetate   [9] 
4-Amorphen,3,11-diol (454) 1-Naphthalenemethanol, 1,2,3,4,4a,5,6,8a-octahydro-6-
hydroxy-α,α,4,7-tetramethyl- 
[159662-32-5]  [66] 
4-Amorphen,3,11-diol 3-(2-
methylpropanoyl) (455) 
3-Isobutylcadin-4-en-11-ol [159662-30-3]  [66] 
Amorph-4-en-7-ol  (456) 1-Naphthalenol, 1,2,3,4,4a,5,6,8a-octahydro-4,7-dimethyl-1-
(1-methylethyl)-, (1R,4R,4aS,8aR)- 
[140385-39-3]  [134] 
 
Annulide (457) Naphtho[1,8-bc]pyran-2(3H)-one, decahydro-6-methyl-3,9-
bis(methylene)-[3aR-3aα,6α,6aα,9aβ,9bα)- 
[103739-95-3]  [97, 128, 129, 182, 
197] 
trans-Arteannuic alcohol (458) Artemisinic alcohol  
Amorpha-4,11-dien-12-ol  
1-Naphthaleneethanol, 1,2,3,4,4a,5,6,8a-octahydro-4,7-
dimethyl-β-methylene-, (1R,4R,4aS,8aR) 
[125184-95-4] [27, 32, 43, 135, 196]  
 
cis-Arteannuic alcohol (459) 4,11(13)-Cadinadien-12-ol [147648-62-2]  [27, 32, 43] 
Artemisinic aldehyde (460) 1-Naphthaleneacetaldehyde, 1,2,3,4,4a,5,6,8a-octahydro-4,7-
dimethyl-α-methylene-, (1R,4R,4aS,8aR)- 
[125276-60-0]  [135, 196] 
Arteannuin A (461) Artemisinin I  
Qinghaosu I 
[82442-48-6]  [56,171,172, 
198,199] 
 
Arteannuin B  (462) Qing Hau Sau II  
Arteannuin C 
[50906-56-4] [15, 20, 25, 55, 59,69 
 96, 105, 147, 149, 
153] 
Arteannuin E (463) Qinghaosu V 
 4-Hydroxy-11(13)-amorphen-12,5-olide; 4,5  
[82003-84-7] 
 
 [56, 132, 147, 150, 
176, 180, 182, 199, 
205] 
Arteannuin F (464) Artemisilactone  
4-Hydroxy-11(13)-amorphen-12,5-olide 4,5 
[92691-97-9] [56, 99, 132, 147, 150, 
Arteannuin H (465) Naphtho[1,8-cd]-1,2-dioxepin-3(4H)-one, decahydro-4,7-
dimethyl-10-methylene- (4R,4aR,7R,7aS,10aS,10bS)- 
[207446-83-1]  [166, 183] 
Arteannuin I (466) Naphtho[1,8-bc]pyran-2(3H)-one, decahydro-3,6-dimethyl-9-
methylene- (3R,3aR,6R,6aS,9aS,9bS)- 
[207446-85-3]  [129, 166] 
Arteannuin J (467) Naphtho[1,8-bc]pyran-2(3H)-one, 3a,4,5,6,6a,7,9a,9b-
octahydro-3,6,9-trimethyl (3R,3aR,6R,6aS.9aS,9bS)-   
[207446-87-5]  [129, 166, 201] 
Arteannuin K (468) 2H-Naphtho[8a,1-b]furan-2-one, 3,3a,4,5,6,6a,7,10-
octahydro-10-hydroxy-3,6,9-trimethyl-, 
(3R,3aS,6R,6aS,10R,10aS)- 
[207446-88-6]  [166, 206] 
Arteannuin L (469) 2H-Naphtho[8a,1-b]furan-2-one, decahydro-10-hydroxy-3,6-
dimethyl-9-methylene-, (3R,3aS,6R,6aS,10R,10aS)- 
[207446-89-7]  [166, 206] 
Arteannuin M (470) 2H-Naphtho[8a,1-b]furan-2-one, decahydro-9,10-dihydroxy-
3,6,9-trimethyl-, (3R,3aS,6R,6aS,9R,10R,10aS)- 
[207446-90-0]  [166, 186, 187] 
Arteannuin N (472) 5-Oxo-3-amorphen-12-oic acid [207446-92-2]   [166] 
Arteannuin O (471) 2H-Naphtho[8a,1-b]furan-2-one, decahydro-9,10-dihydroxy-
3,6,9-trimethyl-, (3R,3aS,6R,6aS,9S,10R,10aS)- 
[382600-19-3]  [184] 
Artemisinic acid (473) Arteannuic  acid 
4,11(13)-Amorphadien-12-oic acid 
Qing Hau acid 
[80286-58-4] [15, 20, 31, 55, 56, 59 
61, 65, 69, 105, 143,  
147, 148, 153, 160, 
163, 164, 184, 198 
200, 204, 207-211] 
Artemisinic acid, methyl ester (474) Methyl artemisinate 
4,11(13)-Amorphadien-12-oic acid methyl ester 
[82869-24-7]    [97, 143, 166, 212] 
Artemisinin B (475) 1-Naphthaleneacetic acid, 1,2,3,4,4a,5,8,8a-octahydro-8,8a-
dihydroxy-4,7-dimethyl-α-methylene-, (1S,4R,4aS,8R,8aR)- 
[145941-07-7]  [65] 
6,7-Dehydroartemisinic acid (476) 4,11(13)-Amorphadien-12-oic acid 
6,7-didhydro 
 4,6,11(13)-Cadinatrien-12-oic acid 
[120193-24-0]  [160, 163, 213]  
 
Deoxyarteannuin B (477) Deoxyisoartemisinin C [128301-55-3]  [97, 129, 163, 175, 
201, 214, 215] 
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Table 36. Cont. 
epi-Deoxyarteannuin B (478) Deoxyisoartemisinin B [84237-06-9]  [68, 96, 97, 129, 158, 
160, 163, 164, 197] 
Dihydroarteannuin B (479) 3H-Oxireno[7,8]naphtho[8a,1-b]furan-3-one, 
decahydro-4,7,9a-trimethyl- [1aR-
(1aα,1bR,4β,4aβ,7β,7aβ,9aα)]- 
[64390-16-5]  [166] 
11R-(-)-Dihydroartemisinic acid  (480) 4,11(13)-Amorphadien-12-oic acid (11R,13-dihydro) [85031-59-0]  [20, 32, 43, 135, 166, 
167, 216] 
Dihydroartemisinic acid hydroperoxide  (481) 4-Hydroxyperoxy-5-amorphen-12-oic acid, 4, 11R [85031-60-3]  [167, 170, 185] 
Dihydroartemisinic alcohol (482) 1-Naphthaleneethanol, 1,2,3,4,4a,5,6,8a-octahydro-
α,4,7-trimethyl-, (1R,4R,4aS,8aS)- 
[855425-50-2]  [135] 
Dihydroartemisinic aldehyde (483) 1-Naphthaleneacetaldehyde, 1,2,3,4,4a,5,6,8a-
octahydro-α,4,7-trimethyl-, (1R,4R,4aS,8aS)- 
[855425-51-3]  [135] 
Dihydro-deoxyarteannuin B (484) 2H-Naphtho[8a,1-b]furan-2-one, 3,3a,4,5,6,6a,7,8-
octahydro-3,6,9-trimethyl- [3R-(3α,3aβ,6β,6aβ,9aR)]- 
[89956-69-4]  [129] 
Dihydro-epi-deoxyarteannuin B (485) 4-Cadinen-12,6-olide (6,10H,12H) [104196-16-9]  [60, 68, 129, 166] 
Dihydroxycadinanolide (486)    [217] 
α-Epoxyartemisinic acid (487) -Epoxy-arteannuic acid   [129, 160, 194] 
-Epoxy-dihydroartemisinic (488)    [9]   
4,5-Epoxy-6-hydroxy amorphan-12-oic 
acid (489) 
   [9] 
Isoannulide (490) Naphtho[1,8-bc]pyran-2(3H)-one, 3a,4,5,6,6a,7,9a,9b-
octahydro-6,9-dimethyl-3-methylene-, [3aR-
(3aα,6α,6aα,9aβ,9bα)]- 
[103739-94-2]  [97, 128, 129, 182, 
197] 
2-Naphthalenol, decahydro-1-methyl-6-
methylene-4-(1-methylethenyl)- (491) 
 [159662-33-6]  
 
 [66] 
Verboccidentene (492) Amorpha-4,7(11)-diene [79982-58-4]  [134] 
 
       
(449) (450) (451) (452) R1=OH; R2=OH; R3=H 
(453) R1=O-(C=O)CH3; R2=OH; R3=H 
(454) R1=OH; R2=H; R3=OH 
(455) R1=O-(C=O)CH(CH3)2; R2=H; R3=OH 
(456) R1=H; R2=OH; R3=H 
 
 
     
(457) (458) α‐H; R=CH2OH
(459) β‐H; R=CH2OH 
(460) α‐H; R=CHO 
(461) (462) 
   
(463) β‐C‐O 
(464) α‐C‐O 
(465) (466) (467) 
H
H R2
R1
R3
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Table 36. Cont. 
  
 
(468) (469) (470) α‐C‐O 
(471) β‐C‐O 
(472) 
   
(473) R=H 
(474) R=Me 
(475) (476) (477) α‐C‐O 
(478) β‐C‐O 
 
   
(479) (480) R=CO2H 
(482) R=CH2OH 
(483) R=CHO 
(481) (484) α‐C‐O 
(485) β‐C‐O 
 
  
(486) (487) (488) R=H 
(489) R=OH 
(490) 
  
 (491) (492)  
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It is interesting to note that nine of the structures reported in Tables 36 and 38 occur in both their 
11,13-dihydro and 11,13-dehydro forms. These nine pairs are listed in Table 37. 
 
Table 37. Amorphane and seco-amorphane natural products from A. annua which occur as 
both 11,13-dihydro and 11,13-dehydro forms. 
11,13-Dihydro form 11,13-Dehydro form 
Dihydroartemisinic acid (480) Artemisinic acid (473) 
Dihydroarteannuin B(479) Arteannuin B (462) 
Dihydro-epi-deoxyarteannuin B(485) epi-Deoxyarteannuin B (478) 
Dihydro-deoxyarteannuin B (484) Deoxyarteannuin B (477) 
α-Epoxy-dihydroartemisinic acid (488) α-Epoxy-artemisinic acid (487) 
Dihydro-seco-cadinane (493) seco-Cadinane (494) 
Arteannuin I (466) Annulide (457) 
Arteannuin J (467) Isoannulide (490) 
Artemisinin (495) Artemisitene (497) 
Feeding labelled dihydroartemisinic acid (480) to A. annua resulted in sixteen labelled amorphane 
and cadinane sesquiterpenes [185], which included all nine of the 11,13-dihydro forms in the “pairs” in 
Table 37 (*The complete list of metabolites of (480) is: artemisinin (495), dihydroarteannuin B (479), 
dihydro-epi-deoxyarteannuin B (485), arteannuin M (470), the seco-cadinane (493), the tertiary 
hydroperoxide of dihydroartemisinic acid (481), dihydro-deoxyarteannuin B (484), deoxyartemisinin 
(499), arteannuin K (468), arteannuin L (469), arteannuin H (465), arteannuin I (466), arteannuin J 
(467) and -epoxy-dihydroartemisinic acid (488). 
* The most significant products from this feeding study were dihydroarteannuin B (479), dihydro-
epi-deoxyarteannuin B (485) and the dihydro seco-cadinane (493). The pattern of transformations of 
dihydroartemisinic acid (480) which was observed in vivo very closely paralleled the spontaneous 
autoxidation chemistry for dihydroartemisinic acid which had previously been demonstrated in 
vitro [193,218]. This has lead to the proposal that the main metabolic route to all three of these 
metabolites and artemisinin (495) in A. annua involves the spontaneous autoxidation of 
dihydroartemisinic acid (480) and the subsequent chemical reactions of the derived tertiary allylic 
hydroperoxide (481), as is shown  in Scheme 6.  
Scheme 6. The most dominant products from metabolism of dihydroartemisinic acid (480) 
in vivo in A. annua plants. 
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When labeled artemisinic acid (473), the 11,13-dehydro analogue of dihydroartemisinic acid (480), 
was fed to intact A. annua plants, slightly fewer labeled metabolites were isolated [155]. However, all 
seven metabolites from this experiment are also known as natural products from A. annua and six of 
the seven feature in the pairs of metabolites discussed in Table 37. The most abundant metabolite from 
feeding artemisinic acid (473) was arteannuin B (462), followed by epi-deoxyarteannuin B (478) and 
the seco-cadinane (494) as shown in Scheme 7 (the remaining four metabolites are: annulide (457), 
isoannulide (490), deoxyarteannuin B (477) and artemisinic acid methyl ester (474), which were all 
isolated in trace amounts. 
It is intriguing to note that there are exact structural homologies between six of the seven highly 
oxygenated 11,13-dehydro sesquiterpenes which have been isolated as metabolites of artemisinic acid 
(473) and a subset of the sixteen 11,13-dihydro metabolites which were obtained in the preceding 
study with dihydroartemisinic acid (480) (see Table 37). Clearly, the in vivo transformations of 
artemisinic acid (473) closely parallel those of its 11,13-dihydro analogue, dihydroartemisinic acid 
(480), as is shown by Schemes 5, 6 and 7. (However, note that in the case of artemisinic acid (473), no 
allylic hydroperoxide analogous to (481) in Scheme 6 was isolated in vivo as a natural product, and its 
existence as an intermediate in Scheme 7 must therefore be inferred. Such an allylic hydroperoxide 
can, however, be produced in the laboratory by chemical reactions with 1O2 and it is known to  undergo 
in vitro several of the transformations which are depicted in vivo in Scheme 7). 
Scheme 7. The most dominant products from metbolism of artemisinic acid (473) in vivo 
in A. annua plants.  
 
It seems likely therefore that similar mechanisms are operative in the metabolism of both 
dihydroartemisinic acid (480) and artemisinic acid (473). These biological transformations have been 
proposed to involve spontaneous autoxidation of the 4,5 double bond in (473)/(480) and subsequent 
rearrangements of the resultant allylic hydroperoxides [155,185]. In addition, feeding experiments with 
both labeled precursors appear to show that artemisinic acid (473) and dihydroartemisinic acid (480) 
are NOT mutually interconvertible; rather, each is the committed precursor to the two large families of 
highly oxygenated 11,13-dehydro and 11,13-dihydro sesquiterpene metabolites which are known from 
this species (see, for example, the nine pairs of compounds in Table 37). This observation fits well 
with the reported occurrence of two chemical races of A. annua: a low-yielding-artemisinin 
chemotype, which is rich in artemisinic acid;  and a high-yielding-artemisinin chemotype, which also 
contains significant quantities of dihydroartemisinic acid, as discussed in Section 4.1. 
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2.6.3.3. Seco-Cadinanes 
Artemisinin (495) is a seco-cadinane sesquiterpene, which was first isolated from A. annua in 1972. 
The unusual endoperoxide group in artemisinin  has been confirmed by a variety of means  [219-226] 
and the absolute stereochemistry of artemisinin has been established by X-ray crystallography [227]. 
Many total [171,228-235] and partial syntheses [236-239] of artemisinin have been reported and the 
various synthetic strategies have been reviewed [144]. Artemisitene (497), the 11,13-dehydro analogue 
of artemisinin, is present in A. annua at much lower levels than artemisinin (typically concentrations in 
the order of 0.01%, as compared with 1%) [240], although artemisitene can be obtained readily by 
chemical transformations of artemisinin [165,213,241,242]; and a partial synthesis of artemisitene 
from artemisinic acid (473) has also been reported [243].  
Artemisinin (495) is believed to be localized primarily within the glandular trichomes of A. annua, 
which are loosely attached to the leaf surface [244]. Perhaps because of this highly accessible location, 
it has been claimed that artemisnin can be extracted in 97% yield simply by dipping a leaf in 
chloroform for 5 seconds!  
Table 38. Seco-Cadinane, nor-Cadinane and abeo-Cadinane Sesquiterpenoids. 
Name Alternative Name(s) CAS 
Number 
References 
1-Aldehyde-2-[3-butanone]-3-
methyl-6-[2-propanoic acid]-
cyclohexane (493) 
   [9] 
1-Aldehyde-2-[3-butanone]-3-
methyl-6-[2-propenoic acid]-
cyclohexane (494) 
4,5-Dioxo-4,5-seco-11(13)cadinen-12-oic acid    [9, 217] 
Artemisinin  (495) Arteannuin 
Qinghaosu  
Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-
pyrano[4,3-j]-1,2,benzodioxepin-10(3H)-one 
[63968-
64-9] 
 [4, 5, 15, 20, 34, 55, 56, 59, 69, 82, 91, 
95, 96, 98, 105, 147, 150, 156, 171, 198, 
200, 203, 204, 211, 213, 214, 215, 220, 
230, 231, 234, 236, 239, 245- 252] 
Arteannuin G (496)    [9, 56, 132, 147, 150, 176, 180, 182, 
199, 205, 253] 
Artemisitene (497) Artemisinin, 11,13-didehydro [101020-
89-7] 
 [25, 55, 149, 200, 213, 250] 
Arteannuin D (498) 3α-Hydroxy-deoxyartemisinin  
Qinghaosu IV  
Artemisinin IV 
[82003-
85-8] 
 [15, 56] 
Deoxyartemisinin (499) Deoxyarteannuin 
Qing Hau Sau III 
Artemisinin III 
Octahydro-3,6,9-trimethyl-10αH-9,10b-epoxy-
pyrano[4,32-jk][2]benzoxepin-2(3H)-one 
[72826-
63-2] 
[56,59,60,105,132,145,147,169,229,254] 
3-Hydroxy-4,5-epoxy-7-oxo-
(8[76]-abeo-amorphane (500) 
   [9] 
Norannuic acid (501)  [152135-
59-6] 
 [199] 
Norannuic acid formyl ester (502)    [9] 
15-nor-10-Hydroxy-oplopan-4-oic 
acid  (503) 
   [9] 
 
1-Oxo-2-[3-butanone]-3-
methyl-6-[2-propanoic acid]-
cyclohexane (504) 
   [9] 
1-Oxo-2-[3-butanone]-3-
methyl-6-[2-propanol formyl 
ester]-cyclohexane (505) 
   [9, 218] 
 
 
Molecules 2010, 15                            
 
 
7652
Table 38. Cont. 
   
(493) R=CH3       
(494) R=CH2 
(495) R1=H; R2=Me; n=2 
(497) R1=H; R2=CH2; n=2 
(498) R1=OH; R2=Me; n=1 
(499) R1=H; R2=Me; n=1 
(496) 
 
 
 
(500) (501) R=H  
(502) R=CHO 
(503) 
  
 (504) R=CO2H 
(505) R=CH2OCHO 
 
 
Deoxyartemisinin (499) is some 100-300 times less potent than artemisinin (495) as an antimalarial 
drug, which demonstrates that the peroxy linkage in artemisinin is indeed necessary for its biological 
activity. Several syntheses of deoxyartemisinin have been reported [171,229,236,254,255]. Fully 
assigned 2D-NMR data are available for artemisinin (495) [221], the seco-cadinane 493 [9] and 
deoxyartemisinin (499) [165]. 
The formyl ester in nor-amorphane 502 is thought to have been derived from the carbon at the 12-
position of an amorphane precursor by oxidative rearrangements. This group has been lost altogether, 
presumably as the result of ester hydrolysis, in the bis-nor-amorphane sesquiterpene, norannuic acid 
501 [66,199]. Similarly, the formyl group in 1-oxo-2-[3-butanone]-3-methyl-6-[2-propanol formyl 
ester]-cyclohexane (505) [218] is probably also derived from oxidative rearrangements, this time 
deriving from the 5-position of an appropriate bicyclic precursor (the related seco-cadinane natural 
product 504 has also been reported from the in vitro autoxidation of dihydroartemisinic acid in organic 
solution) [193]. It seems likely that the ethyl substituent in artemisinin G (496) might be derived from 
the 4- and 15-positions of a conventional amorphane precursor.  
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The novel carbon skeleton of compound 500 is thought to be derived from the amorphane skeleton 
by migration of C-8 from C-7 to C-6 (i.e., compound 500 is an 8(76) abeo amorphane), which 
results in a contraction of the B ring from six atoms to five. Similarly, the unusual carbon skeleton of 
503 might also have arisen from an amorphane precursor, in which the A ring has been contracted 
from six to five atoms, as a result of carbon-carbon bond migration of C-3 from C-4 to C-5 [9]. 
2.6.3.4. Guaianes 
Guaianes (Table 39) are bicyclic sesquiterpenes which contain fused 5- and 7-membered rings. 
Guaianes are often found together with eudesmanes (which contain two fused 6-membered rings – see 
Table 34) and may be derived by an alternative cyclization of the same germacrane precursor which 
gives rise to eudesmanes.  
Table 39. Guaiane Sesquiterpenoids (Decahydro-1,4-dimethyl-7-(1-methylethyl)azulene, 9CI). 
Name Alternative Name(s) CAS Number References 
-Guaiene (506) 1(5),11-Guaiadiene [3691-12-1]  [28, 36] 
β-Guaiene  (507) 1(5),7(11)-Guaiadiene [88-84-6]  [32] 
γ-Gurjunene (508) 5,11-Guaiadiene [22567-17-5]  [31, 34] 
Guaiazulene (509) 2,4-Dimethyl-7-(1-methylethyl)azulene [492-45-5]  [24] 
 
     
(506) (507) (508) (509) 
 
Aromadendrane sesquiterpenes (Table 40) are 6,11-cycloguaianes, in which an additional 
cyclopropyl ring has been formed by further cyclization of a guaiane precursor. The unusual 
metabolite, nortaylorione (15-nor-1,10-seco-1(5)-aromadendrene-4,10-dione [163128-16-3]) 
(519) [257], might be viewed as the product of oxidative rearrangements of such an aromadendrane 
precursor. The cubebane sesquiterpenoids (octahydro-3,7-dimethyl-4-(1-methylethyl)-1H-cyclo-
penta[1,3]-cyclopropa-[1,2]-benzene, 9CI): α-cubebene  (3-cubebene [17699-14-8]) (520) [51] and -
cubebene [4(15)-cubebene [13744-15-5], (521)] [19,38,51,66], are also representatives of guaianes 
which have undergone a further cyclization, with the cyclopropyl ring now being formed between 
positions 1- and 6-. α-Guaiane (506) is the most abundant guaiane sesquiterpene in A. annua [22], 
whilst spathulenol (515) is the most common aromadendrane [41] (both can reach levels up to 5% of 
the essential oil). 
 
 
 
 
1
2
3
4 5
6 7
8
9
10
11
12
13
14
15
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Table 40. Aromadendrane Sesquiterpenoids (Decahydro-1,1,4,7-tetramethyl-1H-
cycloprop[e]azulene. 9CI). 
Name Alternative Name(s) CAS Number References 
α-Aromadendrene (510) allo-Aromadendrene 
10(14)-Aromadendrene 
[25246-27-9] 
[14682-34-9] 
 [23, 40, 43] 
 
α-Gurjunene (511) 4-Aromadendrene [489-40-7]    [48] 
Globulol (512) (1α,4α,5β,6α,7α,10α)-10-Aromadendranol [489-41-8]  [19, 28, 34] 
epi-Globulol (513) 1H-Cycloprop[e]azulen-4-ol, decahydro-1,1,4,7-
tetramethyl-, (1aR,4S,4aR,7R,7aS,7bS)- 
[88728-58-9]   [34] 
Ledol  (514) 10-Aromadendrol (1β,4α,5β,6β,7β,10α) [577-27-5]  [28] 
(-)-Spathulenol  (515) 
 
10(14)-Aromadendren-4-ol [77171-55-2] 
[6750-60-3] 
 [19, 27, 31, 32, 
41, 43, 45] 
Cycloprop[7,8]azuleno[3a,4
-b]oxirene, decahydro-
1,4a,7,7-tetramethyl-, 
(1R,6aR,7aR,7bS)- (516) 
 [199983-75-0]  [34] 
 
Aromadendrene epoxide 
(517) 
Isoaromadendrene epoxide 
10(14)-Aromadendrene 10β,14-epoxide 
[85710-39-0] 
[499134-59-7] 
 [23, 34] 
Cyclocolorenone (518) 4-Aromadendren-3-one [489-45-2]  [45] 
 
 
  
(510) (511) (512) 1α‐H; 6α; 7α; 10α‐OH 
(513) 1α‐H; 6α; 7α; 10β‐OH 
(514) 1β‐H; 6β; 7β; 10α‐OH 
 
(515) (516) (517) 
  
(518) (519) (520) 
  
 (521)  
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2.6.4. Tricyclic Sesquiterpenes 
Several tricyclic sesquiterpenes are known from A. annua, although none have been reported in 
very significant quantities. These include  α-longipinene (522) (3-longipinene [5989-08-2]) [22,66], β-
longipinene (523) ([41432-70-6]) [27] and trans-longipinocarveol (524) ([889109-69-7]) [23], which 
are representatives of the longipinane (2,6,6,9-tetramethyltricyclo[5.4.4.0 2,8]undecane, 9CI) skeleton. 
Longifolene  (junipene  [475-20-7]) (525) [28] is a longifolane sesquiterpenoid (decahydro-4,8,8,9-
tetramethyl-1,4-methanoazulene, 9CI). 
 
   
(522) (523) R=H 
(524) R=OH 
(525) 
 
The acorane (1,8-dimethyl-4-(1-methylethyl)spiro[4.5]decane, 9CI) and chamigrane (11,5,9-
tetramethylspiro[5,5]undecane, 9CI) sesquiterpenoids: β-acorenol  (3-acoren-11-ol [28400-11-5]) 
(526)  [19] and β-chamigrene  (2,7(14)-chamigradiene [18431-82-8]) (527) [19] are also included here. 
    
                       (526)                                                      (527) 
The largest group of tricyclic sesquiterpenes to be described rom A. annua is the cedranes (Table 
41). A cDNA clone encoding epi-cedrol synthase has been shown to catalyze the formation of the 
oxygenated sesquiterpene epi-cedrol  from FPP (378) [258,259]. Trace amounts of the sesquiterpene 
hydrocarbons α-cedrene, β-cedrene, (E)-β-farnesene, α-acoradiene and (E)-β-bisabolene were also 
produced by the operation of this enzyme [258]. The structure of 3,15-dihydroxycedrane (534) from 
A. annua has been rigorously determined both by 2D-NMR and by synthesis from ()--cedrene [9]. 
Table 41. Cedrane Sesquiterpenoids (Octahydro-3,6,8,8-tetramethyl-1H-3α-7-methanoazulene). 
Name Alternative Name(s) CAS Number References 
Cedrol (528)  3-Cedranol  
Cedran-8-ol 
6-Isocedrol 
epi-Cedrol 
[77-53-2] [19903-73-2]  [19, 27, 32, 43, 45, 48] 
Cedryl acetate  (529) 3-Cedranol acetate [77-54-3]  [27] 
Cedra-8(15)-en-9α-ol (530) β-Cedren-9-ol   
Cedrenol 
[13567-41-4]  
[28231-03-0]  
 [27, 43] 
 
Cedra-8(15)-en-9α-ol acetate (531)  [65082-66-8]  [27, 32, 43] 
3-Cedren-12-ol (532)  [18319-35-2]  [27] 
Cedra-8-en-13-ol, acetate (533)  [18319-34-1]  [27] 
3,15-Dihydroxy cedrane (534)    [9] 
R
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(528) R=H 
(529) R=(C=O)CH3 
(530) R=H 
(531) R=(C=O)CH3 
(532) R=H 
(533) R=(C=O)CH3 
(534) 
 
Other tricyclic sesquiterpenes from A. annua belong to the silphinane (decahydro-1,4,4,5a-tetra-
methylcyclopenta[c]-pentalene); isocomane (dehydro-1,3α,4,5-tetramethylcyclopenta[c]pentalene); α-
santalane (2,3-dimethyl-2-(4-methyl-pentyl)tricycle[2.2.1.02,6]-heptane); copaane (1,3-dimethyl-8-(1-
methylethyl)tricyclo[4.4.4.42,7]decane, 9CI); bourbonane (decahydro-3a,6-dimethyl-1-(1-methylethyl)-
cyclobuta[1,3:3,4]-dicyclopentene, 9CI); and α-trans-bergamotol classes of sesquiterpenoid. These 
include: silphinene (1-silphinene [74284-57-4]) (535) [27], α-isocomene (isocomene [65372-78-3]) 
(536) [27], -isocomene (3(13)-isocomene [74311-15-2]) (537) [27], (Z)-α-santalol (α-santal-10-
en-12-ol [115-71-9])  (538) [19], -copaene (3-copaene [3856-25-5]) (539) [19, 22-24, 31, 43, 45, 48, 
50, 66], β-copaen-4α-ol (tricyclo[4.4.0.02,7]decan-4-ol, 1-methyl-3-methylene-8-(1-methylethyl)-, 
(1R,2R,4S,6S,7S,8S)- [124753-76-0]) (540) [43], α-ylangene ([14912-44-8]) (541) [25,30,40,113], β-
bourbonene  (4(15)-bourbonene [5208-59-3]) (542) [45], α-bergamentol [88034-74-6]) (543) [27, 32, 
43], trans-α-bergamotyl acetate ([87978-33-4]) (544)  [27, 43], trans-α-bergamotyl acetic anhydride 
([960148-87-2]) (545) [32], α-neoclovene ([4545-68-0]) (546) [41,50], (-)-neoclovene-(II) [56684-96-
9] (547) [46], neoisolongifolene [79982-57-3] (548) [48] and 4,4,8-trimethyltricyclo[6.3.1.0(1,5)]-
dodecane-2,9-diol ([372968-04-2]) (549) [20]. 
 
 
(535) (536) (537) 
  
(538) (539) (540) 
1
2
3
4
5
6
78
9
10
11
12
13
14
15
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(541)                               (542)                               (543) R=CH2OH 
(544) R=CH2O‐(C=O)CH3 
(545) R=(C=O)‐O‐(C=O)CH3 
 
 
(546) (547) (548) 
  
 (549)  
  
2.7. Higher Terpenoids 
 
2.7.1. Diterpenes 
The structure of the diterpene phytene-1-ol-2-hydroperoxide (553) [9,260] was wrongly assigned as 
phytene-1,2-diol (552), when it was first described as a natural product from A. annua [261]. Structural 
revision was made on the basis of studies of the photo-oxygenation of commercially-available phytol, 
which produced both phytene-1,2-diol (552) (in racemic form), as well as its 2-hydroperoxy analogue 
(553) [260]. Both phytol (550) itself and an authentic sample of phytene-1,2-diol (552) were 
subsequently obtained as natural products from the seeds of A. annua [9]. Natural phytol is expected to 
have the 7R,11R absolute configuration [16], and natural phytene-1,2-diol (552) was therefore assigned 
as being a mixture of epimers at the 2-position on the basis of its NMR spectra and on the assumption 
that the configuration at the 7- and 11-  positions of (552) remained fixed, as in phytol. The observance 
of epimers is most easily explained if both the hydroperoxide (553) and alcohol (552) are products of 
the spontaneous autoxidation of phytol (550), occurring within the tissues of A. annua plants as is 
shown in Scheme 8.  
Scheme 8. Proposed formation of phytene-1-ol-2-hydroperoxide (553) by spontaneous 
autoxidation of phytol (550) and subsequent homolysis/reduction of 553 to phytene-1,2-
diol (552). 
 
 
R
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Table 42. Phytane Diterpenoids (2,6,10,14-Tetramethylhexadecane). 
Name Alternative Name(s) CAS Number References 
Phytol  (550) 2-Phyten-1-ol (2E, 7R,11R) [150-86-7]  [27, 31, 43, 
45] 
Isophytol (551) 1-Phyten-3-ol   
3,7,11,15-Tetramethyl-1-hexadecen-3-ol 
[505-32-8]  [27] 
Phytene-1,2-diol  (552)  3(20)-Phytene-1,2-diol (7R,11R)   [9, 260, 261] 
Phytene-1-ol-2-hydroperoxide (553)    [9, 260, 261] 
(2E)-Hexadecene (554)  
 
 3,7,11,15-Tetramethylhexadec-2-ene [2437-936]  
[532426-78-1] 
 [20] 
Phytone (555)      
 
Hexahydrofarnesyl acetone 
6,10,14-Trimethyl-2-pentadecanone 
[502-69-2]   [23] 
 
 
(550) (551) 
(552) R=H 
(553) R=OH 
(554) 
(555) 
 
A handful of cyclic diterpenes are also known from A. annua, including 13-epi-manool (8(17),14-
labdadien-13-ol [1438-62-6]) (556) [43], 8(14),15-isopimaradiene ([1686-56-2]) (557) [32] and 
abscisic acid ([21293-29-8]) (558) [262].        
 
 
 
(556) (557) (558) 
2.7.2. Triterpenes and Sterols 
The most abundant  sterols from A. annua  are stigmasterol (570) and sitosterol (568)  [96], which 
are ubiquitous components of plant cell membranes. Squalene synthase (SQS) is the enzyme which 
catalyses the first committed step in the pathway leading from FPP (378) to triterpenes and 
phytosterols, such as these (Table 43). The SQS gene and cDNA have been successfully cloned and 
sequenced from A. annua on several occasions [263-265]. Much of the interest in SQS stems from its 
position at a key point in terpenoid biosynthesis, in which FPP (378) branches either to triterpenes or 
sesquiterpenes. Thus, it is possible that suppression of SQS expression [267] could be used to enhance 
OR
OH
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the biosynthesis of  artemisinin (495), which is a product of the alternative sesquiterpene pathway  
from FPP (378) [268]. 
A β-amyrin synthase, responsible for cyclization of squalene to the tritepene skeleton, has also been 
obtained from A. annua. It was possible to produce the triterpene β-amyrin (559) in significant 
amounts when this enzyme was engineered into Saccharomyces cerevisiae (two other enzymes in the 
pathway: 3-hydroxy-3-methylglutaryl-CoA reductase and lanosterol synthase were also manipulated in 
these experiments) [269]. 
Table 43. Triterpenoids and Sterols. 
Name Alternative Name(s) CAS Number References 
Oleananes    
-Amyrin (559) 12-Oleanen-3-ol [559-70-6]  [58, 63, 66] 
β-Amyrin 3-acetate (560) 12-Oleanen-3-ol acetate [1616-93-9]  [58, 66, 198] 
Oleanolic acid (561) 3β-Hydroxy-12-oleanen-28-oic acid [508-02-1]  [58, 66, 96] 
Friedalanes    
Friedelan-3--ol  (562) Epifriedelanol [5085-72-3]  
[16844-71-6] 
 [105] 
Friedelin (563)   [559-74-0]  [105] 
Ursanes    
-Amyrin (564) 
  
12-Ursen-3-ol   [638-95-9]  [58, 63, 66, 198] 
-Amyrenone (565)      
 
α-Amyrone 
12-Urs-en-3-one   
[638-96-0]  [58, 66] 
Taraxastanes    
Taraxasterone  (566) 20(30)-Taraxasten-3-one [6786-16-9]  [58, 66] 
Baurenol (567) 7-Bauren-3-ol [6466-49-0]  [58, 66] 
Sterols    
β-Sitosterol  (568) Stigmast-5-en-3-ol [83-46-5]  [15, 59, 61, 63, 69, 75, 
78, 96, 198] 
Daucosterol   (569) Stigmast-5-en-3-ol O-beta-D-
glucopyranoside 
[474-58-8]  [15] 
Stigmasterol  (570)  Stigmast-5,22-dien-3-ol 3β (22E,24S)  [83-48-7]  [56, 59, 61, 63, 65, 69, 
75, 78, 96, 105, 198] 
 
(559) R1=H; R2=Me 
(560) R1=(C=O)CH3; R2=Me 
(561) R1=H; R2=CO2H 
(562) 
 
(563) (564) 
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(565) (566) 
 
(567) (568) R=H 
(569) R=Glc 
 
(570) 
  
2.8. Nitrogen-Containing Natural Products 
Only a small number of peptides and other nitrogen-containing natural products are reported from 
A. annua. These include: aurantinamide acetate ([97558-66-2]) (571)] [75], 6-amino-7,8-dihydro-2-
hydroxypurine (7,8-dihydro-2-hydroxyadenine) (572) [270] and benzothiazole ([95-16-9]) (573)  [24].  
 
 
 
(572) (573) 
(571)   
 
3. The Biosynthesis of Artemisinin (Qinghaosu) 
 
Terpene biosynthesis [271-276] and its regulation [277,278] in A. annua have been well reviewed, 
including the central role of amorpha-4,11-diene (451) in the biosynthesis of artemisinin (495) [279] 
N
H N
N
H
N
NH2
OH
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and the likelihood that glandular trichomes are the location wherein artemisinin biosynthesis actually 
occurs [244,280] (indeed, it has recently been concluded that artemisinin biosynthesis occurs in the 
two outer apical cells of the glandular secretory trichomes [104] – the glandular trichomes of A. annua 
are comprised of 10 cells in total). The biosynthesis of artemisinin will be considered in three phases, 
as depicted in Scheme 9. 
It should be emphasised that this view of the biosynthetic route to artemisinin is still not universally 
accepted. Although  there is increasing experimental evidence in support of its general correctness, 
there are a significant number of experimental results (particularly in the “older” literature) which 
might appear to contradict Scheme 9. Thus, for many years, it was assumed that artemisinic acid 
(R=CH2 for 473 in place of R=CH3 for 480 in Scheme 9) [148,215,251,281-284], rather than 
dihydroartemisinic acid (480; R=CH3), was the late-stage precursor to artemisinin at the juncture 
between phases 2 and 3. 
Scheme 9. Three phases in the biosynthesis of artemisinin (495). 
 
 
A large number of other cadinane and amorphane sesquiterpenes, including: arteannuin B 
(462) [248,285]; epi-deoxyarteannuin B (478) [286]; dihydroarteannuin B (479) [249]; dihydro-epi-
deoxyarteannuin B (485) [286]; the seco-cadinane (494)  [217]; and artemisitene (497) [211,248,284] 
have also been suggested as late-stage intermediates at or around this point in the biosynthesis (in 
addition, α-epoxyartemisinic acid (487) has been stated not to be a biosynthetic intermediate to 
artemisinin [194]). The experimental evidence for each of these precursors is discussed individually in 
some detail in Section 3.3 (phase 3 of the biosynthesis of artemisinin). However, as the length of the 
foregoing list shows, there have been so many different proposals for phase 3 of the biosynthesis, that 
not all of them can be correct. In fact, none of 462, 478, 479, 485, 494 or 497 feature in the most likely 
biogenetic route to artemisinin (495) which is discussed first in Section 3.3, although many of these 
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compounds have been implicated as side-products, in reactions which diverge away from this main 
biosynthetic route to (495) (see Schemes 5, 6 and 7 in Section 2.6.3 for example). 
3.1. Phase 1 (Isopentenyl Pyrophosphte to Amorpha-4,11-diene) 
 
This first phase in the biosynthesis of artemisinin is the least controversial, and most of the enzymes 
involved in the conversion of isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl 
pyrophosphate (DMAPP) to amorpha-4,11-diene (451) have now been isolated and characterized from 
A. annua. It has been proposed that the IPP used in the biosynthesis of artemisinin comes from both 
the mevalonate and the mevalonate-independent pathways [287], and it has recently been demonstrated 
that the cental isoprenoid unit in the FPP (378) precursor to artemisinin is predominantly 
biosynthesized from the non-mevalonate pathway [102]. 14C-Labelling studies have confirmed the C5 
terpenoid precursor IPP as a starting point for the biosynthetic pathway to artemisinin [288] and 13C 
labeling studies have also been used to characterize the photosynthetic mechanism of A. annua as 
C3 [289]. 
The first step in phase 1 involves the conversion of  IPP and DMAPP (both C5) to the C15 
intermediate, farnesyl pyrophosphate (FPP; 378) by the enzyme farnesyl diphosphate synthase (FPPS). 
A cDNA encoding this enzyme, which catalyses the “head-to-tail” chain extension of a DMAPP starter 
by two molecules of IPP, has now been cloned from A. annua [290]. FPP sits at a branch point in 
terpenoid metabolism. Further elaboration to triterpenes and plant sterols (Table 43) requires the 
“head-to-head” coupling of two molecules of FPP, which is catalysed by the enzyme squalene synthase 
(SQS), as discussed in Section 2.7.2. Conversion of FPP (378) to sesquiterpenes, on the other hand, 
requires the operation of ionase and cyclase enzymes, such as: (E)--farnesene synthase (Section 
2.6.1); germacrene A synthase (Section 2.6.2); -caryophyllene synthase (Secton 2.6.2); and epi-cedrol 
synthase (Section 2.6.4). The comitted intermediate in the biosynthesis of artemisinin (495) is the 
bicyclic sesquiterpene-amorpha-4,11-diene (451) [291], which is formed from FPP (378) by the action 
of the sesquiterpene cyclase, amorpha-4,11-diene synthase (ADS) [138,292]. 
Scheme 10. Cyclization of FPP (378) to amorpha-4,11-diene (451), catalysed by the enzyme ADS. 
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cDNAs encoding ADS from A. annua have been isolated, sequenced, and expressed  [293,294]. The 
mechanism of this particular enzymatic cyclization of FPP has now been studied in detail using a 
recombinant amorpha-4,11-diene synthase from A. annua. It is proposed that FPP is first isomerized to 
nerolidyl diphosphate; ionization of nerolidyl pyrophosphate is followed by C-1,C-6-ring closure to 
generate a bisabolyl cation; next, this cation undergoes a 1,3-hydride shift  [295] permitting a second 
ring closure between the 1- and 10-positions to generate the amorphane skeleton; and, finally, 
deprotonation at either C-12 or C-13 affords amorpha-4,11-diene (451) [136], as is shown in Scheme 
10. This mechanism is supported by GC-MS analysis of several minor sesquiterpene products which 
are also produced by ADS. These include the known metabolites (E)-β-farnesene (382), α-bisabolol 
(385), amorph-4-en-7-ol (456) and amorpha-4-7,(11)-diene (492). Other minor products from ADS 
have not yet been reported as natural products from A. annua, including  the amorphane, amorph-4-en-
11-ol (574); the bisabolanes: -sesquiphellandrene (1,3(15),10-bisabolatriene [20307-83-9]) 
(575) [134], zingiberene (1,3,10-bisabolatriene[495-60-3]) (576) and zingiberenol (1,10-bisaboladien-
3-ol [58334-55-7] [495-60-3]) (577); and the humulane: γ-humulene  (1,3(15),6-humulatriene [26259-
79-0]) (578) (Figure 3) [296]. 
Figure 3. Minor products from the cyclization of FPP (378) by ADS, which have not yet 
been reported as natural products from A. annua. Amorph-4-en-11-ol (574) is probably 
formed by quenching of the C-11 amorphane cation by water; β-sesquiphellandrene (575) 
by elimination of H-15 from the C-1 bisabolyl cation; zingiberene (576) from elimination 
of H-4 from the C-1 biasabolyl cation; zingiberenol (577) by quenching of the allylic C-1 
bisabolyl cation by water; and γ-humulene (578) by an alternative cyclization of nerolidyl 
pyrophosphate. 
   
(574) (575) (576) 
  
(577) (578) 
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3.2. Phase 2 (Amorpha-4,11-diene to Dihydroartemisinic Acid) 
The second phase in the biosynthesis of artemisinin (495) involves modification to the 
isopropylidene group (C-11, C-12 and C-13) in amorpha-4,11-diene (451), yielding putative 
biosynthetic intermediates such as dihydroartemisinic acid (480) and artemisinic acid (473). Phase 2 of 
the biosynthesis has only recently been the subject of experimental investigation and is therefore less 
well understood than phase 1. In 2005, artemisinic alcohol (458), artemisinic aldehyde (460), 
dihydroartemisinic alcohol (482) and dihydroartemisinic aldehyde (483) were all isolated as natural 
products from A. annua [135]. Collectively, these metabolites suggested the presence of two 
interlinked pathways for the conversion of amorpha-4,11-diene (451) to either dihydroartemisinic acid 
(480) or artemisinic acid (473), as is shown in Scheme 11 [135]. 
Scheme 11. Various possible routes for the oxidation of the isopropylidene group in 
amorpha-4,11-diene (451), yielding artemisinic acid (473) and/or dihydroartemisinic acid 
(480) in phase 2  of the biosynthesis of artemisinin. 
  
 
Although it has been assumed that all transformations at the 11-, 12- and 13- positions of (451) in 
phase 2 would proceed either by oxidation reactions (horizontal) or by reduction reactions (vertical), it 
is also possible to postulate more “economical” routes, such as those involving isomerases, which the 
author has depicted by diagonal dashed arrows in Scheme 11. Thus, isomerization of the 11,13 bond to 
the 11,12 position in (458) would produce an enol, which would spontaneously tautomerize to the 
carbonyl group in (483), without any necessity for either reduction at C-11/13 or oxidation at C-12. A 
trichome-specific cDNA  for the cytochrome P450 enzyme, CYP71AV1, which catalyzes three 
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successive oxidations at the 12-position of amorpha-4,11-diene (451) in the “upper” oxidative pathway 
in Scheme 11, has now been isolated (see also Section 4.4). These three sequential oxidations of 
amorpha-4,11-diene (451) produce artemisinic acid (473) via artemisinic alcohol (458) and artemisinic 
aldehyde (460) [196] (note that the exocyclic 11,13-double bond remains intact in this route). 
Historically, it has often been assumed that artemisinic acid (473) is then the starting point for the 
third and final phase of the biosynthesis of artemisinin. However, the most recent evidence suggests 
that dihydroartemisinic acid (480), produced from the saturated “lower” branch in Scheme 11, is, in 
fact, the true precursor to artemisinin. Kim and Kim have reported that artemisinic acid is not 
converted to dihydroartemisinic acid in A. annua [297] and more recent biosynthetic studies, 
employing both labeled artemisinic acid [155] and dihydroartemisinic acid [185], have confirmed that 
there is no interconversion in either direction between dihydroartemisinic acid (473) and artemisinic 
acid (480), as is represented by the “crossed” double-headed arrow in Scheme 11. 
Therefore, if dihydroartemisinic acid (480) is the true precursor to artemisinin (495) in phase 3 of 
the biosynthesis, then reduction of the exocyclic double bond in amorpha-4,11-diene (451) must be 
occurring before artemisinic acid (473) in Scheme 11. Interestingly, there is now some evidence for 
such a route to dihydroartemisinic acid (480), which involves two oxidations at C-12 of amorpha-4,11-
diene (451), producing artemisinic aldehyde (460) via artemisinic alcohol (458); followed by reduction 
of the 11,13 double bond in (460) to dihydroartemisinic aldehyde (483); and, finally, oxidation of (483) 
at C-12 to yield dihydroartemisinic acid (480) [135]. A recombinant DBR2 enzyme has been purified 
to approximately 90% from E. coli and found to be capable of reducing the 11(13) double bond in 
artemisinic aldehyde (460) [but not in artemisinic alcohol (458), artemisinic acid (473), arteannuin B 
(462) or artemisitene (497)] [298]. This enzyme appears to be a member of the enoate reductase family 
of enzymes, with similarities to 12-oxophytodienoate reductases  [298], and its discovery is potentially 
very significant with regard to defining the biosynthetic route from (451) to (480) in Scheme 11. 
 
3.3. Phase 3 (Dihydroartemisinic acid to Artemisinin) 
 
3.3.1. Dihydroartemisinic Acid as a Late-Stage Precursor to Artemisinin 
In this review, it is assumed that the final steps in the biosynthetic pathway to artemisinin (495) 
proceed from dihydroartemisinic acid (480), rather than artemisinic acid (473) (or, indeed, any of the 
other late stage intermediates: 462, 478, 479, 485, 494 or 497 which have been proposed in the past). 
Discussions of phase 3 of the biosynthesis therefore commence with dihydroartemisinic acid (480) - 
although the other possibilities are also evaluated in some detail in parts b) - e) of this section. 
Artemisinin is a seco-cadinane (Table 38), and carbon-carbon cleavage at C-4/C-5 in (495) therefore 
accompanies formation of the 1,2,4-trioxane ring in this final phase of the biosynthesis. No enzymes 
have yet been described for any of these putative reactions in phase 3. Indeed, experiments with 
classical plant peroxidases, a class of enzyme with the potential for involvement in these kinds of 
reactions, have failed to increase the yield of artemisinin [299,300].   
It is also possible that the final transformations of dihydroartemisinic acid to artemisinin might 
proceed via non-enzymatic processes. In this regard, it is interesting to note that artemisinin 
biosynthesis has recently been correlated with increased levels of singlet oxygen -although this has 
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been explained in terms of the upregulation of genes involved in artemisinin biosynthesis, rather than 
the operation of non-enzymatic processes [256]. A non-enzymatic mechanism involving molecular 
oxygen is particularly attractive in view of the variety of spontaneous autoxidation reactions which 
have already been suggested for the biogenesis of many other highly oxygenated terpenes from A. 
annua. For example, the formation of regular acyclic monoterpenes 263-265, 267, 271 and 272 in 
Scheme 1 (Section 2.5.1); irregular acyclic monoterpenes 279 and 280 in Scheme 3 (Section 2.5.2); 
eudesmane sesquiterpenes 413 and 414 in Scheme 4 (Section 2.6.3); amorphane sesquiterpenes 457, 
465-467, 477, 478, 481, 484, 485 and 490 in Scheme 5; 479, 481, 485 and 493 in Scheme 6; 462, 478 
and 494 in Scheme 7 (Section 2.6.3); and diterpenes 552 and 553 in Scheme 8 (Section 2.7.1) have all 
been proposed to proceed by spontaneous autoxidation chemistry. 
The proposal that the final transformations to artemisinin (495) in phase 3 may be non-enzymatic 
also receives strong support both from in vivo studies [168,185] and from experiments which have 
been performed in vitro [167,193,218], under conditions that are relevant to the living plant. Together, 
in vivo and in vitro experiments have suggested a mechanism for the conversion of dihydroartemisinic 
acid (480) to artemisinin (495) via a spontaneous autoxidation process, involving four steps, as is 
shown in Scheme 12. 
Scheme 12. A four-step mechanism for the spontaneous autoxidation of dihydroartemisinic 
acid (480) to artemisinin (495) in A. annua. 
 
The four steps shown in Scheme 12 are: i) photo-sensitized reaction of the 4,5-double bond in 
dihydroartemisinic acid (480) with singlet molecular oxygen (via an “ene-type” mechanism); ii) Hock 
cleavage of the resulting tertiary allylic hydroperoxide 481; iii) oxygenation of the enol product from 
Hock cleavage; and iv) cyclization of the resulting vicinal hydroperoxyl-aldehyde to the 1,2,4-trioxane 
system of artemisinin (495). The tertiary allylic hydroperoxide 481, which is produced in step i), has 
already been shown to be a biosynthetic intermediate, linking dihydroartemisinic acid (480) and 
artemisinin (495), by in vivo experiments with labeled dihydroartemisinic acid (480) [185,189]. 
Compound 481 has also been described independently as a natural product from A. annua [167,170]; 
and quantitative studies, which monitored the decline of dihydroartemisinic acid (480) and the increase 
of artemisinin (495) during leaf development and senescence have confirmed that an intermediate, such 
as 481, is probably involved in this conversion [301] [it is interesting to note that the alternative 
secondary allylic hydroperoxide from the spontaneous autoxidation of dihydroartemisinic acid (480) in 
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step i] has also been proposed as the precursor to another amorphane sesquiterpene endoperoxide from 
A. annua, arteannuin H (465) [166], as is shown in Scheme 5 in Section 2.6.3).  
There is – as yet – no direct evidence from in vivo studies to suggest how further transformation of 
481 to the 1,2,4-trioxane ring in artemisinin might occur in A. annua. The evidence for steps ii)-iv) 
which are proposed in Scheme 12 comes solely from in vitro studies, conducted with the tertiary allylic 
hydroperoxide 481 [171,236,237,239,254], which can be obtained in good yield from photosensitized 
oxygenation of 480 [193,218]. These in vitro experiments have shown that 481 can indeed undergo 
sponataneous conversion to a transient enol as proposed in step ii) of Scheme 
11 [204,238,243,302,303], and it has even been possible to fully characterize this unstable intermediate 
by 2D-NMR at low temperature [193]. This known reaction of allylic hydroperoxides is referred to as 
a Hock cleavage (or a Criegee rearrangement) and it is in this step that carbon-carbon bond cleavage 
occurs between C-4 and C-5, thereby producing the seco-cadinane skeleton of artemisinin (495).  
The double bond in the enol which is produced by step ii) then reacts rapidly with a second 
molecule of oxygen in step iii). This reaction most probably proceeds via an “ene-type” mechanism 
similar to that for the conversion of 480 to 481, although apparently without the requirement for light 
(i.e. 3O2 rather than 1O2 is perhaps the active species) [193,236,304,305]. All carbons in the resultant α-
aldehydo hydroperoxide [238] are now at the correct oxidation level and this intermediate immediately 
“zips up” to the 1,2,4-trioxane ring of artemisinin (495) in step iv).  
It has been speculated that the proximity of the 12-carboxylic acid group to the 4,5-double bond in 
480 and the hydroperoxide functionality in 481 might be the reason why both transformations i) and ii) 
proceed with such apparent ease in vitro [218]. Finally, it is worth reiterating that both in vivo and in 
vitro studies have shown that the tertiary allylic hydroperoxide 481 can be transformed into a wide 
variety of other compounds, in addition to artemisinin (495). Many of these compounds have been 
obtained previously as natural products from A. annua (see Schemes 5 and 6 in Section 2.6.3). 
Inspection of Scheme 12 suggests that some of these metabolites, such as dihydroarteannuin B (479) 
and dihydro-epi-deoxyarteannuin B (485) may be formed by alternative reactions to the Hock cleavage 
of 481 in step ii), while others such as the seco-cadinane 493 may arise by alternative reactions of the 
enol from Hock cleavage in step iii). 
  
3.3.2. Artemisinic Acid (473) as a Late-Stage Precursor to Artemisinin 
[2-14C]-Mevalonic acid lactone has been shown to be incorporated into artemisinic acid (473) in A. 
annua using plantlet hydroponic and stem tip feeding methods [306]. Several experiments in the older 
literature (1990’s and earlier) have suggested that artemisinic acid (473) can then be converted in to 
both arteannuin B (462) and artemisinin (495) [215,281,285]. All these experiments employed 
radiolabelled forms of artemisinic acid that were presented to cell-free systems, which had been 
derived by extensive manipulations of A. annua plants. However, the most recent biosynthetic 
study [155], which employed stable isotope-labeled artemisinic acid [15-[2H313C]-(473)] administered 
to a whole plant system, seemed to show that artemisinic acid was not a biosynthetic precursor to 
artemisinin.  The experimental conditions for this study were purposely chosen to allow comparison 
with a previous investigation, which had demonstrated that dihydroartemisinic acid [15-[2H313C]-
(480)] was a precursor to artemisinin (495)) [185] (see discussion in a) above). In addition, it should be 
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noted that a separate study with a cell-free system has also confirmed that dihydroartemisinic acid 
(480) is a precursor to artemisinin in A. annua, while artemisinic acid (473) is not [307].   
One explanation for these apparently contradictory results with artemisinic acid (473) may lie in the 
differing experimental approaches which have been adopted. The threshold for detection by NMR of a 
metabolite which is labeled with a stable isotope is likely to be several orders of magnitude higher than 
the corresponding threshold for a radioisotpic label. Thus, it is possible that the “older” experiments 
(1990s and earlier), which detected radiolabel, might - in reality - be identifying only trace quantities 
of metabolites, which were not derived directly from the labeled precursor. It is possible that partial 
degradation of a radio-labeled precursor can lead to some radioactivity appearing in a “pool” of small 
molecules, such as acetyl-CoA (see Scheme 13). These small molecules would then serve as 
precursors for several biosynthetic pathways, including the terpenoid pathway, and could thereby be 
incorporated indirectly into many metabolites from such pathways. By contrast, the stable isotope-
labeled metabolites which have been detected by NMR [155] represented at least 1% (very often 
between 5-30%) of the label that had been supplied and therefore provide a picture only of the most 
significant and direct transformations which have been undergone by the precursor. In addition, it 
should also be pointed out that the possibilities for introducing artifacts when performing feeding 
studies with whole plants, which require no external manipulation, is likely to be significantly reduced 
as compared to cell-free extracts, which must endure many perturbations to the biological system 
(homogenization, addition of buffers etc..). 
Although the most recent experiments with artemisinic acid (473) failed to observe any detectable 
incorporation into artemisinin, a very significant conversion was observed into arteannuin B (462), as 
well as six other highly oxygenated sesquiterpene natural products, all of which retained the 11,13- 
double bond, as shown in Scheme 7 in Section 2.6.3 [155]  [furthermore, there was no evidence for 
conversion to any 11,13-dihydro metabolite, including artemisinin (495)]. Such transformations can 
most easily be accounted for by oxidation of the 4,5-double bond in 473 to a hydroperoxide, 
analogous to that postulated in Scheme 12 for dihydroartemisinic acid (481). There is indeed ample 
precedent for the formation of such hydroperoxides from 473 by photooxygenation reactions in 
vitro [243], which lead both to arteannuin B (462) [251] and 11,13-dehydro analogues of 
artemisinin [254,308]. 
In conclusion, although the absence for any detectable transformation of artemisinic acid into 
artemisinin in the most recent study [155] is at variance with the earlier literature (pre-
1990’s) [281,284,286] for the biosynthesis of artemisinin, it is consistent with much of the more recent 
literature (post-1990’s), in which there is now a gathering consensus that dihydroartemisinic acid 
(480), rather than artemisinic acid (473), is the true late-stage precursor to artemisinin (495).  
3.3.3. Arteannuin B (462) and Dihydroarteannuin B (479) as Late-Stage Precursors to Artemisinin 
As noted above, in the most recent study of the metabolism of artemisinic acid, arteannuin B (462) 
was obtained as the major metabolite of artemisinic acid (473), without any evidence for the 
accompanying formation of artemisinin (495) [155]. However, because both arteannuin B (462) and 
artemisinin (495) were often reported together from “older” biosynthetic studies with artemisinic acid 
(473), some authors have previously proposed that arteannuin B (462) might be an intermediate in the 
Molecules 2010, 15                            
 
 
7669
proposed conversion of artemisinic acid (473) [215,251] to artemisinin (495) [203,248,285]. It is 
indeed possible to convert arteannuin B into artemisinin by chemical transformations [239] and there 
have been  various suggestions as to mechanisms by which this transformation might also occur in 
vivo [209,217]. A microbial system which is capable of converting arteannuin B (462) to artemisinin 
(495) has recently been described [309] and an enzyme with the appropriate activity has also been 
purified [310,311]. On the other hand, a study which found that epoxyartemisinic acid (487) could be 
converted to arteannuin B (462) also stated that epoxyartemisinic acid (487) could not be transformed 
into artemisinin (495) and therefore – by implication – arteannuin B cannot be a precursor to 
artemisinin [284]. It has also been claimed that the 11,13-dihydro analogue of arteannuin B (462), 
dihydroarteannuin B (479), can be converted into artemisinin by cell free extracts of  A. 
annua [249,312]. 
3.3.4. epi-Deoxyarteannuin B (478) and Dihydro-epi-deoxyarteannuin B (485) as Late-Stage 
Precursors to Artemisinin 
epi-Deoxyarteannuin B (478) was obtained as a minor metabolite of artemisinic acid (473), without 
any evidence for the accompanying formation of artemisinin (495), in the most recent study of the 
metabolism of artemisinic acid [155]. However, experiments in the “older” literature (1990’s and 
before), using radiolabelled forms of both epi-deoxyarteannuin B (478) and its 11,13-dihydro 
analogue, dihydro-epi-deoxyarteannuin B (485), have suggested that both were intermediates [286] in 
the respective biotransformations of artemisinic acid (473) and dihydroartemisinic acid (480) to 
artemisinin (495) [284]. However, once again, more recent experiments using dihydro-epi-
deoxyarteannuin B (485) which had been labelled with a stable isotope [169] and fed to an intact plant 
system have shown no detectable incorporation into artemisinin (495); although three novel 
hydroxylated metabolites were obtained in significant quantities from this feeding experiment [190]. 
 
3.3.5. The seco-Cadinane (494) and Artemisitene (497) as Late-Stage Precursosr to Artemisinin 
The seco-cadinane aldehyde (494) has been hypothesized to be a precursor to artemisinin (495) via 
its enol tautomer, which undergoes reaction with molecular oxygen * to produce artemisitene (497), 
the 11,13-dehydro analogue of artemisinin (this reaction was proposed to occur in a similar manner to 
the transformations which have now been established experimentally for the enol in steps iii) and iv) in 
Scheme 12 [217,313]). Artemisitiene (497) can then reportedly be converted into artemisinin (495) in 
vivo [240] [the enol of 494 was proposed to be derived from Grob fragmentation of the vicinal diol 
486, which is in turn derived from arteannuin B (462)]. 
4. Strategies for the Production of Artemisinin from A. annua and Derived Systems 
 
Although artemisinin can be produced by chemical synthesis  [171,228-239], the structural 
complexity of this target and the large number of steps involved in all published synthetic routes 
render this approach far too expensive for many in the Third World who are most affected by malaria. 
Various alternative possibilities for the production of artemisinin from A. annua and derived systems 
have therefore been extensively investigated, and this topic has been amply reviewed [313-320]. Four 
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strategies are considered in this review, all of which might benefit from a knowledge of the full 
biosynthetic pathway to artemisinin. These are: 1. Plant breeding programmes; 2. Plant tissue culture; 
3. Endophytic fungi; and 4. Genetic engineering. The most successful strategy to date has been plant 
breeding, resulting in the cultivar “Artemis”, which was registered in Switzerland in 1999, and 
contains up to 1.4% artemisinin (by comparison, the extremely variable yields obtained from wild 
varieties of A. annua typically range between 0.01-0.5% artemisinin [321]). There is a  potential for 
even higher yields in the future from on-going plant breeding programmes, such as that of the CNAP 
Artemisia project at the University of York (UK) [195].  
Recent attempts to produce artemisinin through fermentation, by genetically engineering several 
enzymes from A. annua in to a microbial host, would seem to have the greatest promise for the cheap 
and reliable production of artemisinin. This approach, pioneered by the synthetic biologist Jay 
Keasling at UC Berkeley (USA), has so far yielded microbially-produced artemisinic acid (473), which 
is then transformed to artemisinin (495) in a separate chemical process [see Section 3.3b for a 
discussion of the confusion surrounding the true biosynthetic status of artemisinic acid (473)]. Amyris 
Biotechnologies and Sanofi-aventis are currently developing a commercial-scale manufacturing 
process, which is based on this semi-synthetic approach to artemisinin. 
The discussions in Sections 4.1-4.4 emphasize how a full understanding of both the phytochemistry 
of A. annua and the biosynthesis of artemisinin can be helpful for improving the production of this 
important antimalarial drug by each of these four strategies. 
 
4.1. Plant Breeding Programmes 
Plant selection and breeding programmes have often sought to combine the properties of 
artemisinin-rich clones of A. annua (such as the Chinese and Vietnamese varieties), with more 
vigorous but lower-yielding clones (such as some of the European varieties) in order to achieve a 
robust hybrid with a high yield of artemisinin (typically 1% or more – corresponding to an agricultural 
yield of approximately 200 Kg/ha for dry leaves)  [322-324]. There is increasing evidence that 
artemisinin production in A. annua is localized in the biseriate glandular trichomes: specialized 
structures, found predominantly on the surface of leaves and flowers [244,325]. Several authors have 
reported that the artemisinin content is highest just before flowering [326-328] (interestingly, this trend 
is apparently not followed by other metabolites: the content of artemisia ketone (276) decreases before 
flowering and then increases afterwards; caryophyllene (405) shows the opposite trend; while levels of 
monoterpenes, such as cineole (326), bornyl acetate (335) and camphor (341) all remain relatively 
constant throughout growth [112]) and it has also been noted that the content of artemisinin can be up 
to ten-fold higher in flowers, as compared with leaves [19,329,330]. These observations may simply 
reflect an increased density of glandular trichomes in the flowers [301], and hence a correspondingly 
higher yield of artemisinin. By contrast, artemisinic acid (473) seems to be obtained in maximum yield 
at the late vegetative stage (however, the concentration of artemisinic acid in A. annua (473) is 
strongly dependant on chemotype – it can be up to ten-fold higher than that of artemisinin in European 
and Chinese varieties, although this is reversed in Vietnamese strains). 
It has also been observed that increased illumination or sunlight results in a higher yield of 
artemisinin [331-333]. This would be consistent with the hypothesis that the final steps in the 
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biosynthesis of artemisinin proceed in the trichomes by spontaneous autoxidation reactions of 
dihydroartemisinic acid (480), requiring 1O2, which is produced in the presence of light and a 
photosensitizer (e.g., chlorophyll – see step i) in Scheme 12). Several researchers have endeavoured to 
quantify not just the amount of artemisinin (495)  [334], but also its presumed biosynthetic precursors, 
dihydroartemisinic acid (480) [335] and artemisinic acid (473) [335-337], when studying the 
developmental biology of A. annua. One particularly interesting study has concluded that correlated 
variations in all three natural products prove the existence of chemotypes of A. annua. Thus, plants 
with a high artemisinin (495) level were found also to have a high dihydroartemisinic acid (480) level, 
but a relatively low concentration of artemisinic acid (473); while chemotypes with low levels of 
artemisinin (495) and dihydroartemisinic acid (480) contained a correspondingly high concentration of 
artemisinic acid (473) [338]. These findings were explained [20] on the assumption that the enzymatic 
reduction of artemisinic acid (473) to dihydroartemisinic acid (480) might represent a "bottle neck" in 
the biosynthetic pathway to artemisinin (495). However, given that it seems now to be proven that 
artemisinic acid (473) is not a precursor to dihydroartemisinic acid (480) (see crossed arrow in Scheme 
11) [155,185], the existence of these two chemotypes might instead be explained on the assumption 
that artemisinic acid (473) is a “dead end” metabolite, leading “away” from artemisinin (495) in phase 
2 of the biosynthetic route, as is implied in Scheme 11. 
Finally, there have been several recent attempts to create transgenic A. annua plants with elevated 
levels of artemisinin [339-341] by transferring genes for various enzymes in the biosynthetic pathway 
to artemisinin (e.g. HMGR, FPPS, ADS and CYP71AV1 – see Scheme 13).  
4.2. Plant Tissue Culture 
The production of artemisinin from plant tissue cultures of A. annua has been reviewed [342]. 
Although artemisinin can be obtained in reasonable quantities from differentiated shoot cultures  
[343-345], it is produced in only small or undetectable amounts [346-348] by callus or suspension cell 
cultures of A. annua. Instead, the chemistry of undifferentiated callus and suspension cultures of A. 
annua seems to be dominated by sterols, such as stigmasterol (570) and sitosterol (568) (Section 2.7.2) 
[86,313]; as well as phenylpropanoids, such as scopoletin (184) (Section 2.3; Table 17), all of which 
are also found in significant quantities in the parent plants [86,313]. Other phenylpropanoids, such as 
4-methoxycinnamaldehyde (579), coniferaldehyde (580), (2-glyceryl)-O-coniferaldehyde (581) [87], 
(2-propenal)-O-coniferaldehyde (582) [87] and balanophonin (583) [87] are not yet known from A. 
annua  plants themselves (Figure 4). The triglyceride, glycerol 1,2-di-9-octadecenoate 3-octadecanoate 
(584), with some structural similarities to 9-octadecenoic acid, 2,3-dihydroxypropyl  ester (82) (Table 
5), has also been obtained from plant tissue culture [86]. These major alterations observed in the 
metabolism of undifferentiated callus and suspension cultures may reflect the absence of glandular 
trichomes, in which  much of the biosynthesis of the mono- and sesquiterpenoids which are described 
in Sections 2.5 and 2.6 is thought to occur.  
Much of the current research activity into the production of artemisinin by plant tissue culture 
revolves around hairy root cultures of A. annua [349] which have been transformed by Agrobacterium 
tumefaciens [350,351] (elicitors from endophytic fungi – see the next section – have also been employed in A. 
annua plant tissue cultures [202,352,353]). Correlations have been observed between peroxidase activity and 
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artemisinin levels in hairy roots [354], although it has also been suggested that a high peroxidase activity in 
cell cultures may be partly responsible for their very low artemisinin contents  observed [355]. 
Figure 4. Metabolites which have been isolated from tissue culture of A.annua, but which 
have not yet been reported from A. annua plants. 
 
 
(579) R1=OMe; R2=H 
(580) R1=OH; R2=OMe 
(581) R1 = (HOCH2)CH(CH2OH); R2=OMe 
(582) R1 = H2C=C(CHO); R2=OMe  (583) 
4.3. Endophytic fungi 
Endophytic fungi live symbiotically within the tissues of many plants. Interest in endophytic fungi 
as a novel source of plant-derived drugs was first sparked by the observation of the lateral transfer of 
genes which are involved in the biosynthesis of taxol (paclitaxel) from Taxus brevifolium L. [356] - the 
plant which produces this important anti-cancer compound - to an endophytic symbiont. Thus, if it 
were found that some of the genes for the biosynthetic pathway to artemisinin in A. annua had been 
“naturally” transferred to an endophyte which inhabited this species, then it might be possible to utilize 
that endophyte for the production of artemisnin in a fermentation process. Several endophytes have 
now been described from A. annua [357]. While chemical studies of such endophytic fungi have 
demonstrated a fascinating variety of natural product chemistry (see Table 44), only one strain is so far 
reported as a potential source of artemisinin [358]. 
Table 44. Natural Products from Endophytic Fungi Found in A. annua. 
Endophyte Compound Reference 
Myrothecium roridum (IFB-E009; IFB-E012) Myrothecine A (585) [359] 
 Myrothecine B (586) [359] 
 Myrothecine C (587) [359] 
Hypoxylon truncatum (IFB-18) Daldinone C (588) [360] 
 Daldinone D (589) [360] 
 Altechromone A (590) [360] 
 (4S)-5,8-Dihydroxy-4-methoxy-α-tetralone (591) [360] 
Leptosphaeria sp. (strain number IV403) Leptosphaeric acid (592) [361] 
 Leptosphaerone (593) [362] 
Colletotrichum sp. 3β-Hydroxy-ergosta-5-ene (594) [363] 
 Ergosterol (595) [363] 
 3β,5α,6β-Trihydroxyergosta-7,22-diene (596) [363] 
 3β,5α-Dihydroxy-6β-acetoxy-ergosta-7,22-diene (597) [363] 
 3β,5α-Dihydroxy-6β-phenylacetyloxy-ergosta-7,22-diene (598) [363] 
 3β-Hydroxy-5α,8α-epidioxy-ergosta-6,22-diene (599) [363] 
 3β-Hydroxy-5α,8α-epidioxy-ergosta-6,9(11),22-triene (600) [363] 
 3-Oxo-ergosta-4-ene (601) [363] 
 3-Oxo-ergosta-4,6,8(14),22-tetraene (602) [363] 
 Indole-3-acetic acid (603) [363] 
 6-Isoprenylindole-3-carboxylic acid (604) [363] 
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Table 44. Cont. 
 
 
(588) R1,R2 = C=O 
(589) R1=OMe, R2=H 
(585) R=OAc 
(586) R=(C=O)CH2OH 
(587) (590) 
   
(591) (592) (593) 
 
 
 
(603) R=H 
(604) R= CH2CH=C(CH3)2 
(594) 7,8‐saturated; 22,23‐saturated 
(595) 7,8; 22,23 
(596) R=H 
(597) R=(C=O)CH3 
(598) R=(C=O)CH2C6H5 
(599) 9,11‐saturated 
(600) 9,11 
(601) 6,7‐saturated; 8,14‐saturated; 22,23‐saturated 
(602) 6,7; 8,14; 22,23 
 
 
O
OOH
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4.4. Genetic Engineering 
Metabolic engineering has attracted increasing attention over recent years as an alternative means 
for the production of plant-derived drugs. Both artemisnin from A. annua and taxol from Taxus 
brevifolium are attractive targets for this emerging science of synthetic biology since both drugs are 
available in only limited quantities from the natural source and are also difficult to synthesize 
chemically [364]. Research into the production of artemisinin from such genetically modified 
microorganisms has been well reviewed [365-369]. 
The goal of synthetic biology is to reprogram a microorganism for the efficient production of a 
natural product by establishing new metabolic pathways, which lead to the formation of the desired 
metabolite, whilst simultaneously removing existing metabolic pathways which detract from the 
formation of such a product.  To date, investigators have concentrated on expressing the enzymes from 
phases 1 and 2 of the biosynthetic route to artemisinin in transgenic organisms (see Scheme 9 in 
Section 3). These have included: HMG-CoA reductase (HMGR) [370]; farnesyl diphosphate synthase 
(FPPS) [371-374]; amorpha-4,11-diene synthase (ADS) [375-377]; and the P450 enzyme which oxidises 
amorpha-4,11-diene to artemisinic acid (CYP71AV1) [378] (Scheme 13). Both Saccharomyces 
cerevisiae [379,380] and  Escherichia coli [381-383] have been used as hosts when attempting to 
establish a viable recombinant microbial pathway for the biosynthesis of artemisinin. 
The approach outlined in Scheme 13 has succeded in producing  high levels of amorpha-4,11-diene 
(451) from E. coli [384] and artemisinic acid (473) from S. cerevisiae in quantities which exceed those 
from A. annua itself (100 mg–1·g·L-1) [385,386]. The semi-synthesis of artemisinin (495) from 
microbially-produced artemisinic acid (473) then requires two further chemical steps: reduction of the 
exocyclic double bond; and photo-sensitized oxidation of the endocyclic double bond to produce the 
1,2,4-trioxane ring in (495) [156,237]. Fortunately, the genetically-engineered yeast transports 
artemisinic acid (473) outside of the cell, where it is retained on the cell wall, and can easily be 
released simply by altering the pH. It is then necessary to purify microbially-produced artemisinic acid 
(473) prior to these chemical transformations. 
Scheme 13. Genetic engineering of enzymes for the production of artemisinic acid (473) 
from A. annua in to a microbial host. 
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In order to achieve the heterologous production of artemisinin (495) by a large-scale fermentation 
process, it will be necessary to express every step in the biosynthetic pathway to artemisinin in a 
microbe. Keasling has observed that “the production of drugs via heterologous pathways in microbial 
hosts is frequently hindered by insufficient knowledge of the native metabolic pathway and its cognate 
enzymes; often the pathway is unresolved, and the enzymes lack detailed characterization” [387]. 
These comments are certainly pertinent to the biosynthesis of artemisinin in A. annua, as is evident 
from the foregoing discussions in Sections 3.2 and 3.3. The author would argue that the prerequisite 
for the reconstruction of the complete biosynthetic pathway to artemisinin (495) in a transgenic yeast 
or bacterium is the elucidation of the full details of phase 2 of the biosynthesis in A. annua, in which 
amorpha-4,11-diene (451) is converted to dihydroartemisinic acid (480); as well as a better 
understanding of phase 3, in which 480 is then converted to 495 (see Scheme 9). If this can be 
achieved, then it should - at the very least - be possible to produce dihydroartemisinic acid (480), 
rather than artemisinic acid (473), by the fermentation of simple sugars (in fact, the production of 
dihydroartemisinic acid (480) in yeast using the Dbr2 gene has now been described [298] – see also 
discussion at the end of Section 3.2 – and the use of substrate-promiscuous enzymes as an alternative 
means for the microbial production of (480) is also under investigation [387]).  
If the final stages in the conversion of dihydroartemisinic acid (480) to the 1,2,4-trioxane ring in 
artemisinin (495) (phase 3 in Section 3.3) do turn out to be enzymatically catalysed, then it may indeed 
be possible to genetically engineer all the enzymes for the complete biosynthetic pathway to 
artemisinin (495) into a microbial system. The current evidence, however, points to the final steps in 
the biosynthesis of artemisinin (495) being non-enzymatic – most probably proceeding by spontaneous 
autoxidation reactions, which occur in the hydrophobic environment of a glandular trichome. If this is 
the case, then the simplest approach might be to engineer a microorganism to produce  
dihydroartemisinic acid (480) which is exported out of the cell, where it can more easily be isolated 
and purified [in much the same way that genetically-engineered yeast accumulates artemisinic acid 
(473) on the cell surface]. Inevitably, a chemical oxidation step would still then be required in order to 
convert microbially-produced dihydroartemisinic acid (480) to artemisinin (495), but this would 
certainly represent a saving in time and cost by comparison with the two-step chemical transformation 
(both reduction and oxidation), which is required for microbially-produced artemisinic acid (473).  
An alternative more radical approach would be to attempt to mimic within the microbial 
fermentation medium the spontaneous autoxidation reactions of dihydroartemisinic acid (480) which 
are believed to occur in the glandular trichomes of A. annua plants. This would require the inclusion of 
some kind of hydrophobic phase in intimate association with the fermentation medium. Previously, 
dodecane has been incorporated into the culture medium, in order to provide a separate hydrophobic 
layer in which volatile amorpha-4,11-diene (451) produced by microbial fermentation can be trapped 
[382, 385]. It would be interesting to investigate whether alternative hydrophobic phases can be found 
which provide a lipophilic environment similar to that of the glandular trichome, in which spontaneous 
autoxidation is favoured. (Such a phase would also need to be able to efficiently “trap” 
dihydroartemisinic acid and to be non-toxic to the fermenting organism). It should be noted that our 
understanding of how the spontaneous autoxidation of natural products such as 480 occurs in the 
absence of a photosensitizer [388] (or, indeed, any other additional chemical reagents [218]), leading 
to highly oxidized products such as 495, is still incomplete. This is a relatively unexplored area which 
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requires fundamental research, but the ultimate prize would be the production of artemisinin, both 
cheaply and reliably, by a single fermentation process, which incorporates an “in-built” spontaneous 
autoxidation step. 
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